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Abstract
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) derived from large
mammals reproduce few characteristics displayed by rodent or human counterparts. This is
complicated by the inherent plasticity of mammalian ESC/iPSC cultures that resemble a
variety of developmental stages including the naïve and primed pluripotent states. Defining
the extrinsic signals that modulate the developmental identity of canine ESC/iPSC (i.e.
primed versus naïve) will improve knowledge integration with more sophisticated rodent and
primate research. In this thesis, I sought to determine if manipulation of the culture
environment can promote nuclear and metabolic reprogramming of canine cell lines towards
a more primitive state of pluripotency. Using growth factors and kinase inhibitors to
modulate pluripotency of canine ESCs (cESCs), I demonstrated that cESCs exhibit the
plasticity to adopt multiple developmental identities. I observed that lineage-specific
differentiation of cESCs is influenced by pluripotent state modulation, coincident with
changes to colony architecture, transcriptional and epigenetic markers of developmental
maturity. I found that primed- and naïve-like cESCs exhibit pluripotent-state specific
mitochondrial structure and function, including differential reliance on glucose oxidation
pathways for steady-state proliferation in vitro. Lastly, using comparative sequence analysis
and biochemical assays, I observed that evolutionary differences in genomic CpG density at
pluripotency-associated promoters correlate with functionally relevant cytosine modifications
to the induction and maintenance of pluripotency. I showed the utility of physiological
metabolites that regulate 5-methylcytosine oxidation in promoting cellular and transcriptional
features associated with early nuclear reprogramming of canine fibroblasts (e.g.
mesenchymal-to-epithelial transition). Taken together, my work establishes a binary cESC
model of primed- and naïve-pluripotent states, providing insight into shared and divergent
features of pluripotency progression and acquisition in placental mammals.

i

Keywords
Embryonic Stem Cell, Induced Pluripotent Stem Cell, Canine, Pluripotency, Naïve
Pluripotent State, Metabolism, Mitochondria, DNA Methylation, TET Dioxygenase

ii

Co-Authorship Statement
Chapter 2
Tobias, I.C., Brooks, C.R., Teichroeb, J.H., Villagómez, D.A, Hess, D.A., Séguin, C.A., and
Betts, D.H. (2016). Small-molecule induction of canine embryonic stem cells toward naive
pluripotency. Stem Cells and Development 25 (16), 1208-1222. Text and figures are
reproduced here with permission from Mary Ann Liebert, Inc. (Appendix B), and modified
for relevance to the thesis. IC Tobias designed all experiments with the assistance of Drs.
Cheryle A. Séguin, David A. Hess and Dean H. Betts. All data was generated by IC Tobias in
the laboratory of DH Betts. All figures were prepared by IC Tobias. The manuscript was
written by IC Tobias with the assistance of DH Betts.
Chapter 3
Tobias, I.C., Isaac, R.R., Dierolf, J.G., Khazaee, R., Cumming, RC, and Betts, D.H. (2018).
Metabolic plasticity during transition to naïve-like pluripotency in canine embryo-derived
stem cells. Stem Cell Research 30, 22-33. Text and figures are reproduced here with
permission from Elsevier publishers (Appendix B) and modified for relevance to the thesis.
IC Tobias designed all experiments with the assistance of RC Cumming and DH Betts. IC
Tobias generated all data and prepared all figures. The manuscript was written by IC Tobias
with the assistance of RC Cumming and DH Betts.
Chapter 4
Chapter four is entitled “L-ascorbic acid and retinoic acid promote 5-hydroxymethylcytosine
accumulation and epithelialization in early canine reprogramming”. Courtney R Brooks
performed emGFP control Sendai virus transduction. Courtney R Brooks performed flow
cytometry data collection of emGFP cells with assistance from IC Tobias. Custom
oligonucleotide design, culture of canine fibroblasts, RT-qPCR analysis of TET expression
was performed by IC Tobias with the assistance of Mian Mian C Kao. IC Tobias designed all
experiments with the assistance of DH Betts. IC Tobias generated all data and prepared all
figures. The manuscript was written by IC Tobias with the assistance of DH Betts.
iii

Acknowledgments
Thank you to all the past and current members of the Betts lab for your friendship, guidance
and insightful discussion. The laboratory and office were always lively and collegial spaces
to work. A special thank you to Courtney Brooks, who provided technical assistance and
instruction in cell culture and clonal line derivation, and to Hailey Hunter who provided
efficient and friendly laboratory management. I would like to extend thanks to Dr. Jonathan
Teichroeb, who offered mentorship and guidance when I first began research in the Betts lab.
I would also like to thank previous and current members of the Watson, Regnault and Hardy
labs for exemplifying the spirit of collaboration and creating a supportive environment.
Particularly, Dr. Lin Zhao and Dr. Christina Vanderpoor, who did a wonderful job
maintaining a safe and productive laboratory. I would also like to thank my colleagues in the
Departments of Physiology & Pharmacology and the Department of Biology for their
feedback and advice.
Thank you to Dr. Richard Gardner, Karen Nygard and Reza Khazaee of the Integrated
Microscopy division of the Biotron for their technical expertise and assistance with
transmission electron microscopy. I would also like to thank Dr. Robert Cumming for
lending his help, reagents and live-cell imaging equipment.
A special thanks to my thesis advisory committee members – Drs. Cheryle Séguin, John
DiGuglielmo, Timothy Regnault and Lina Dagnino – for offering their guidance and
scholarly critique throughout my graduate studies.
Thank you to my family for being so understanding about my commitment to graduate
studies. I would also like to thank Laura for being the most supportive partner I could ask for.
Lastly, thank you to my supervisor, Dr. Dean Betts. I am extremely grateful to have worked
with you and I have become a better scientist with your guidance. Thank you for all your
support.

iv

Table of Contents
Abstract ................................................................................................................................ i
Keywords ............................................................................................................................ ii
Co-Authorship Statement................................................................................................... iii
Acknowledgments.............................................................................................................. iv
Table of Contents ................................................................................................................ v
List of Tables ..................................................................................................................... xi
List of Figures ................................................................................................................... xii
List of Appendices ........................................................................................................... xvi
List of Abbreviations ...................................................................................................... xvii
Chapter 1 ............................................................................................................................. 1
1 Introduction .................................................................................................................... 1
1.1 Overview ................................................................................................................. 1
1.1.1

Stem Cells, Fate Decisions and Cellular Plasticity ..................................... 1

1.2 Mammalian Development and Embryo-derived Pluripotent Stem Cells ............... 3
1.2.1

Overview of Early Mammalian Development ............................................ 3

1.2.2

Mouse Pluripotent Stem Cells from Peri-implantation Embryos ............... 5

1.2.3

Naïve and Primed Pluripotent States .......................................................... 7

1.2.4

Generation of Transient Embryonic States in vitro .................................... 9

1.3 Characteristics of Mammalian Pluripotent Stem Cells ......................................... 10
1.3.1

Techniques to Study Self-Renewal and Differentiation ........................... 10

1.3.2

Gene Regulatory Networks in Pluripotency ............................................. 11

1.3.3

Transcriptional and Epigenetic Crosstalk at Developmentally-Regulated
Genes......................................................................................................... 12

1.3.4

Hyperdynamic and Poised Features of the Pluripotent Regulatory
Epigenome ................................................................................................ 14
v

1.3.5

Dynamic Heterogeneity and Epigenetic Barriers to Pluripotent State
Transitions................................................................................................. 15

1.4 Metabolism in Pluripotent Stem Cells .................................................................. 19
1.4.1

Overview of Cell Metabolism................................................................... 19

1.4.2

Metabolic Regulation of Self-Renewal and Differentiation ..................... 20

1.4.3

Metabolic Reprogramming in Pluripotent State Transitions .................... 21

1.5 Induced Pluripotent Stem Cells ............................................................................ 23
1.5.1

Overview of Induced Pluripotent Stem Cell Generation .......................... 23

1.5.2

Phase-Dependent Obstacles to Somatic Cell Reprogramming ................. 25

1.5.3

Modifiers of DNA Methylation to Facilitate Reprogramming ................. 26

1.6 Pluripotent Stem Cells from Domesticated Large Mammals ............................... 30
1.6.1

Livestock and Companion Animals in Regenerative Medicine ............... 30

1.6.2

Regulative Implications of Evolutionary Variation to Pluripotency ........ 32

1.6.3

Canine Embryogenesis and Embryonic Stem Cells.................................. 33

1.6.4

Canine Induced Pluripotent Stem Cells .................................................... 35

1.7 Rationale and Study Aims .................................................................................... 36
1.8 References ............................................................................................................. 38
Chapter 2 ........................................................................................................................... 72
2 Manipulation of developmental signaling pathways alters the pluripotency
characteristics of canine embryonic stem cells ............................................................ 72
2.1 Introduction ........................................................................................................... 73
2.2 Materials and Methods .......................................................................................... 74
2.2.1

Feeder layer and Embryonic Stem Cell Culture ....................................... 74

2.2.2

Metaphase Spread Preparation and Karyotyping ...................................... 75

2.2.3

Reverse Transcription and Quantitative PCR ........................................... 76

2.2.4

Indirect Immunofluorescence Microscopy ............................................... 77

2.2.5

Protein Extraction, SDS-PAGE and Western Blotting ............................. 79
vi

2.2.6

Embryoid Body Formation and Directed Differentiation of Outgrowths . 79

2.2.7

Neural Progenitor Cell Formation Assay.................................................. 80

2.2.8

Manipulation of TGFβ Signaling .............................................................. 80

2.2.9

Single-cell Cloning Efficiency Assay ....................................................... 81

2.2.10 Cell Counting and Population Doubling Time Calculation ...................... 81
2.2.11 5-methylcytosine Enzyme-linked Immunosorbent Assay (ELISA) ......... 81
2.2.12 Immunodeficient Mouse Xenograft Assay ............................................... 82
2.2.13 Statistical Analysis .................................................................................... 82
2.3 Results ................................................................................................................... 82
2.3.1

PD0325901, CHIR99021 and LIF (2iL) induce compact cESC colony
morphology ............................................................................................... 82

2.3.2

2iL cESCs are pluripotent and up-regulate transcript markers of an earlier
developmental identity .............................................................................. 83

2.3.3

STAT3 phosphorylation but not SMAD2/3 signaling are influenced by 2iL
culture ....................................................................................................... 87

2.3.4

L/F cESCs exhibit a greater lineage-specific bias for neurectoderm and
mesoderm differentiation .......................................................................... 92

2.3.5

DNA methylation and H3K27me3 modifications are depleted in 2iL
cESCs ........................................................................................................ 96

2.3.6

Enhanced colony-forming efficiency but not tumorigenicity of 2iL cESCs
................................................................................................................... 99

2.4 Discussion ........................................................................................................... 102
2.5 References ........................................................................................................... 106
Chapter 3 ......................................................................................................................... 112
3 Pluripotent state influences metabolic activity and mitochondrial structure in canine
embryonic stem cells .................................................................................................. 112
3.1 Introduction ......................................................................................................... 113
3.2 Materials and Methods ........................................................................................ 115
3.2.1

Feeder Layer and Embryonic Stem Cell Culture .................................... 115
vii

3.2.2

Oxygen Consumption Rate and Extracellular Acidification Rate .......... 115

3.2.3

Protein Extraction, SDS-PAGE and Western Blotting ........................... 116

3.2.4

Flow Cytometric Analysis of cESC-MEF Co-cultures ........................... 117

3.2.5

Chemifluorescence and Flow Cytometry................................................ 117

3.2.6

Chemifluorescence and Live Cell Imaging............................................. 118

3.2.7

Mitochondrial and Genomic DNA Isolation and Quantitative PCR ...... 119

3.2.8

Sample Preparation for Transmission Electron Microscopy .................. 119

3.2.9

Mitochondrial Morphometric Image Analysis........................................ 120

3.2.10 Metabolic Inhibitor Treatment and Cell Counting.................................. 121
3.2.11 Cellular ATP Detection Assay ................................................................ 121
3.2.12 Cell Death and Apoptosis Assay............................................................. 121
3.2.13 Statistical Analysis .................................................................................. 122
3.3 Results ................................................................................................................. 122
3.3.1

Enhanced glucose oxidation and respiratory capacity in 2iL cESC ....... 122

3.3.2

Altered mitochondrial ultrastructure but not mitochondrial biomass in 2iL
cESC ....................................................................................................... 125

3.3.3

Increased mitochondrial membrane potential and ATP level in 2iL cESC
................................................................................................................. 129

3.3.4

Differentiation regulation of pyruvate metabolizing enzymes is associated
with altered lipid accumulation ............................................................... 133

3.3.5

HXK2 level and glycolytic capacity are correlated among mammalian
ESC lines................................................................................................. 137

3.3.6

Bioenergetic pathway inhibition differentially affects L/F and 2iL cESCs
................................................................................................................. 141

3.4 Discussion ........................................................................................................... 141
3.5 References ........................................................................................................... 148
Chapter 4 ......................................................................................................................... 156
4 Bioactive metabolite supplementation promotes mesenchymal-to-epithelial transition
in early canine reprogramming .................................................................................. 156
viii

4.1 Introduction ......................................................................................................... 156
4.2 Materials and Methods ........................................................................................ 158
4.2.1

Genomic Sequence Retrieval and Processing ......................................... 158

4.2.2

Identification of CpG Islands and Calculation of CpG Sequence Metrics
................................................................................................................. 159

4.2.3

Sequence Alignment and Motif Discovery ............................................. 160

4.2.4

Primary Cell Culture ............................................................................... 160

4.2.5

Somatic Cell Reprogramming................................................................. 160

4.2.6

Reverse Transcription and Quantitative PCR ......................................... 161

4.2.7

Targeted Bisulfite PCR ........................................................................... 162

4.2.8

Clone Sequencing and Methylation Analysis ......................................... 163

4.2.9

DNA Enzyme-linked Immunosorbant Assay (ELISA) .......................... 164

4.2.10 RT2 Profiler PCR Array Analysis ........................................................... 164
4.2.11 Statistical Analysis .................................................................................. 165
4.3 Results ................................................................................................................. 165
4.3.1

A subset of reprogramming-associated orthologues is CpG-rich in the
canine genome assembly......................................................................... 165

4.3.2

OCT4 and NANOG promoters are methylated in canine fibroblasts and
partially reprogrammed cells .................................................................. 169

4.3.3

5-hmC level varies among species and cell type .................................... 172

4.3.4

Identification of L-ascorbic acid and retinoic acid concentrations that
increase TET activity .............................................................................. 172

4.3.5

Physiological oxygen changes the influence of metabolites on TET
activity..................................................................................................... 174

4.3.6

L-ascorbic acid and retinoic acid promote focal epithelialization during
early canine reprogramming ................................................................... 177

4.4 Discussion ........................................................................................................... 184
4.5 References ........................................................................................................... 188
Chapter 5 ......................................................................................................................... 197
ix

5 General Discussion and Conclusions ......................................................................... 197
5.1 Discussion and Significance of Research ........................................................... 197
5.1.1

Pluripotent state-specific signaling and metabolic pathways support cESC
maintenance ............................................................................................ 200

5.1.2

Intracellular signaling pathways may link bioenergetics to self-renewal
and tumorigenicity of cESCs .................................................................. 202

5.2 Future Studies: Purification and analysis of canine reprogramming intermediate
cells ..................................................................................................................... 205
5.3 Summary ............................................................................................................. 210
5.4 References ........................................................................................................... 210
Appendix A: Materials and Methods for cell surface marker validation........................ 216
Immunolabeling for Fluorescence Microscopy ......................................................... 216
Immunolabeling for Flow Cytometry ........................................................................ 216
Appendix B: Copyright Approval ................................................................................... 218
Appendix C: Animal Use Protocol Approval ................................................................. 220
Appendix D: Curriculum Vitae ....................................................................................... 221

x

List of Tables
Table 2-1. Custom oligonucleotide primer sequences ............................................................ 76
Table 2-2. Primary antibody information ............................................................................... 78
Table 3-1. Primary antibody information ............................................................................. 116
Table 3-2. Custom oligonucleotide primer sequences. ......................................................... 119
Table 4-1. Summary of conserved reprogramming-associated gene products. .................... 159
Table 4-2. Custom oligonucleotide primer sequences. ......................................................... 162
Table 4-3. NANOG and OCT4 primer sequences for bisulfite PCR. ................................... 163
Table 0-1. Primary antibody information for flow cytometry. ............................................. 216

xi

List of Figures
Figure 1-1. Conserved features of naïve and primed pluripotency in placental mammals. .... 18
Figure 1-2. Metabolic regulation of self-renewal and pluripotency. ...................................... 22
Figure 1-3. Cellular, transcriptional and epigenetic characteristics of each phase of cellular
reprogramming. ....................................................................................................................... 27
Figure 2-1. PD0325901, CHIR99021 and LIF (2iL) induce compact cESC colony
morphology. ............................................................................................................................ 84
Figure 2-2. 2iL cESCs are dependent on the 2i molecules for compact morphology. ........... 85
Figure 2-3. Establishment of 2iL cultures in the IO3 cESC line and preliminary
characterization by stage-specific embryonic antigen 4 (SSEA4) staining. ........................... 86
Figure 2-4. 2iL cESCs express SOX2 and OCT4 with nuclear localization. ......................... 88
Figure 2-5. 2iL cESCs accumulate NANOG and down-regulate OTX2 compared to L/F
cESCs. ..................................................................................................................................... 89
Figure 2-6. Canine ESCs expanded in 2iL retain tri-lineage differentiation capacity in vitro.
................................................................................................................................................. 90
Figure 2-7. 2iL cESCs up-regulate several known naïve pluripotency-associated transcripts
but not primed pluripotency-related markers. ......................................................................... 91
Figure 2-8. Enhanced STAT3 phosphorylation in 2iL-enriched cESCs................................. 93
Figure 2-9. Steady-state L/F cESCs exhibit cytosolic phospho-SMAD2 and tolerate acute
inhibition Activin-like kinase (ALK) activity......................................................................... 94
Figure 2-10. L/F cESCs exhibit a greater sensitivity for spontaneous neural differentiation
and BMP4-induced mesendoderm differentiation. ................................................................. 95
Figure 2-11. DNA methylation and H3K27me3 modifications are depleted in 2iL cESCs. .. 97
xii

Figure 2-12. Decreased nuclear condensations of H3K27me3 antibody stain are observed in
2iL cESCs. .............................................................................................................................. 98
Figure 2-13. Altered growth kinetics and colony-forming efficiency between L/F and 2iL
cESCs. ................................................................................................................................... 100
Figure 2-14. In vivo tumorigenicity and differentiation potential of typical human ESC line is
not recapitulated by either L/F or 2iL cESCs. ...................................................................... 101
Figure 3-1. Culture in 2iL enhances glucose oxidation and respiratory capacity of BE5
cESCs. ................................................................................................................................... 123
Figure 3-2. 2iL-induced respiration is reproducible in IO3 cESC line. ................................ 124
Figure 3-3. 2iL cESCs show lower MitoTracker Green FM accumulation independent of cell
size. ....................................................................................................................................... 126
Figure 3-4. 2iL cESCs exhibit a selective decrease in the inner mitochondrial membrane
protein MIC60. ...................................................................................................................... 127
Figure 3-5. L/F and 2iL cESCs harbor structurally distinct mitochondria but do not differ in
mitochondrial biomass. ......................................................................................................... 128
Figure 3-6. Remodeling of mitochondrial ultrastructure in 2iL cESC. ................................ 130
Figure 3-7. Dynamic redistribution but not static accumulation of mitochondrial polarizationsensitive dyes correlates with respiratory activity in cESCs. ............................................... 131
Figure 3-8. Selective decrease in mitochondrial but not cytosolic staining with FCCP
treatment. .............................................................................................................................. 132
Figure 3-9. Altered respiratory chain complex subunit abundances between L/F and 2iL
cESCs. ................................................................................................................................... 134
Figure 3-10. 2iL cESCs display elevated ATP content and AMPK signaling. .................... 135

xiii

Figure 3-11. Differential regulation of pyruvate metabolizing enzymes between L/F and 2iL
cESCs. ................................................................................................................................... 136
Figure 3-12. Altered lipogenic properties between L/F and 2iL cESCs. .............................. 138
Figure 3-13. Both L/F and 2iL cESC exhibit lower glycolytic capacities than human or
mouse ESC. ........................................................................................................................... 139
Figure 3-14. Both L/F and 2iL cESCs exhibit lower HXK2 abundance compared to human or
murine ESC. .......................................................................................................................... 140
Figure 3-15. Different chemical inhibitors of bioenergetics influence the acute expansion of
L/F or 2iL cESCs. ................................................................................................................. 142
Figure 3-16. Selective metabolic pathway inhibition affects ATP level of 2iL cESCs but not
L/F cESCs. ............................................................................................................................ 143
Figure 3-17. Titrated metabolic pathway inhibitors do not increase apoptotic or dead cESCs.
............................................................................................................................................... 144
Figure 4-1. Class assignments and CpG-rich sequence score among promoters of genes
associated with somatic cell reprogramming. ....................................................................... 167
Figure 4-2. A subset of promoters associated with reprogramming is exclusively CpG-rich in
the canine genome................................................................................................................. 168
Figure 4-3. Canine dermal fibroblasts exposed transiently to 5-azacytidine (5-AzaC) generate
partially reprogrammed cell lines. ........................................................................................ 170
Figure 4-4. Incomplete demethylation of the NANOG promoter in canine partially
reprogrammed cells. .............................................................................................................. 171
Figure 4-5. 5-hydroxymethylcytosine level varies with species and cell type. .................... 173
Figure 4-6. L-ascorbic acid and retinoic acid modulates 5-hmC level at concentrations
without detectable changes in TET paralog expression. ....................................................... 175

xiv

Figure 4-7. L-ascorbic acid suppresses hypoxia-mediated induction of cTET1 and cTET3.176
Figure 4-8. Optimization of multiplicity of infection (MOI) in canine fibroblast using Sendai
emGFP control vector. .......................................................................................................... 178
Figure 4-9. L-ascorbic acid and retinoic acid promote focal epithelialization and primary
colony formation in early canine reprogramming. ............................................................... 179
Figure 4-10. L-ascorbic acid and retinoic acid enhance a transcriptional response resembling
mesenchymal-to-epithelial transition. ................................................................................... 180
Figure 4-11. Validation of differentially abundant mesenchymal and epithelial transcripts
using custom oligonucleotide primers. ................................................................................. 182
Figure 4-12. Presumptive canine iPSCs are temporarily supported in media containing fetal
bovine serum and LIF supplementation. ............................................................................... 183
Figure 5-1. Conserved and divergent features of pluripotent state progression in canines. . 199
Figure 5-2. Different metabolic pathway activities support proliferation of canine ESCs
approximating primed and naïve pluripotency. .................................................................... 201
Figure 5-3. Strategy to investigate conserved and divergent reprogramming mechanisms in
the dog. .................................................................................................................................. 208
Figure 5-4. Validation of canine-reactive surface markers to discriminate mesenchymal or
epithelial canine cells. ........................................................................................................... 209

xv

List of Appendices
Appendix A: Materials and Methods for cell surface marker validation .............................. 216
Appendix B: Copyright Approval ......................................................................................... 218
Appendix C: Animal Use Protocol Approval ....................................................................... 220
Appendix D: Curriculum Vitae ............................................................................................. 221

xvi

List of Abbreviations
AA

L-ascorbic acid

ACC

Acetyl-coenzyme A carboxylase

ACVR

Activin receptor

A/F

Activin A and fibroblast growth factor

ALK

Activin receptor like kinase

AMPK

Adenosine monophosphate activated protein kinase

ANOVA

Analysis of variance

BMP

Bone morphogenetic protein

BRA

Brachyury

CDH

Cadherin

CDX

Caudal homeobox

cDNA

Complementary deoxyribonucleic acid

cESC

Canine embryonic stem cell

CGI

Cytosine-phosphate-guanine island

CoA

Coenzyme A

CpG

Cytosine-phosphate-guanine dinucleotide

CRM

Cis-regulatory module

DAPI

4′,6-diamidino-2-phenylindole

DNMT

DNA methyltransferase
xvii

EB

Embryoid body

ECAR

Extracellular acidification rate

ECM

Extracellular matrix

EMT

Epithelial-to-mesenchymal transition

EOMES

Eomesodermin

ESC

Embryonic stem cell

ESRR

Estrogen receptor related

ETC

Electron transport chain

FASN

Fatty acid synthase

FBS

Fetal bovine serum

FCCP

Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone

FGF

Fibroblast growth factor

FITC

Fluorescein isothiocyanate

FSC

Forward light scatter

GATA

GATA binding protein

gBGC

GC biased gene conversion

GBX

Gastrulation brain homeobox

gDNA

Genomic deoxyribonucleic acid

GLUT

Glucose transporter

GRN

Gene regulatory network

xviii

GSK

Glycogen synthase kinase

hESC

Human embryonic stem cell

HIF

Hypoxia inducible factor

HXK

Hexokinase

H3Ac

Histone H3 acetylated

H3K4me1/3

Histone H3 lysine 4 mono/trimethylated

H3K9me2/3

Histone H3 lysine 9 di/trimethylated

H3K27me3

Histone H3 lysine 27 trimethylated

ICM

Inner cell mass

IGF

Insulin like growth factor

iPSC

Induced pluripotent stem cells

JAK

Janus kinase

KLF

Krüppel-like factor

LDH

Lactate dehydrogenase

LIF

Leukemia inhibitory factor

MAPK

Mitogen activated protein kinase

MDCK

Madin Darby canine kidney cell line

MEF

Mouse embryonic fibroblast

MEK

Mitogen activated protein kinase kinase

mEpiLC

Mouse epiblast like cells

xix

mEpiSC

Mouse epiblast stem cells

mESC

Mouse embryonic stem cells

MET

Mesenchymal-to-epithelial transition

MIC

Mitochondrial contact site subunit

MOI

Multiplicity of infection

mRNA

Messenger ribonucleic acid

mtDNA

Mitochondrial deoxyribonucleic acid

mTOR

Mechanistic target of rapamycin

MYC

Myelocytomatosis viral oncogene homolog

NAD

Nicotinamide adenine dinucleotide

NANOG

NANOG homeobox

OCR

Oxygen consumption rate

OCT

Octamer binding transcription factor

OTX

Orthodenticle homeobox

OXPHOS

Oxidative phosphorylation

PBS

Phosphate buffered saline

PCR

Polymerase chain reaction

PDH

Pyruvate dehydrogenase

PE

Primitive endoderm

PGC

Primordial germ cell

xx

PKM

Pyruvate kinase muscle

PRDM

PR domain

PSC

Pluripotent stem cell

PTM

Post-translational modification

qPCR

Quantitative polymerase chain reaction

RA

All-trans retinoic acid

RIPA

Radioimmunoprecipitation assay

ROS

Reactive oxygen species

RPS

Ribosomal protein S

SAM

S-adenosylmethionine

SDH

Succinate dehydrogenase

SEM

Standard error of the mean

SeV

Sendai virus

S/L

Serum and leukemia inhibitory factor

SMAD

Mothers against decapentaplegic homolog

SOX

Sex determining region Y box

SSEA

Stage specific embryonic antigen

STAT

Signal transducer and activator of transcription

TBP

TATA binding protein

TBX

T-box

xxi

TCA

Tricarboxylic acid

TDG

Thymidine DNA glycosylase

TE

Trophectoderm

TEM

Transmission electron microscopy

TET

Ten eleven translocation

TF

Transcription factor

TGF

Transforming growth factor

TMRM

Tetramethylrhodamine, methyl ester

TOMM

Translocase of outer mitochondrial membrane

WNT

Wingless integrated

XIST

X-inactive specific transcript

ZIC

Zinc finger protein of the cerebellum

ZFP

Zinc finger protein

2DG

2-deoxy-D-glucose

2i

Two inhibitor (CHIR99021 and PD0325901)

5azaC

5-azacytidine

5-mC

5-methylcytosine

5-hmC

5-hydroxymethylcytosine

7AAD

7-aminoactinomycin D

xxii

1

Chapter 1

1

Introduction

1.1 Overview
1.1.1

Stem Cells, Fate Decisions and Cellular Plasticity

Ontogenesis broadly refers to the formation of an entire multicellular organism, which
includes a vast increase in cell number by means of replication and spatially patterned
differentiation into functionally mature cell types (Longo et al., 2015). A population of
undifferentiated cells, referred to as stem cells, exist at many developmental stages and
are defined by two fundamental cellular processes: self-renewal and differentiation
(Evans and Kaufman, 1981; Till and McCulloch, 1961). Self-renewal describes the
replication of undifferentiated cells without age-related deterioration or transformation,
thereby maintaining the stem cell reserve (Zeng and Rao, 2007). Whereas differentiation
describes the commitment to a more specialized cell type by the coordinated expression
of gene products critical for that lineage (Bruno et al., 2004). These observable traits
comprise the stem cell phenotype, however stem cells are further classified by the niche
they reside in and their latent capacity to derive one or more lineages (Barker et al., 2010;
De Los Angeles et al., 2015). The ex vivo culture of a variety of stem cells and
knowledge of external stimuli that regulate self-renewal and differentiation, hold exciting
promise in regenerative medicine and drug discovery (Hanna et al., 2007; Kondo et al.,
2013).
Cell fate decisions are partially determined by the range of commitment opportunities
available to a cell (i.e. potency) (Mitalipov and Wolf, 2009). Pluripotent stem cells
(PSCs) can differentiate into all cell types found in postnatal tissues (Nagy et al., 1993)
and are conventionally derived from the inner cell mass or epiblast of mammalian
preimplantation embryos (Martin, 1981; Thomson et al., 1998). Embryonic stem cells
(ESCs) are authenticated by prolonged self-renewal in vitro and differentiation into
progenitor cells from all three primary lineages (i.e. endoderm, mesoderm, ectoderm)
(Huang et al., 2011). Cell potency is subject to varying degrees of restriction or
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broadening (i.e. plasticity) in response to environmental and experimental perturbations
(Lakshmipathy and Verfaillie, 2005). This notion that cell fate is progressively and
irreversibly restricted was famously conceptualized as an epigenetic landscape by Conrad
Waddington (Waddington, 1957). It is now understood that epigenetic modification of
chromatin regulates the developmental competence of PSCs to respond to environmental
cues and enables the maintenance of acquired information in their derivatives (Mohn and
Schübeler, 2009). However, persistent disruption of signal transduction pathways or gene
regulatory networks can ectopically induce or prevent the formation of a lineage
(Ladewig et al., 2013).
The extent of cellular plasticity is exemplified by direct reprogramming of somatic cells
to an ESC-like phenotype, known as induced pluripotent stem cells (iPSCs) (Takahashi
and Yamanaka, 2006). These reprogramming technologies progressively reconfigure the
cytoskeleton, organelles, active signaling pathways and modifications to chromatin to
attain a self-perpetuating pluripotency gene regulatory network (Jaenisch and Young,
2008; Sakurai et al., 2014). Interestingly, cellular reprogramming to a pluripotent state is
associated with changes in cellular metabolism (Folmes et al., 2011; Panopoulos et al.,
2012). Functional studies interrogating metabolic pathway activity and metabolite
availability perceive metabolism as a determinant in cellular reprogramming and
differentiation (Moussaieff et al., 2015; Sone et al., 2017). In this metabolic-epigenomic
axis, metabolites regulate cell fate by functioning as rate-limiting reactants or cofactors
for post-translational modifying enzymes that target chromatin (Carey et al., 2014;
Sperber et al., 2015).
The variation among developmental gene expression and range of differentiation
potentials exhibited by different PSC lines and their embryonic correlates in vivo
(Beddington and Robertson, 1989; Gardner et al., 1985; Huang et al., 2012) are currently
observed and modeled as pluripotency comprising multiple discrete phases rather than a
unitary state (Ghimire et al., 2018; Yachie-Kinoshita et al., 2018). Developmental
progression through pluripotency may be conditionally paused or reversed by modulating
activities of protein kinases through cytokines, growth factors and selective inhibitors
(Morgani et al., 2017; Weinberger et al., 2016). Alterations to mitochondrial dynamics or
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the metabolites produced and/or consumed by mitochondria appear to regulate these
pluripotent state transitions (Bahat et al., 2018; Tischler et al., 2019). Present findings
support the notion that pluripotency progression is conserved in placental mammals
(Bernardo et al., 2018). However, identifying the species-specific requirements for
culture, molecular and functional attributes remains an ongoing challenge (Roberts et al.,
2016).

1.2 Mammalian Development and Embryo-derived
Pluripotent Stem Cells
1.2.1

Overview of Early Mammalian Development

Embryonic development begins with the fertilization of the oocyte and later continues as
fetal development during gestation. Progression through mammalian embryonic
development is best understood in murine embryogenesis, where lineage-tracing and
transplantation studies have resolved the spatiotemporal variations of embryonic cell
potency (Lokken and Ralston, 2016). Fertilization of the oocyte initiates a series of fixed
mitotic divisions (i.e. cleavage) followed by a gradual strengthening of basolateral cellcell interactions resulting in compaction of blastomeres (White et al., 2016). Successful
completion of cleavage is dependent on activation of zygotic transcriptional programs by
maternal factors that decondense chromatin and erase much of the epigenetic
modifications to the genome (Evsikov et al., 2006; Svoboda et al., 2015). The zygote and
blastomeres of two-to-eight cell murine embryos are generally considered totipotent with
the capacity to contribute to either embryonic or extra-embryonic lineages and develop
into viable offspring under appropriate conditions (Cockburn and Rossant, 2010).
Totipotency is lost in the sixteen-cell embryo, known as the morulae, as the apical-basal
polarity established by compaction initiates positional and mechanical cues essential to
the first lineage specification event (Leung et al., 2016; Suwińska et al., 2008; Tarkowski
et al., 2010).
The innermost cells of morulae embryos give rise apolar cluster of pluripotent cells called
the inner cell mass (ICM) enveloped by an epithelial layer known as trophectoderm (TE)
(Rossant, 1987). The TE contains only the multipotent cells that derive placental tissues
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for implantation, whereas the ICM will give rise to all embryonic tissues including some
extraembryonic membranes (Rossant, 1987). Cell restriction to either lineage is mediated
by signaling pathways and gene regulatory mechanisms that reinforce differential
expression of transcription factors (TFs) associated with TE identity (e.g. CDX2,
EOMES) versus ICM identity (e.g. POU5F1/OCT4, SOX2 and NANOG) (Strumpf et al.,
2005; Wicklow et al., 2014). Formation of a fluid-filled space (i.e. blastocoele) after
ICM-TE lineage segregation is an indication successful progression to the early
blastocyst stage (Madan et al., 2007).
ICM proliferation and enhanced integrin-mediated interactions with the extracellular
matrix (ECM) are associated with a second differentiation event that generates the early
epiblast and primitive endoderm (Copp, 1978; Sakai et al., 2003). The early epiblast
retains the pluripotent cell population, but transitions from spherical morphology to a
radially symmetric monolayer (Beddington and Robertson, 1999). Epiblast
morphogenesis creates a cylinder-like shape in rodents, as opposed to the disc-like
morphology adopted by the primate epiblast (Bedzhov and Zernicka-Goetz, 2014). It is
believed that probabilistic variation in fibroblast growth factor (FGF) ligand and receptor
expression among ICM cells randomly restricts either NANOG or GATA6 to the epiblast
or primitive endoderm (PE), respectively (Guo et al., 2010; Kang et al., 2017). Cells
differentiating into PE upregulate several TFs (e.g. GATA4, SOX17), migrate towards
the blastocoele-facing surface of the early epiblast and give rise to the extraembryonic
endoderm portions of the yolk sac (Chazaud and Yamanaka, 2016; Gardner and Rossant,
1979).
At gastrulation, a subpopulation of the epiblast undergoes epithelial-to-mesenchymal
transition (EMT), resulting in a loss of epithelial adhesive junctions and increased cell
motility (Shook and Keller, 2003; Thiery et al., 2009). Migration of epiblast cells
undergoing EMT through a dorsal structure known as the primitive streak establishes the
definitive mesoderm (Ciruna and Rossant, 2001; Sun and Stathopoulos, 2018). Whereas
the cells within the anterior third of the primitive streak form definitive endoderm (Ang et
al., 1993). Continued cellular migration elongates the whole embryo and rearranges the
late epiblast into an asymmetric structure known as the anterior to posterior epiblast
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(Brennan et al., 2001; Lawson et al., 1991). Late epiblast cells continue to proliferate and
expand, becoming spatially restricted, yet remaining pluripotent until the onset of
somitogenesis (DeVeale et al., 2013; Osorno et al., 2012). Epiblast-derived primordial
germ cells (PGCs) are induced during gastrulation and actively migrate to genital ridge
via the posterior endoderm (Ginsburg et al., 1990). PGCs represent a form of unipotent
stem cell in vivo which do not continue specification into gametes until gonad
development (Ginsburg et al., 1990). Migrating PGCs undergo programmed epigenetic
erasure and may be isolated and expanded in vitro with defined extracellular factors as
pluripotent embryonic germ cells (Resnick et al., 1992; Stewart et al., 1994). Marked
differences in the timing of transcriptional events, the wiring of regulatory circuits, and
epiblast morphogenesis are observed when embryonic development of the mouse is
compared to other mammals (Rossant and Tam, 2017). However, the functional
relevance of these evolutionarily divergent features to the establishment or resolution of
embryonic pluripotency remains less clear.

1.2.2

Mouse Pluripotent Stem Cells from Peri-implantation
Embryos

Although pluripotent cells exist only transiently in vivo, it is possible to research stem
cell lines that are paused in a stable pluripotent identity within a defined milieu.
Pluripotent stem cells (PSCs) maintain the ability to differentiate into the all somatic and
germline cell types of the ectoderm, mesoderm and endoderm (Doetschman et al., 1985;
Leahy et al., 1999). In contrast to pluripotent cells within early embryos, PSCs in culture
acquire the distinct ability to undergo prolonged self-renewal (Evans and Kaufman, 1981;
Thomson et al., 1998). The precise molecular alterations that conditionally adapt
embryonic cells to an ex vivo environment remain unclear (Buehr et al., 2003). Mouse
embryonic stem cells (mESCs) are routinely established from the epiblast outgrowths of
preimplantation embryos explanted on a mouse embryonic fibroblast (MEF) layer (Brook
and Gardner, 1997; Evans and Kaufman, 1981; Martin, 1981). When embryos retrieved
at an earlier developmental time point, embryos progress to the blastocyst stage under
derivation conditions before mESCs arise (Boroviak et al., 2014).
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Among the supportive factors secreted by MEFs or present in serum, leukemia inhibitory
factor (LIF) was identified as the component with anti-differentiation activity (Smith et
al., 1988). Exogenous LIF preparations have enabled the feeder-free propagation of
mESCs (Makino et al., 2004). Supplementation with LIF promotes mESC self-renewal
and expression of pluripotency-associated TFs through the LIF receptor-gp130 complex
and activation of Janus kinase (JAK)-signal transducer and activator of transcription 3
(STAT3) signaling (Matsuda et al., 1999; Niwa et al., 1998). LIF-STAT3 signaling can
synergize with the bone morphogenetic protein 4 (BMP4)-SMAD1 signaling to support
the maintenance of undifferentiated mESC (Ying et al., 2003a). The observation that
BMP4 bioactivity is partly mediated by repression of mitogen-activated protein kinase
(MAPK) pathways was followed by the identification of two kinase inhibitors (2i) that
negate pro-differentiation stimuli in mESCs and established a minimal input so-called
ground state of pluripotency (Qi et al., 2004; Ying et al., 2008).
Cell lines equivalent to mESC cannot be derived from the murine post-implantation
epiblast in serum and LIF (S/L) conditions. However, culture with Activin A and FGF2
(A/F) mimics the signaling within the peri-gastrulation niche and enables the
establishment of cell lines known as mouse epiblast stem cells (mEpiSC) (Brons et al.,
2007; Tesar et al., 2007). mEpiSC meet the self-renewal and tri-lineage differentiation
criteria of a PSC population (Brons et al., 2007; Tesar et al., 2007). In contrast to mESC,
mEpiSC cannot autonomously produce the ECM components needed to maintain their
undifferentiated state, and therefore are propagated on a layer of MEFs or synthetic ECM
(Hunt et al., 2012; Veluscek et al., 2016). Activin A supports mEpiSC pluripotency via
SMAD2/3 transactivation of NANOG expression, which operates in a negative feedback
loop to repress SMAD2/3. In this delicately balanced mechanism, Activin A signaling
opposes neuroectoderm differentiation by maintaining NANOG, while NANOG prevents
mesendoderm cell fate by limiting the transcriptional activity of SMAD2/3 (Vallier et al.,
2009). FGF2-MAPK kinase (MEK) signaling does not appear to directly promote
pluripotency-associated TFs, but rather dually suppresses regulators of neuroectoderm
fate and krüppel-like factor 2 (KLF2) (Greber et al., 2010).
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1.2.3

Naïve and Primed Pluripotent States

Given that pluripotent cells can be isolated from different compartments of developing
embryos with different requirements for self-renewal, it was proposed that mESC and
mEpiSC represent different temporal iterations of pluripotency in vitro (Tesar et al.,
2007). Importantly, the divergent features of mESC and mEpiSC were not explained by
the mouse strain of origin (Brons et al., 2007). The observation that mEpiSC exhibit
transcriptional signatures and signaling requirements similar to human ESC (hESC)
suggests that PSC subtypes are conserved in mammals (Rossant, 2008; Tesar et al.,
2007). A combination of evolutionary variation among pluripotency regulatory
mechanisms and developmental maturity of human blastocysts donated from fertility
clinics to derive conventional hESCs, likely contribute to their homology to mEpiSCs
(Hanna et al., 2010, 2009a). The generic terminology naïve or primed pluripotent state
were adopted to describe the pan-mammalian existence of two discrete phases of
pluripotency exemplified by mESC (S/L and 2i conditions) or mEpiSC and hESC,
respectively (Nichols and Smith, 2009).
Primed and naïve PSC exhibit similar ultrastructural features including a large nucleus,
scant cytoplasm, perinuclear mitochondria and intercellular junctional complexes (i.e.
desmosomes) (Baharvand and Matthaei, 2003; Sathananthan et al., 2002). A notable
exception is the mitochondria of mESC are oval in shape, whereas tubular mitochondria
are observed in mEpiSC and hESC (Zhou et al., 2012). Obvious differences exist in the
morphological appearance of multicellular colonies formed by naïve or primed PSC.
mESCs proliferate in multi-layer, hemispherical colonies of compacted cells which are
difficult to distinguish by light microscopy (Baharvand and Matthaei, 2003). In contrast,
mEpiSC/hESC form planar, disc-shaped colonies with compacted interior cells with a
“cobblestone” appearance, surrounded by distended columnar cells at the margins
(Sathananthan et al., 2002). The colony-forming ability (i.e. clonogenicity) of PSC is
influenced by the pluripotent state, which impacts culture protocols and the efficiency of
cell selection. mESC are routinely passaged by enzymatic dissociation into single cells.
However, primed PSC are intrinsically hypersensitive to apoptotic stimuli and
mechanical fragmentation often improves viability and self-renewal of mEpiSC or hESC
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(Hartung et al., 2010; Pernaute et al., 2014). Clonogenicity of hESC can be improved
with Rho-associated kinase (ROCK) inhibition or epithelial-type cadherin (CDH1)
overexpression, suggesting that cytoskeletal and cell adhesion dynamics regulate PSC
clonality (L. Li et al., 2010; Watanabe et al., 2007).
Mouse naïve or primed PSC contribute to chimeric embryos within a defined range of
development following orthotopic transplantation, suggesting that intrinsic properties to
either pluripotent state influences differentiation capabilities in vivo. Whereas mESCs
readily differentiate to somatic tissues and the germ line upon reintroduction into the
preimplantation blastocyst, mEpiSC do not contribute to the embryo proper at this
developmental time point (Bradley et al., 1984; Guo et al., 2009; Tesar et al., 2007).
Identification of the variables that influence cellular competence for embryonic
integration have greatly improved the efficiency and reproducibility of chimeric embryo
generation including matched developmental timing, reducing competition with host cells
or dampening cell responsiveness to pro-apoptotic stimuli (Masaki and Nakauchi, 2017;
Wu et al., 2016). The in vivo pluripotency of mEpiSC was demonstrated by functional
engraftment into the anterior-mid primitive streak of post-implantation host embryos
(Huang et al., 2012; Kojima et al., 2014; Tsakiridis et al., 2014). The use of chimeric
blastocyst functional assays to unambiguously dichotomize PSC as naïve or primed,
generally excludes primate PSC lines in many jurisdictions for technical, legal and ethical
reasons (Streiffer, 2007). However, the conceptual barriers to interspecies embryonic
chimerism are receding with improved cell fate-mapping, developmental stage-matching
and a softening international stance on procedures which include early termination
policies (Mascetti and Pedersen, 2016; Wu et al., 2016). The development of teratomas
upon PSC engraftment into somatic tissues of immune-deficient mice is a shared feature
among mESC, mEpiSC or hESC (Brons et al., 2007; Reubinoff et al., 2000; Tesar et al.,
2007). Therefore, teratoma formation assays are not useful in discriminating between
naïve or primed PSC.
Collections of molecular genome annotations and transcriptional output associated with
those regions have generated integrated global signatures of any given cell type
(Roadmap Epigenomics Consortium et al., 2015). Transcriptional profiling studies
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indicate that mESC transcriptomes resemble the ICM or preimplantation epiblast,
depending on the culture conditions (Boroviak et al., 2014; Martin Gonzalez et al., 2016;
Tang et al., 2010). Debate and imprecision with regards to the precise developmental
correlate of mESC likely stem from variables that influence the transcriptome such as the
inclusion of serum, application of 2i, use of MEF feeders or different substratum
(Kolodziejczyk et al., 2015; Marks et al., 2012). Conversely, mEpiSC exhibit
transcriptomic features of primitive streak cells found within gastrulating embryos rather
than the post-implantation epiblast from which they are derived (Kojima et al., 2014;
Tsakiridis et al., 2014). Therefore, mESC and mEpiSC exhibit both molecular and
functional equivalence to temporally distinct stages of embryonic development (Morgani
et al., 2017). Both pluripotent states represent generalizable phenotypes among PSC
derived from mice, humans and likely other mammals (Theunissen et al., 2016;
Weinberger et al., 2016). Recently, ectopic stabilization of naïve pluripotency in
developing mouse and human embryos was shown to disrupt amniotic cavity formation,
thereby demonstrating a conserved physiological relevance of pluripotent state
progression in tissue morphogenesis (Shahbazi et al., 2017).

1.2.4

Generation of Transient Embryonic States in vitro

Cells resembling mEpiSC can be generated from mESC in A/F conditions, but this
appears to be a prolonged and inefficient transition that features a strong negative
selection (Turco et al., 2012). This suggests that the naïve-to-primed pluripotent state
transition is not a single-step, but rather a dynamical process that is poorly recapitulated
in vitro (Kalkan and Smith, 2014). Access and characterization of this embryonic stage
has not been possible due to the methodological difficulty of isolating these transient
cells in mouse preimplantation development (Bedzhov et al., 2014). These mouse
epiblast-like cells (mEpiLC) can generate PGCs in response to BMP4, recapitulating the
developmental potential exhibited by a subpopulation of the native epiblast in vivo
(Hayashi et al., 2011; Lawson et al., 1999). If an intermediate PSC population were to be
purified, a theoretical “formative” pluripotent state is proposed to relinquish aspects of
naïve pluripotency before upregulating gastrulation-stage lineage markers observed in the
primed pluripotent state (Smith, 2017). Because mEpiLC are a heterogeneous mixture,
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moderate expression levels of both naïve and primed pluripotency markers are not
considered to be strong evidence of formative pluripotency.

1.3 Characteristics of Mammalian Pluripotent Stem Cells
1.3.1

Techniques to Study Self-Renewal and Differentiation

The clonogenicity, self-renewal, broad differentiation abilities of PSC lines make feasible
large-scale functional genomics and high-throughput screening approaches, compared to
embryo models where limitations cell numbers and embryo availability exist (Boiani and
Schöler, 2005; Desbordes and Studer, 2013). Despite the existence of cell culture-related
artifacts, both naïve and primed PSC are viewed as complementary in vitro systems to
animal models of preimplantation development to dissect the molecular basis of
pluripotency and lineage specification (Niwa, 2010). PSCs are typically studied under
self-renewing conditions in vitro (i.e. steady-state) and static comparisons may be made
to an independent culture of differentiated PSC progeny (Reubinoff et al., 2000). When
higher temporal resolution is desirable, reporter genes (e.g. fluorescent proteins) are
introduced under the genetic control of either pluripotency or differentiation affiliated
regulatory elements to dynamically track changes in gene expression (Gossler et al.,
1989).
In the absence of essential self-renewal factors (i.e. S/L or 2i for mESC, A/F for
mEpiSC/hESC), PSCs will spontaneously differentiate into an assortment of stem or
progenitor cell types from the ectoderm, mesoderm and endoderm lineages (Spencer et
al., 2011). Spontaneous differentiation of PSC in low adherence conditions yields
spherical aggregates of committed progeny (i.e. embryoid bodies), which crudely mimics
postimplantation development to achieve an even distribution of the primary embryonic
lineages compared to adherent culture (Doetschman et al., 1985; Martin and Evans,
1975). A basic understanding of the soluble or matrix-dependent signals for lineage
specification, permits the use of selective differentiation protocols, which can be
advantageous for PSC lines with skewed lineage bias (Murry and Keller, 2008). Stepwise
application of specific differentiation stimuli to differentiating PSC over multiple weeks
can guide the maturation of cell types formed later in gestation (Ying et al., 2003b).
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1.3.2

Gene Regulatory Networks in Pluripotency

Gene regulatory networks (GRNs) are critical for the integrity of pluripotent states and
for stable commitment to a given lineage upon differentiation. The architecture of GRNs
include few “master” TFs, many “collaborating” TFs, regulatory non-coding RNA and
chromatin modifying enzymes, which act in auto- and cross-regulatory circuits to exert
combinatorial control on cis-regulatory modules (CRMs) of target genes (Hackett et al.,
2014; Peter and Davidson, 2016). GRNs frequently act upstream of pluripotency and
lineage related genes such that cell fate decisions are executed only when pre-existing
cell state and differentiation stimulus is appropriate (Martín et al., 2016). The
transcription factors OCT4, SOX2 and NANOG (O-S-N) are central to naïve mouse
pluripotency GRNs both in vivo and in vitro (Mitsui et al., 2003; Nichols et al., 1998).
Strong imbalances in O-S-N expression leads to extraembryonic or germ lineage
differentiation, rather than reinforcing a stable pluripotent state (Niwa et al., 2000;
Thomson et al., 2011). However, minute fluctuations in the core GRN factors are
effectively buffered by dense regulatory interconnectivity and redundant CRM
occupancy with collaborating TFs (MacArthur et al., 2009). Under steady-state
conditions the pluripotency GRN collectively antagonizes lineage-specific GRNs, while
simultaneously remaining sensitive to differentiation cues (Jaenisch and Young, 2008). In
this model, variations in pluripotency GRN membership (i.e. TFs expressed) and
wiring/topology (i.e. available CRMs in genome) would account for the different
properties of spatiotemporal or evolutionary iterations of PSCs (Li and Belmonte, 2017).
Input from several developmentally regulated signaling pathways can be finely tuned to
either support or destabilize the pluripotency GRN. In many cases, small molecule
inhibition of protein kinases or knockdown of epigenetic modifiers are titrated to levels
of partial antagonism or depletion (Cheloufi et al., 2015; Mor et al., 2018). Dual
inhibition of glycogen synthase kinase 3β (GSK3β) and MEK in the 2i condition
synergistically reinforces the naïve pluripotency GRN in mice (Ying et al., 2008).
Stimulation of WNT signaling induces nuclear localization of β-catenin, which derepresses OCT4-SOX2 targeted genes (Cole et al., 2008; Qiu et al., 2015; Wray et al.,
2011). Partial blockade of FGF–ERK signaling elevates KLF2/4 and NANOG
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accumulation by transcriptional and post-translational mechanisms (Kim et al., 2014; Yeo
et al., 2014). Beyond the direct impact on NANOG and KLF2, several collaborating TFs
associated with naïve pluripotency are reinforced by 2i such as TBX3, ZFP42/REX1,
GBX2 or ESRRB (De Los Angeles et al., 2015). By these mechanisms, the 2i condition
is proposed to reduce spontaneous differentiation and increase mESC derivation
efficiency from refractory strains by optimally stabilizing the naïve pluripotency GRN
(Hanna et al., 2009a; Wray et al., 2011).
Whereas hESCs also exhibit an O-S-N centric GRN, mEpiSCs operate with Zic family
member 2 (ZIC2) and orthodenticle homeobox 2 (OTX2) in place of NANOG (Boyer et
al., 2005; Iwafuchi-Doi et al., 2012; Matsuda et al., 2017). NANOG is required for
acquisition of naïve pluripotency during ICM development in vivo but is dispensable for
transactivation of target pluripotency genes and overall mESC maintenance (Chambers et
al., 2007; Silva and Smith, 2008). Several collaborative TFs associated with naïve
pluripotency are direct targets of NANOG and downregulated in mEpiSCs (Festuccia et
al., 2012; Osorno and Chambers, 2011). Therefore, primed PSC appear to possess a less
densely interconnected GRN owing to fewer collaborating TFs that directly support the
undifferentiated state (Iwafuchi-Doi et al., 2012). Rather, hESC/mEpiSCs exhibit
sporadic expression of early lineage specification genes from each germ layer including
FGF5, SOX17 and brachyury (T/BRA) (Tsakiridis et al., 2014). The combination of
variably co-expressed lineage-specific genes and a less insulated GRN may explain the
considerable heterogeneity and propensity for spontaneous differentiation in the primed
pluripotent state (Ghimire et al., 2018; Hough et al., 2009).

1.3.3

Transcriptional and Epigenetic Crosstalk at
Developmentally-Regulated Genes

The basic unit of genomic DNA (gDNA) organization is the nucleosome, an octamer of
histone proteins each surrounded by roughly 147 bp of the gDNA string (Kaplan et al.,
2009). CRMs contained within nucleosomal gDNA are generally inaccessible to TFs and
RNA polymerase (Lee et al., 2004; Lorch et al., 1987). The active (i.e. euchromatin) and
inactive (i.e. heterochromatin) portions of the genome are physically segregated through
interactions with architectural chromatin proteins to presumably facilitate chromosomal
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interactions pertinent to cell identity (Novo and Rugg-Gunn, 2016). Euchromatin
domains are enriched for interactions with the transcriptional coactivators, whereas
heterochromatin is associated with laminin B that tethers transcriptionally inert regions to
the inner nuclear membrane (Handoko et al., 2011). TFs, RNA polymerase and
architectural proteins compete with histones for occupancy of CRMs in order liberate
segments of gDNA from the nucleosome (Gilchrist et al., 2010; Krebs et al., 2017).
Epigenetic modifications affecting local chromatin accessibility regulate the influence of
pluripotency or lineage GRNs by modulating the ability of TFs to physically engage with
target CRMs (John et al., 2011; Mao et al., 2011).
Targeted and reversible covalent modifications on gDNA or histones control the
accessibility of a given CRM by changing the steric properties of the chromatin interface
and alter the affinity of DNA or chromatin binding proteins (Keshet et al., 1986; Yin et
al., 2017). DNA methylation involves transfer of a methyl group to the 5-position of
cytosine base (5-mC), which occurs predominantly in the context of cytosine-phosphateguanine (CpG) dinucleotides (Gruenbaum et al., 1982). Whereas, histone proteins can
undergo a variety of post-translational modifications (PTM) at the histone tail domain
that protrudes from the nucleosome (Jenuwein and Allis, 2001). Specific histone tail
modifications may be either correlated or anti-correlated with overlapping DNA
methylation, implying extensive crosstalk between these enzyme families.
The variety of distinct PTM and/or DNA methylation patterns introduces different levels
of epigenetic resistance and non-uniform regulatory control over transcriptional activity
dependent on the genomic context (Cedar and Bergman, 2009). Constitutive
heterochromatin is marked by co-occurrence DNA methylation and histone H3 lysine 9
di/tri-methylation (H3K9me2/3), which is believed to encourage chromatin compaction
and a non-permissive transcriptionally state (Sarraf and Stancheva, 2004; Smallwood et
al., 2007). Large repressive domains of constitutive heterochromatin are characteristic of
repetitive sequences, mobile elements and subsets lineage-specific genes needed for
stable differentiated cell fates (Becker et al., 2016; Saksouk et al., 2015). Conversely,
facultative heterochromatin involves H3 lysine 27 trimethylation (H3K27me3) and the
absence of DNA methylation, that promotes transcriptional repression yet maintains
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accessibility to general transcriptional machinery (Dellino et al., 2004; Jermann et al.,
2014; Reddington et al., 2013). H3K27me3 offers a reversible mode of silencing for
CRMs of lineage-associated genes that are dynamically expressed during development
(Margueron and Reinberg, 2011; Trojer and Reinberg, 2007).
Several mechanisms exist to grant certain TFs access to gDNA within a fully constituted
nucleosome and initiate local epigenome remodeling. Certain TFs have affinity for partial
binding sites in nucleosomal gDNA or histone proteins themselves, granting these TFs
“pioneer activity” to engage previously inaccessible chromatin (Cirillo et al., 2002;
Sekiya et al., 2009). Pioneer TFs can provide a platform for sequence-independent
recruitment of histone modifying and/or chromatin remodeling enzymes, which can
destabilize, reposition or remove histones to generate nucleosome depleted regions
(Klemm et al., 2019). Transcriptionally active CRMs are associated with acetylation of
histone H3 and H4 proteins, which is proposed to accumulate in regions with frequent
nucleosome destabilization (Henikoff, 2008; Müller and Leutz, 2001).

1.3.4

Hyperdynamic and Poised Features of the Pluripotent
Regulatory Epigenome

The nuclei of PSC contain smaller, more diffuse H3K9me3 domains that is suggestive of
a lower prevalence of heterochromatin genome-wide, compared to lineage restricted cells
(Ahmed et al., 2010; Fussner et al., 2011; Park et al., 2004). PSCs also exhibit
hyperdynamic chromatin compared to committed progenitor cells, which is exemplified
by rapid turnover of architectural chromatin proteins (Meshorer et al., 2006). As a likely
consequence of a permissive chromatin state, PSCs are transcriptionally hyperactive and
feature greater histone acetylation levels (Efroni et al., 2008; Meshorer et al., 2006).
Chromatin plasticity in PSCs manifests as frequent non-specific chromosomal
interactions and less prominent insulator boundaries (i.e. topologically associating
domains) (De Wit et al., 2013; Pękowska et al., 2018). Differentiation of PSCs is
associated with greater chromosomal interaction specificity and enhanced
compartmentalization of the genome by chromatin architectural proteins (Melcer et al.,
2012; Pękowska et al., 2018).
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One mechanism employed by PSCs to transcriptionally repress the euchromatic portions
of the genome, while remaining poised for lineage specifying cues is the maintenance of
bivalent chromatin (Azuara et al., 2006; Bernstein et al., 2006; Mikkelsen et al., 2007).
Bivalent domains are characterized by the co-occurrence of H3K27me3 at H3K4me3marked promoters on different histone tail domains within the same nucleosome (Shema
et al., 2016). Resolution of bivalent domains to single activating or silencing marks could
be theoretically mediated by the selective recruitment of the appropriate lysine
demethylase enzyme (Pasini et al., 2008). However, bivalent domain partitioning is
representative of only a minority of developmentally-regulated promoters and epigenetic
remodeling during differentiation occurs principally at distal CRMs bearing the enhancerassociated H3 lysine 4 monomethylation (H3K4me1) mark (Hawkins et al., 2011). Distal
CRMs marked solely by H3K4me1 are considered poised enhancers, which are
discriminated from actively-used enhancers with H3K4me1 and acetylated histone H3
(H3Ac) (Creyghton et al., 2010). Core pluripotency GRN TFs preferentially interact with
poised enhancers, which is believed to maintain or bookmark a repertoire of distal CRMs
available to be activated when a lineage if specified (Creyghton et al., 2010; Hawkins et
al., 2011).

1.3.5

Dynamic Heterogeneity and Epigenetic Barriers to
Pluripotent State Transitions

The permissive chromatin landscape of PSCs allows dynamic fluctuations between
closely-related pluripotency GRNs and introduces variation among individual cells,
known as dynamic heterogeneity (Rompolas et al., 2013; Singer et al., 2014). Initially,
single-cell analyses demonstrated at least two molecularly and functionally distinct subpopulations exist interchangeably among S/L mESCs (Hayashi et al., 2008). Promoting
hyper-acetylation of nucleosomes can skew the sub-populations in dynamic equilibrium,
therefore highlighting the contribution of epigenetic plasticity to this phenomenon
(Hayashi et al., 2008). External input from the microenvironment, such as paracrine
signals or exogenously supplemented molecules, stabilize different cell identities without
differentiation so long that perturbations do not exceed the buffering capacity of
pluripotency GRNs (Davey and Zandstra, 2006; Yachie-Kinoshita et al., 2018). The
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notion that extrinsic signals dictate the predominant phenotype adopted among available
cell identities is loosely referred to as metastability (Hanna et al., 2009a). Cell intrinsic
sources of variation also contribute to dynamic heterogeneity of pluripotent cell
populations both in vitro and in vivo such as transcriptional noise and cell cycle stage
(Navarro et al., 2012; Singh et al., 2013).
Changes in cell fate that follow a developmental progression are relatively efficient by
making use of epigenomic plasticity and poised GRNs. In contrast, experimental
manipulations that force the rejuvenation of a mature nuclear environment (i.e. nuclear
reprogramming) must overcome epigenetic barriers established during development
leading to inefficiency (Morgani et al., 2017; Weinberger et al., 2016). Switching the
mESC media containing S/L to a composition with F/A will promote a naïve-to-primed
transition and generate mEpiSCs (Guo et al., 2009; Onishi et al., 2012). Overexpression
of NANOG in mESC resists naïve-to-primed transition despite prolonged exposure to
F/A conditions (Osorno and Chambers, 2011). The mESC-to-mEpiSC conversion is
dependent on FGF2-mediated induction of OTX2, which is co-expressed in low NANOG
expressing cells among the originating S/L mESC population (Acampora et al., 2012).
Naïve-to-primed transition involves the decommissioning of naïve-specific enhancers
through gains in DNA methylation (Buecker et al., 2014; Factor et al., 2014).
The reversion of mEpiSC to mESC is infrequent yet reproducibly observed when F/A
conditions are replaced with S/L media (Bao et al., 2009). Forced expression of NANOG,
KLF2/4, ESRRB or STAT3 can induce nuclear reprogramming of mEpiSC to reset
mESCs when F/A is replaced with S/L (Guo et al., 2009; Hall et al., 2009; Silva et al.,
2009; Yang et al., 2010). mEpiSC are also considered to be in dynamic equilibrium with
sub-states exhibiting low levels of naïve pluripotency TF expression (Han et al., 2010).
The mEpiSC subpopulation that is poised to transition towards naïve pluripotency can
spontaneously transition to the mESC phenotype with greater (~15-fold) efficiency (Han
et al., 2010). The addition of 2i to either growth factor or transgene mediated
reprogramming of mEpiSC to mESC promotes NANOG expression and reactivation of
naïve pluripotency-specific enhancers (Adachi et al., 2018). Reset mESC exhibit
transcriptomic, epigenomic and morphological similarity to steady state mESC as well as
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competency to repopulate the germline in chimeras (Bao et al., 2009; Lai and Bu, 2016;
Zhang et al., 2016b). These outcomes suggest that a subset of mEpiSCs are poised to
adopt a naïve pluripotency GRN and overcome the epigenetic barriers established during
lineage priming in a LIF/STAT3 signaling environment, which can be augmented by
reintroduction of naïve pluripotency TFs (Fig. 1-1).
Global comparisons of DNA methylation show that S/L mESC have a less methylated
genome compared to mEpiSC (Habibi et al., 2013; von Meyenn et al., 2016). Moreover,
2i mESC display even greater DNA hypomethylation, in part by repression of DNA
methyltransferase expression (DNMT) (Hackett et al., 2013; Leitch et al., 2013; Yagi et
al., 2017). Additionally, mEpiSCs show more frequent facultative heterochromatin
indicated by greater numbers of H3K27me3 domains, whereas gains in H3K9me3
heterochromatin are disputed as cell culture artifacts (Joshi et al., 2015; Marks et al.,
2012). Genetically female mEpiSCs exhibit inactivation of one X-chromosome, a form of
dosage compensation that occurs late in embryogenesis, that is mediated by the noncoding RNA Xist and H3K27me3 deposition (Augui et al., 2011; Plath et al., 2003).
Erasure of genome-wide DNA methylation and reactivation of the silent X-chromosome
are both reproducible features of steady state and reset mESC (Bao et al., 2009; Guo et
al., 2009). DNA methylation exhibits a strong correspondence with restricted
developmental potential and is associated with stronger interactions between histones and
nucleosomal DNA (Choy et al., 2010; Smith and Meissner, 2013). Accordingly, the
chromatin of primed PSC is comparatively less hyperdynamic than naïve mESCs but
remain more plastic than differentiated cells (Pękowska et al., 2018). In addition to
nuclear determinants of pluripotency, nutrient-sensing and mitochondrial crosstalk
pathways are emerging as coordinators self-renewal and cell fate decisions in embryos
and PSCs.
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1.4 Metabolism in Pluripotent Stem Cells
1.4.1

Overview of Cell Metabolism

Metabolism broadly describes the collection of enzyme-catalyzed reactions organized
parallel and sequential pathways that provide molecular energy, substrates or cofactors
necessary for cell viability, division and function. Eukaryotic cells produce chemical
energy in the form of adenosine triphosphate (ATP) molecules through the breakdown of
carbohydrates, amino acids and lipids (i.e. catabolism). The major ATP-producing
pathways are segregated into oxygen-independent cytosolic reactions (glycolysis) and
oxygen-dependent mitochondrial processes, known as oxidative phosphorylation
(OXPHOS). However, most molecules are never completely consumed by bioenergetic
pathways, and instead diverted at a variety of branch points to alternative metabolic
pathways (i.e. shunts) that produce essential substrates for biosynthetic reactions (i.e.
anabolism) (Folmes et al., 2011). Otherwise, metabolic intermediates with cofactor or cosubstrate functions can be made available to non-metabolic reactions through redirection
to a different subcellular compartment such as the nucleus (DeBerardinis et al., 2008).
The relative activity of glycolysis, mitochondrial metabolism and intermediary metabolic
pathways depends on the functional demands of a cell type and the physicochemical
composition of the extracellular environment (Gardner, 1998). Glycolysis involves a
series of phosphorylation, isomerization and oxidoreduction (redox) reactions that
converts glucose to pyruvate. Metabolite turnover through glycolysis reactions (i.e. flux)
regulates the availability of glycolytic intermediates to alternative biosynthetic pathways
such as the pentose phosphate pathway or the hexosamine biosynthetic pathway (Reitzer
et al., 1980; Wellen et al., 2010). Glycolysis-derived pyruvate is shunted away from
mitochondrial metabolism in a metabolic configuration known as aerobic glycolysis.
Lactate dehydrogenase (LDH) is central to this mode of metabolism by regenerating
electron acceptor NAD+ for the GAPDH enzyme, thereby sustaining glycolysis
independent of OXPHOS (Brand and Hermfisse, 1997; Ochocki and Simon, 2013).
Reduced electron transport chain (ETC) activity limits the efficiency of ATP synthesis by
OXPHOS but offers a rapid source of anabolic substrates and decreases cell exposure to
reactive oxygen species (ROS) produced by mitochondria (Lunt and Vander Heiden,

20

2011). Therefore, aerobic glycolysis may be selectively beneficial for cell types that
rapidly proliferate or reside in hypoxic niches.

1.4.2

Metabolic Regulation of Self-Renewal and Differentiation

Mouse preimplantation embryos show elevated glucose consumption at the blastocyst
stage, suggesting that pluripotent cells of the epiblast exhibit high glycolytic flux
(Houghton et al., 1996; Leese and Barton, 2004). Indeed, mESCs display high glycolytic
activity in self-renewing conditions but upregulate genes involved in mitochondrial
biogenesis and OXPHOS upon differentiation into specialized lineages (Cho et al., 2006;
Chung et al., 2007; Kondoh et al., 2007). The rapid pace of cell division set by glycolytic
flux in PSC likely promotes self-renewal by desensitizing PSC to pro-differentiation
stimuli. PSCs continuously transit through the cell cycle due to an abbreviated G1
checkpoint, spending most of the cell cycle in S-phase where PSCs are refractory to
developmental cues (Becker et al., 2006; Neganova et al., 2009; Pauklin and Vallier,
2013). High glycolytic flux in mESC or hESC drives pentose phosphate pathway activity
which is important to maintain the cytosolic NADPH pool and a reducing redox
environment in vitro (Filosa et al., 2003; Zhang et al., 2016a). Manipulating the cellular
redox state by the addition of pro-oxidative metabolites encourages germ layer
differentiation from PSCs (Yanes et al., 2010). Endogenous levels of ROS appear to be
regulated by multiple developmental stimuli and likely has signal transduction
functionality to coordinate early lineage specification (Sharifpanah et al., 2008). The
observation that OCT4 DNA-binding ability is negatively affected in oxidizing
conditions suggests that the redox environment can induce functionally-relevant
biochemical changes to pluripotency TFs (Marsboom et al., 2016).
Both mESC and hESC possess structurally immature mitochondria compared to
differentiated cells and express several isoenzymes limiting the availability of pyruvate to
oxidative metabolic pathways in the mitochondria (Prigione and Adjaye, 2010; Varum et
al., 2011, 2009; Zhang et al., 2011). Coupling of glycolysis to reactions within the
mitochondria offers efficient ATP generation for energy-consuming processes in
specialized cells. Inhibition of the ETC does not impair PSC self-renewal, suggesting that
glycolysis alone is sufficient to meet energy demands (Varum et al., 2009). Mitochondria
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also produces a variety of metabolites such as tricarboxylic acid (TCA) cycle
intermediates, which may be used in anabolism or participate in non-metabolic processes
(Nagaraj et al., 2017; Wellen et al., 2009) (Fig. 1-2A). Beyond conventionally recognized
retrograde signals (e.g. ROS, ATP), fluctuations in nucleo-cytosolic levels of metabolites
are sensed by chromatin modifying enzymes (Shi and Tu, 2015).
Histone acetylation and chromatin remodeling in mammalian cells is regulated by the
conversion of TCA intermediate citrate to acetyl-coenzyme A (CoA), the universal acetyl
group donor, by the ATP citrate lyase enzyme (Wellen et al., 2009). Acetyl-CoA level is
also dependent on the upstream provision of pyruvate by glycolysis. High glycolytic flux
maintains histone acetylation and pluripotent gene expression signatures in naïve mESC,
primed mEpiSC and hESC (Moussaieff et al., 2015). Depletion of cytosolic acetyl-CoA
with mechanistically distinct pathway inhibitors promotes PSC differentiation, whereas
acetate supplementation supports the undifferentiated state (Moussaieff et al., 2015).
Similarly, histone and DNA methyltransferase enzymes primarily use the methyl donor
S-adenosylmethionine (SAM), an intermediate of the one-carbon metabolism pathway
(Finkelstein, 1990; Locasale, 2013). Physiological variations in threonine or methionine,
the amino acids upstream of SAM synthesis in mice or humans respectively, have been
shown to affect histone methylation patterns in mammalian cells (Mentch et al., 2015;
Ulrey et al., 2005). Supplementation of threonine/methionine is necessary for the selfrenewal of both mESCs and hESCs, whereas depletion of these respective molecules
selectively decreases the promoter-associated H3K4me3 modification and augments
differentiation (Shiraki et al., 2014; Shyh-Chang et al., 2013). These observations shed
light on an emerging metabolo-epigenetic axis and suggest that the variations in the
metabolic state of PSCs contribute to differention into a variety of lineages and cell types
(Fig 1-2B).

1.4.3

Metabolic Reprogramming in Pluripotent State Transitions

Redistribution and local dynamics of certain epigenetic modifications (e.g. DNA
methylation, H3K27me3) are recognized to facilitate stable naïve-to-primed transitions
without complete exit from the pluripotent state (Joshi et al., 2015; Tosolini et al., 2018).
LIF-STAT3 signaling in mESC synergistically promotes mitochondrial respiration
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Figure 1-2. Metabolic regulation of self-renewal and pluripotency.
(A) Glucose uptake fuels the pentose cycle and provides subtrates for intermediary
metabolism. Glutamine metabolism replenishes the tricarboxylic acid (TCA) cycle at the
level of alpha-ketoglutarate (αKG). Metabolic intermediates are diverted to anabolic
pathways such as lipid synthesis. (B) The relative balance of glycolytic and
mitochondrial metabolism and the one carbon cycle (1C) are implicated in regulating
epigenetic cofactors acetyl-coenzyme A (Ac-CoA) and s-adenosylmethionine (SAM) to
facilitate epigenetic events during pluripotent state transitions. Implicated epigenome
modifiers are histone acetyltransferase (HAT), histone methyltransferase (HMT) and
ATP-dependent chromatin remodelers (BAF).
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alongside accessory naïve GRN members such as ESRRB (Carbognin et al., 2016; Sone
et al., 2017). As a result, naïve mESC maintain greater steady-state ATP levels than
primed mEpiSC or hESC through glucose and lipid oxidation (Sperber et al., 2015).
Interestingly, mESC are metabolically flexible and tolerate pharmacological blockade of
glycolysis or ETC activity without loss of pluripotency (Vlaski-Lafarge et al., 2019). The
functional relevance of emphasizing ATP generation by oxidative phosphorylation is still
unclear. However, it has recently been proposed that efficient ATP generation is
necessary to maintain ATP-dependent chromatin remodeling, histone acetyltransferase
activity and hyperdynamic chromatin characteristic of the naïve pluripotent state (Zhang
et al., 2018).
Activation of SMAD2 signaling in F/A conditions used to maintain and derive primed
mEpiSC or hESC suppresses the expression of cytochrome c oxidase subunits (Zhou et
al., 2012). Hypoxia inducible factor 1α (HIF1α) is necessary for naïve-to-primed
transition and reinforces the SMAD2-driven transcriptional program (Sperber et al.,
2015). Although primed PSC display a relative suppression of ETC activity and
glycolytic bias, they exhibit mature tubular-shaped mitochondria compared to naïve PSC
(Zhou et al., 2012). Primed PSC contain mitochondria with an active, albeit truncated
TCA cycle that siphons and replaces different intermediate metabolites found in the
mitochondrial matrix (Tohyama et al., 2016). These studies posit that a switch from a
balanced glycolysis/OXPHOS metabolic state to a preferentially glycolytic mode is
reinforced by the extrinsic signals and GRNs associated with each pluripotent state. The
knowledge that cell metabolism can influence both specific TF activity and higher levels
of genome organization, has informed culture media preparations to enhance
reprogramming from a relatively constrained somatic nuclear environment.

1.5 Induced Pluripotent Stem Cells
1.5.1

Overview of Induced Pluripotent Stem Cell Generation

Nuclear reprogramming of somatic cells directly to a pluripotent state with similar
attributes to ESCs has been a widely adopted technique to study mechanisms in
development, model a variety of diseases or establish a renewable cell source for
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regenerative medicine (Robinton and Daley, 2012). The original induced pluripotent stem
cell (iPSC) generation protocol involved the forced expression of exogenous TFs namely
OCT4, KLF4, SOX2 and c-MYC (O-K-S-M) (Takahashi et al., 2007; Takahashi and
Yamanaka, 2006). Ectopic expression of O-K-S-M can reprogram donor cells to either
naïve or primed pluripotent state depending on the derivation environment (Han et al.,
2011). Nucleic acid constructs encoding O-K-S-M are typically delivered to cells by
integrative DNA, non-integrative DNA or RNA-based systems (Hussein and Nagy,
2012). Regardless of delivery method, O-K-S-M overabundance initiates widespread
interactions between reprogramming factors with pioneer activity and somatic chromatin
(Soufi et al., 2012). The selection of donor cell type affects the route to induced
pluripotency, but most data are collected in dermal fibroblast to date (Nefzger et al.,
2017). In a fraction of the reprogramming cell population, O-K-S factors outcompete the
somatic GRN to allow de novo silencing of lineage-related CRMs antagonizing
pluripotency induction (Hanna et al., 2008; Shao et al., 2016). Transfactors recruit
endogenous transcriptional coactivators to previously silent CRMs to facilitate local
epigenetic remodeling and reactivation of the endogenous pluripotency GRN (Ho et al.,
2009; Singhal et al., 2010).
Somatic cell reprogramming is associated with a stepwise progression of few cells
through intermediate cell states, which is reflected in measurable changes in cell
phenotype over a period of days to weeks (Polo et al., 2012; Stadtfeld et al., 2008). The
fluctuant latency involved in putative iPSCs emergence is partially attributed to
experimental variables such as O-K-S-M stoichiometry, cell cycle stage or the existence
of privileged cell subpopulations within a heterogeneous culture (Carey et al., 2011; Chen
et al., 2012; Guo et al., 2014). However, even when the aforementioned variables are
controlled, successful reprogramming remains inefficient (<1%) due to the ordered,
probabilistic mechanisms associated with overcoming somatic epigenetic constraints and
acquiring pluripotency (David and Polo, 2014). Complicating the study of
reprogramming intermediates is that many observed changes to bulk reprogramming cells
are not specific to those undergoing successful reprogramming (i.e. productive trajectory)
compared to bulk intermediates that adopt alternative cell fates (Koche et al., 2011).
Many O-K-S-M expressing cells undergo alternative trajectories (e.g. senescence,
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apoptosis) because reprogramming factor binding is largely non-specific and capable of
inadvertently activating antagonistic processes that restrict the frequency of pluripotency
acquisition (Lujan et al., 2015; Polo et al., 2012).

1.5.2

Phase-Dependent Obstacles to Somatic Cell
Reprogramming

Two major reconfiguration events of the transcriptome and proteome occur during
reprogramming, which broadly segment reprogramming into early, mid and late phases
(Hansson et al., 2012; Polo et al., 2012; Samavarchi-Tehrani et al., 2010). The early
phase (i.e. initiation) occurs within the first few days of reprogramming and is
characterized by a loss of somatic identity, acquisition of glycolytic metabolism and a
hyperproliferative state (Hansson et al., 2012; Mikkelsen et al., 2008; Polo et al., 2012).
Changes to cell phenotype in early reprogramming are dependent on persistent O-K-S-M
expression and reprogramming factor engagement with pre-existing accessible regions on
somatic chromatin (Chen et al., 2016; Smith et al., 2010; Stadtfeld et al., 2008). Immune
and DNA damage responses to ectopic TF expression are barriers to early reprogramming
by inducing cell cycle arrest and apoptosis (González et al., 2013; Kawamura et al., 2009;
Li et al., 2009). Experimental manipulations that promote cell evasion of apoptosis,
increase proliferation or high glycolytic flux reproducibly facilitate early reprogramming
progression (Folmes et al., 2011; Hanna et al., 2009b). Repression of somatic identity
genes by reprogramming factors elicits a variable response dependent on the donor cell
population but manifests as mesenchymal-to-epithelial transition (MET) in
reprogramming dermal fibroblasts (R. Li et al., 2010; Samavarchi-Tehrani et al., 2010).
The mid phase (i.e. maturation) occurs after the first week of reprogramming and
involves gradual and probabilistic transactivation of a theoretical endogenous gene
subset, called pluripotency-initiating or maturation factors (Chung et al., 2014).
Expression of these early maturation markers is reversible, dependent on the exogenous
transgenes and therefore does not guarantee complete reprogramming (Teshigawara et
al., 2016). Maturation is characterized by a high rate of reprogramming failure, accounts
for most of the latency in reprogramming and may be further subdivided at a single-cell
resolution (Natarajan et al., 2017; Tanabe et al., 2013). Transcriptome analysis of
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reprogramming intermediates showed the maturation phase exhibits the greatest
transcriptional variability, likely due to a combination of clonal dominance of highly
proliferative cells and activation of competing transcriptional responses (Kuno et al.,
2018; Tanabe et al., 2013). Chromatin modifying complexes with negative rheostatic
functions such as polycomb repressive complex 2 (PRC2) and nucleosome remodeling
deacetylase (NuRD) are implicated in the maturation phase (Khazaie et al., 2016; Rais et
al., 2013). PRC2 and NuRD are necessary for de novo silencing of lineage-related genes
during maturation but may be inadvertently recruited to critical pluripotency regions and
oppose reactivation (Dos Santos et al., 2014; Pereira et al., 2010; Rais et al., 2013).
Integrated analysis of reprogramming factor binding, and epigenetic modifications show
a gradual enrichment of TF binding at previously silent pluripotency enhancers during
iPSC maturation. Subsequent epigenetic remodeling at targeted pluripotency loci is
followed by promoter reactivation and pluripotency gene expression, marking the
transition to the final phase of reprogramming (Chen et al., 2016).
The late phase (i.e. stabilization) occurs after two or three weeks and is characterized by
transgene independent (through depletion or epigenetic silencing) self-renewal and stable
expression of endogenous pluripotency GRN (David and Polo, 2014; Golipour et al.,
2012). Concurrently, a small set of pluripotency-associated genes appear to elicit
deterministic completion of reprogramming by a coordinated and hierarchical
transcriptional program (Buganim et al., 2012). The factors at the top of the deterministic
hierarchy are considered refractory to O-K-S-M binding because they are spanned by
large constitutive heterochromatin domains (Soufi and Zaret, 2013). Provided that
stabilized iPSC intermediates are in a permissive signaling environment for pluripotency
GRN maintenance, they will adopt transcriptional and epigenetic signatures as well as
differentiation capabilities equivalent to ESC (Hanna et al., 2008; Wang et al., 2018;
Wernig et al., 2007) (Fig. 3-1).

1.5.3

Modifiers of DNA Methylation to Facilitate Reprogramming

Reprogramming progress is constrained by repressive chromatin modifications at
pluripotency-specific CRMs, and a lack thereof at lineage-associated CRMs (Chen et al.,
2013; Wang et al., 2011). Therefore, the extent of epigenetic remodeling that must occur
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at both pluripotency and lineage-specific genes can play a role in the relative efficiency
of reprogramming (i.e. colony yield) or reprogramming kinetics (i.e. time interval to
iPSC establishment) (Chen et al., 2011). For instance, variations in reprogramming
efficiency between somatic cell types shows a strong positive correspondence with the
number shared hypermethylated CRMs for tissue-related genes that are shared with ESCs
(Barrero et al., 2012). Furthermore, incomplete DNA methylation of lineage-related
CRMs during reprogramming can propagate a transcriptional memory, which affects the
differentiation potential of the resultant iPSC (Kim et al., 2011; Ohi et al., 2011).
Understanding the network of proteins that evoke targeted remodeling of genome-wide
methylation with desirable reprogramming outcomes are important to the development of
experimental manipulations that improve reprogramming efficiency, kinetics and quality
of iPSC lines.
Genes related to pluripotency or the germline tend to be regulated by CpG-rich promoter
and/or enhancer sequences, which are stably silenced in differentiated cells by DNA
methylation (Li et al., 2007; Smith and Meissner, 2013). Transfer of the methyl group
from the co-substrate SAM to CpG dinucleotides are catalyzed by the DNMT family of
enzymes (Robertson and Jones, 2000). The DNMT1 enzyme, known as the maintenance
methyltransferase, has a distinguishable preference for hemi-methylated CpG
palindromes established by semi-conservative DNA replication (Sharif et al., 2007;
Yoder et al., 1997). Small molecule inhibitors of DNMTs, such as the cytidine analogue
5-azacytidine (5azaC), induce genome-wide demethylation largely by disrupting
maintenance DNMT1 from re-establishing DNA methylation on the daughter strand
leading to progressive dilution of methylated cytosine with each cell division (i.e. passive
DNA demethylation) (Christman, 2002; Wu and Zhang, 2010). Non-specific DNMT
inhibitors can modestly increase reprogramming efficiency, particularly when applied
late in reprogramming such that lineage-related CRMs are appropriately silenced
(Mikkelsen et al., 2008). 5azaC treatment has also been shown to promote the
stabilization of partially reprogrammed cells (i.e. intermediates stuck in maturation
phase) or erasing residual epigenomic memory (Bilic and Izpisua Belmonte, 2012;
Mikkelsen et al., 2008). However, prolonged DNMT inhibition exposure is not desirable
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due to elevated transposable element motility and loss of genomic imprints (Eden et al.,
2003; Walsh et al., 1998).
The TET dioxygenase family of enzymes catalyze the iterative oxidation of 5methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) and less stable derivatives
5-formylcytosine and 5-carboxycytosine (Ito et al., 2011; Tahiliani et al., 2009).
Subsequently, thymine DNA glycosylase (TDG) may excise of the oxidized derivatives
and return the non-modified cytosine independent of cell replication (i.e. active
demethylation) via the base-excision repair pathway. Therefore, TET catalyzes the ratelimiting step in the most widely-accepted and biochemically validated mechanism of
DNA demethylation in mammals (Inoue et al., 2011; Zhang et al., 2012). TET family
members (TET1-3) exhibit partial functional redundancy with regards to genomic
affinities but differ in protein-protein interaction partners and substrate preferences (Putiri
et al., 2014; Xu et al., 2011; Zhang et al., 2010). TET enzymes have catalysisindependent functions in protecting CpG-rich regions from de novo methylation, however
these are poorly understood (Williams et al., 2011; Wu et al., 2011). Expression and
activity of TET1 and TET2 are highly correlated with differential methylation, epigenetic
remodeling and pluripotency factor expression (Di Stefano et al., 2014; Gao et al., 2013).
The knockdown or deletion of either paralog negatively affects pluripotency TF binding
and reprogramming success rates (Costa et al., 2013; Doege et al., 2012).
Somatic fibroblasts and early reprogramming intermediates (days 3-6) have similar
genome-wide DNA methylation levels (Schwarz et al., 2018). After the initiation phase,
roughly 25% of 5mC-enriched regions and 10% of 5hmC-enriched regions are
redistributed compared to the initial somatic environment (Sardina et al., 2018). Gains in
5hmC negatively correlate with 5mC level dynamics, suggesting that active, rather than
passive DNA demethylation occurs during early reprogramming (Sardina et al., 2018).
The role of TET-mediated active DNA methylation is substantiated by the inability of
TET triple knockout or thymidine DNA glycosylase knockout MEFs to reprogram (Hu et
al., 2014). Hypomethylated CRMs are established in two distinct waves of demethylation
during that correlate with the progression to maturation and stabilization phases (Schwarz
et al., 2018). Reprogramming transfactors with pioneer activity can bind nucleosomal
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DNA and recruit TET enzymes for active demethylation (Koche et al., 2011; Sardina et
al., 2018; Soufi et al., 2015). After focal DNA demethylation, TET enzymes can recruit
histone modifying enzymes (e.g. SET1-COMPASS, EP300) to gene regulatory regions to
create a more permissive environment for pluripotency TF occupancy (Chen et al., 2016;
Deplus et al., 2013; Wei et al., 2015).

1.6 Pluripotent Stem Cells from Domesticated Large
Mammals
1.6.1

Livestock and Companion Animals in Regenerative Medicine

The establishment of human ESCs and eventually iPSCs has spurred a new generation of
cell-based therapies seeking to replace or repair human tissues (Tsuji et al., 2019).
Dozens of therapeutically desirable cell types can be differentiated from human
ESC/iPSC, each with specific cell maturation and purification strategies (Rodrigues et al.,
2015). Specialized cell types derived from human ESC/iPSC perform reasonably well in
functional assays in vitro (Schwartzentruber et al., 2018). Xenotransplantation
experiments have demonstrated proof-of-concept that therapeutic cells expanded and
manipulated ex vivo are efficacious in a variety of rodent disease models (Nagamoto et
al., 2016). First-in-human trials still pose considerable risk for volunteer participants
because therapeutic cells derived from ESC/iPSC may elicit an immune reaction or
harbor potentially tumorigenic cells (Heslop et al., 2015). Occasionally, mice carrying
disease-relevant mutations do not recapitulate the pathogenic features observed in
humans (Carvalho-Oliveira et al., 2007; Li and Li, 2012). PSCs derived from
domesticated farm or companion animals would offer preclinical mammalian models of
inherited or acquired disease to complement existing transgenic murine systems (Ezashi
et al., 2015). Evidence from preclinical studies in mammals with greater longevity should
affirm the safety, viability and functionality of ex vivo manufactured cell products for the
anticipated duration of therapeutic efficacy in vivo (Trounson and DeWitt, 2016).
Furthermore, the development of dosing and delivery procedures in domesticated
mammals better emulates the organ size and immune system physiology encountered in
human patients (Casal and Haskins, 2006; Harding et al., 2013).
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In livestock species (e.g. porcine, bovine), embryological studies have yielded insights
into evolutionarily conserved or divergent features of embryonic pluripotency (Liu et al.,
2014). Data from both in vivo or in vitro matured preimplantation embryos provide a
comparative reference to scrutinize the specificity of orthologous pluripotency-related
gene products (Bernardo et al., 2018). Consequently, PSCs derived from farm species
have performed more consistently in teratoma assays and have generated a larger
repertoire of functional differentiated cell types (Ezashi et al., 2015). In contrast,
challenges facing the procurement and culture of embryos from companion and work
animals (e.g. canine, equine) have deferred similar embryo characterization studies
causing uncertainty regarding molecular signature of embryonic pluripotency in these
species (Paris et al., 2010; Wilcox et al., 2009).
Among companion animals, the domestic dog (Canis lupus familiaris) shares a variety of
inherited diseases exhibiting complex genetic and environmental interactions including
cancer, respiratory, endocrine, neurological and age-related disorders (Head et al., 2002;
Schneider et al., 2008; Shearin and Ostrander, 2010). In this regard, exposure to common
mutagenic agents throughout human-canine co-evolutionary history and high percentage
(94%) of conserved ancestral DNA is proposed to favor analogous defects in gene
products and similarity in disease presentation (Breen and Modiano, 2008). Given the
high degree of genomic sequence similarity, the research community was initially
optimistic that stem cells derived from dogs would be more representative of stem cell
biology in humans than rodents (Tecirlioglu and Trounson, 2007). However, PSC from
companion species do not maintain their pluripotency characteristics with prolonged
culture (Roberts et al., 2016). The broad availability reprogramming vectors and wellconserved ability of O-K-S-M factors to promote ESC-like state indicates that derivation
of iPSC from large mammals is attainable. Regardless of source, PSC derivation in
domestic mammals will be hindered by an incomplete understanding of speciesdependent variation in pluripotency GRN hierarchies and the unique signaling inputs
needed to stabilize a self-sustaining pluripotent state.
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1.6.2

Regulative Implications of Evolutionary Variation to
Pluripotency

Our knowledge of the signaling pathways and GRNs involved in steady-state
pluripotency, pluripotent state transitions, acquired pluripotency and early lineage
restriction is derived from rodents and primates (Boyer et al., 2005; Loh et al., 2006).
Core pluripotency TFs are well conserved in vertebrates with respect to protein structure
and role in developmental plasticity (Dixon et al., 2010; Morrison, 2006). Comparisons
of gene expression and core pluripotency TF binding sites among mammals has revealed
extensive rewiring of the regulatory interactions (Kunarso et al., 2010; Xie et al., 2010).
Regulatory variation between mammals appears to be driven by single base-pair
mutations that create and destroy individual TF binding sites, or the insertion of entire
CRMs by mobile elements that constitute approximately 40% of mammalian genomes
(Waterston et al., 2002; Xie et al., 2010). Only about 5% of OCT4 and NANOG binding
events occur in homologous sequences between mouse and human ESCs, with the
remaining species-specific regulatory elements harbored in transposable sequences
(Kunarso et al., 2010). Pluripotency TF binding sites within transposable sequence are
co-opted as distal CRMs (Feschotte, 2008) and targeted by DNMT or TET to control
transcriptional output by differential DNA methylation (de la Rica et al., 2016; Muramoto
et al., 2010). The introduction of new TFs or alterations to hierarchical relationships
between existing TFs have driven divergence in orthologous gene expression patterns and
contribute to species-specific phenotypes in development and pluripotency (Barakat et
al., 2018; Glinsky, 2015; Kojima et al., 2017).
CpG islands (CGIs) are regions of CpG dinucleotide overrepresentation spanning a
region of 0.5-1 kilobase on average (Han and Zhao, 2009a). CGIs are hallmarks of
regulatory elements that are silenced by DNA methylation and either situated adjacent to
the 5’ end (i.e. promoter) of a subset of mammalian genes or at distal CRMs (i.e.
enhancer) (Antequera et al., 1990; Bell and Vertino, 2017; Mendizabal and Yi, 2016).
Interestingly, CGI density is the highest in the canine assembly among completely
sequenced placental mammals (2-3 fold greater than mouse or human), despite no
marked difference in overall guanine and cytosine prevalence (Han et al., 2008). The
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dramatic increase in CGI density in dogs is thought to be a consequence of a bias in
meiotic recombination, rather than mobile elements/repeats or differential rates of
cytosine deamination (Han and Zhao, 2009b).
Dogs and all ancestral canids sequenced to date carry a frameshift mutation in PR domain
containing 9 (PRDM9) (Muñoz-Fuentes et al., 2011). PRDM9 is a H3K4 trimethylase
that regulates the distribution of highly recombining regions during meiosis in mammals
(Baudat et al., 2010). Mouse PRDM9 knockouts are infertile in both males and females
(Oliver et al., 2009). It is proposed that meiotic recombination hotspots have remained
the same in canines due to the loss of PRDM9, thereby increasing local CG content
through GC-biased gene conversion (gBGC) (Axelsson et al., 2012). gBGC is a form of
base substitution where AT/CG sites in heteroduplex DNA preferentially include the CG
allele (Dreszer et al., 2007; Mugal et al., 2015). These features may have driven genome
instability, chromosomal rearrangements, altered the local properties of distal CRMs and
decreased the overall euchromatic portion of the dog genome throughout canid evolution
(Auton et al., 2013; Berglund et al., 2015; Lindblad-Toh et al., 2005; Webber and
Ponting, 2005).

1.6.3

Canine Embryogenesis and Embryonic Stem Cells

Embryogenesis in placental mammals is dependent on intricate intercellular
communication mechanisms between the embryo proper and TE. Numerous differences
exist between mammals during early embryogenesis, including divergent responses to
trophic signals or pathway inhibitors (Kuijk et al., 2012; Roode et al., 2012), differences
in the pattern of developmental gene expression (Petropoulos et al., 2015; Xie et al.,
2010), and timing and mechanistic variation in epigenetic events (e.g. X-chromosome
inactivation, zygotic genome activation) (Okamoto et al., 2011). The peculiarities of
canine embryonic development begin at ovulation, where the oocyte is released at the
germinal vesicle stage. Meiosis resumes after 48-72 hours in the oviduct becoming
competent for fertilization soon afterward (Reynaud et al., 2005). Zygotic genome
activation is believed to occur at the eight-cell stage (Hyttel et al., 2010). Canine morulae
and blastocysts can be found in the uterine horn starting 8-10 days after ovulation (Bysted
et al., 2001). Gastrulation and uterine attachment occur around 15-16 days after a period
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of free-floating embryo migration (Renton et al., 1991; Reynaud et al., 2006). Canine
blastocysts exhibit positive immunostaining for OCT4 within the ICM, but the existence
of naïve or primed pluripotency signatures has not been investigated in the embryo
(Wilcox et al., 2009).
Canines have a comparatively short gestation compared to similarly-sized mammals
(Pretzer, 2008) and differ from rodents and primates by their placental architecture.
Primate or rodent embryos invade the uterine epithelium, remaining completely encircled
by TE and directly eroding maternal vasculature (i.e. discoid hemochorial placenta)
(Carter and Enders, 2004). Whereas canine embryo implantation is distinguishable by the
proliferation and invasion of only the middle third of trophoblast forming a single banded
point of attachment which approximates but does not dissolve the maternal endothelial
barrier (i.e. zonary endotheliochorial placenta) (Carter and Enders, 2004). The differences
in both the duration preimplantation embryo migration and fetal membrane organization
may have yet unknown consequences on the nutritional environment and metabolism of
any remaining pluripotent cells within canine peri-implantation embryos.
Attempts to derive ESCs from canine blastocyst embryos have established heterogeneous
cultures exhibiting some of the molecular hallmarks of PSCs from mice or humans. For
instance, various cESC lines show reactivity to cell surface glycoprotein epitopes specific
to mESC (Hatoya et al., 2006; Schneider et al., 2008) or hESC (Vaags et al., 2009;
Wilcox et al., 2009). Loss of pluripotency marker expression and compact colony
morphology upon LIF withdrawal, suggests that exogenous LIF is required for the selfrenewal of cESC (Vaags et al., 2009; Wilcox et al., 2009). The co-supplementation of
LIF and FGF (L/F) appears to promote longer-term maintenance of cESCs (Vaags et al.,
2009; Wilcox et al., 2009). However, these canine ESCs (cESCs) cells tend to
spontaneously differentiate and are tedious to maintain in prolonged culture despite
intensive efforts (Gonçalves et al., 2014; Hayes et al., 2008). Only two groups attempted
different derivation procedures from canine preimplantation embryos (Vaags et al., 2009;
Wilcox et al., 2009), therefore the challenges facing long-term culture of cESCs could
relate to the narrow subset of culture conditions investigated.
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1.6.4

Canine Induced Pluripotent Stem Cells

A variety of donor cell populations from the mesodermal lineage have been used to
produce canine iPSC (ciPSC) including embryonic and adult fibroblast, mesenchymal
cells from testes or adipose tissue. Integrating viral vectors (i.e. retrovirus, lentivirus)
have been the predominant strategy to deliver human O-K-S-M orthologs, with some
exceptions (Menon et al., 2019). Co-transduction of O-K-S-M with LIN28 and NANOG
also supports ciPSC generation (Whitworth et al., 2012), as does the delivery of murine
O-K-S-M orthologs (Gonçalves et al., 2017; Koh et al., 2013). Similar to cESCs, ciPSCs
form heterogeneous cultures and exhibit inherent variability in pluripotency-associated
marker expression, which cannot be resolved with fluorescence activated cell sorting
(FACS) (Koh et al., 2013; Luo et al., 2011). Incomplete silencing and maintained
expression of exogenous O-K-S-M factors is a persistent issue and likely contributes to
the heterogeneous features of ciPSC (Koh et al., 2013; Luo et al., 2011).
L/F conditions appear to be best suited for ciPSC derivation, but lines dependent solely
on either LIF or FGF2 have been reported (Chow et al., 2017; Gonçalves et al., 2017;
Koh et al., 2013; Luo et al., 2011; Nishimura et al., 2013; Whitworth et al., 2012). The
requirement of L/F conditions is peculiar because these signaling pathways have
opposing influences on murine pluripotency (Nichols and Smith, 2009). It is believed that
LIF signaling is mediated by STAT3 similar to mESCs (Luo et al., 2011). Whereas, FGF
signaling is believed to resemble the mechanisms characterized in hESCs, involving
paracrine TGFβ ligand secretion from MEF feeders and SMAD2 induction of NANOG in
ciPSC (Luo and Cibelli, 2016).
The establishment of transgene-dependent, partially reprogrammed ciPSC clones appears
to be reproducible in multiple labs and donor cell populations. However, there is
diminishing value in continuing to characterize transgene-dependent cell populations
stuck within an ill-defined alternative reprogramming trajectory. Recent efforts have
navigated towards commercially available RNA-based sendai virus reprogramming
vectors, which do not integrate into host genomes (Chow et al., 2017). Previous studies
have stressed the importance of studying genomic stability and the epigenetic state of
ciPSC, as aberrations in these attributes may confer selective growth advantages and lead
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to genetic drift in cultures (Koh et al., 2013). Investigations focusing on the precise
nature of signaling networks and GRNs associated with the induction and maintenance of
pluripotency, should build the foundational knowledge required for reproducible
derivation of stable cESC and ciPSC.

1.7 Rationale and Study Aims
PSC represent a tractable system to probe the molecular mechanisms underlying the
acquisition, maintenance and loss of pluripotency (Morgani et al., 2017; Rossant and
Tam, 2017). Once the regulative character and clonogenic attributes of PSC can be
exploited with precision, PSC offer a scalable source of healthy cells for regenerative
medicine or to assess the molecular basis and drug responsiveness of disease states (Ilic
and Ogilvie, 2016; Robinton and Daley, 2012). Evolutionary rewiring of pluripotency
associated regulatory elements and contrasting embryological features will likely drive
the emergence of species-specific phenotypes and culture requirements among
mammalian PSC (Greber et al., 2010; Xie et al., 2010). Although early mammalian
embryos share morphological similarities, there is a lack of clarity regarding the defining
molecular characteristics of pluripotent cells within canine peri-implantation blastocysts.
The derivation and maintenance of PSC analogous to mESC or mEpiSC in canines would
contribute to our understanding of the evolutionary variations in regulatory mechanisms
impacting pluripotency induction or maintenance across mammals. A growing
appreciation of the interdependent epigenetic, transcriptional and metabolic mechanisms
in pluripotent state transitions and nuclear reprogramming, suggests that specific
manipulations to the culture environment can influence the plasticity of mammalian cells.
For my thesis work, I used canine embryonic stem cells (cESCs) as a model system to
evaluate discriminatory markers and functional assays to decipher the developmental
approximate of cESCs in different microenvironments. Additionally, I used transcription
factor-mediated de-differentiation of canine fibroblasts to study the early stages of
nuclear reprogramming. cESC established from in vivo-derived blastocyst explants
exhibit requirements of exogenous LIF and FGF2, clump passaging techniques and MEF
co-culture, neural lineage default in minimal media that are indicative of the primed
pluripotent state (Wilcox et al., 2011, 2009). Furthermore, partial antagonism of MEK1/2
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and activation of WNT signaling in mouse or human PSC appears to have an essential
role in stabilizing a naïve-like pluripotency stage (Weinberger et al., 2016).
Given these observations, I predict that direct manipulation of the culture conditions can
facilitate nuclear reprogramming of canine cells. The overall hypothesis of my thesis is
that the culture environment can promote nuclear and metabolic reprogramming of
canine cell lines towards a more primitive state of pluripotency. First, I will determine if
LIF-FGF2 cESCs exhibit molecular and functional characteristics of primed pluripotency
typified by mEpiSCs, and if manipulation of FGF2-MEK and WNT signaling pathways
can support a less mature state of pluripotency (Chapter Two). Secondly, I aim to
determine the influence of cESC pluripotent state on mitochondrial structure and activity
of relevant bioenergetic pathways to cell proliferation (Chapter Three). Lastly, I aim to
determine if metabolites influencing DNA methylation can promote transcriptional
responses associated with the initiation of canine reprogramming (Chapter Four). These
studies further our understanding of conditions suitable for canine pluripotent stem cell
expansion and establish a framework for cESCs as a model to assess the molecular events
in canine developmental progression. Collectively, these investigations substantiate the
role of extrinsic factors regulating pluripotent states and pose fundamental questions
regarding evolutionarily conserved features of mammalian pluripotency.
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Chapter 2

2

Manipulation of developmental signaling pathways
alters the pluripotency characteristics of canine
embryonic stem cells

A version of this chapter has been published:
Tobias, I.C., Brooks, C.R., Teichroeb, J.H., Villagómez, D.A, Hess, D.A., Séguin, C.A.,
and Betts, D.H. (2016). Small-molecule induction of canine embryonic stem cells toward
naive pluripotency. Stem Cells and Development 25 (16), 1208-1222.
Reproduced here with permission from Mary Ann Liebert, Inc., New Rochelle, NY
(Appendix B).
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2.1 Introduction
Canine reproduction and early embryonic development exhibit peculiar features that have
limited the progress of assisted reproduction technologies and embryo maturation
protocols in this species (Nagashima et al., 2015; Van Soom et al., 2014). Briefly, canids
release oocytes at the immature germinal vesicle-stage and trophoectoderm
differentiation does not occur until ten days post-ovulation (Renton et al., 1991; Reynaud
et al., 2006). In vivo matured canine blastocyst embryos have been collected from the
reproductive tracts of artificially inseminated dams after slightly less than two weeks
after ovulation (Reynaud et al., 2006). A number of canine embryonic stem cell (cESC)
have been established from the outgrowths of spontaneously or mechanically hatched
blastocysts (Hatoya et al., 2006; Hayes et al., 2008; Schneider et al., 2007; Vaags et al.,
2009). However, there is no clear consensus regarding the appropriate embryonic stage
for cESC derivation or which extrinsic signals are required for self-renewal of cESCs
(Betts and Tobias, 2015). As such, most presumptive cESCs rapidly lose in vitro
characteristics of pluripotency before detailed molecular characterizations can be
performed (Koh and Piedrahita, 2014).
We have previously shown that cESCs exhibiting core pluripotency TF expression (e.g.
OCT4, SOX2) and hESC-like cell surface epitopes (e.g. SSEA4, TRA-1-81) can be
reproducibly derived on mouse embryonic fibroblast (MEF) feeders when cultured in
media containing both LIF and FGF (L/F) (Wilcox et al., 2009). Whereas LIF supports
the naïve pluripotent state in mice, primed mEpiSC or hESCs depend on FGF2 and
Activin A-SMAD2/3 signaling (Brons et al., 2007; Dahéron et al., 2004; Tesar et al.,
2007; Vallier et al., 2009). The dual requirement of L/F indicate that cESCs may reflect a
mixture of naïve or primed pluripotency characteristics. Canine iPSCs have been shown
to quickly re-establish variable surface marker abundances after fluorescence-activated
cell sorting (FACS), indicating that the canine pluripotent state is metastable (Hayashi et
al., 2008; Koh et al., 2013).
Similar to primed mEpiSCs, explant-derived cESCs in L/F undergo apoptosis unless
propagated with clump passaging techniques and exhibit a neural lineage default in
minimal media (Greber et al., 2010; Wilcox et al., 2011). These observations indicate that
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L/F cESCs may represent the canine-equivalent of primed pluripotency, despite the
requirement of LIF for prolonged self-renewal. The application of two inhibitors (i.e.
PD0325901 and CHIR99021, known as 2i) that partially suppress MEK and GSK3β
kinase activity maintains mESCs in a naïve pluripotent state (Qi et al., 2004; Ying et al.,
2008). 2i and LIF (2iL) has been shown to overcome intrinsic determinants that promote
an unstable pluripotent state in mouse strains that were previously considered refractory
(Hanna et al., 2009). Supplementation with 2iL also appears to be important to stabilizing
a naïve pluripotent state in primates, although several additional kinase inhibitors are
usually included (Gafni et al., 2013; Hanna et al., 2010; Theunissen et al., 2014). We and
others have reported considerable morphological heterogeneity among the outgrowths of
canine blastocysts in the early derivation process, but there is no direct molecular
evidence that multiple pluripotent states can be adopted by cESC (Vaags et al., 2009;
Wilcox et al., 2009).
Given the partially conserved role of 2iL molecules to stabilize rodent and primate ESCs
in a naïve-like pluripotent state in the absence of ectopic transgene expression, we
explored the possibility that altering the culture conditions may induce an earlier
development state in cESCs. We report the induction of a distinct state of canine
pluripotency through modulation of environmental cues and intracellular signal
transduction using 2iL. Our results demonstrate that the 2iL-enriched canine pluripotent
state correlates with increased expression of genes associated with the preimplantation
mammalian blastocyst, augmented STAT3 signaling, improved clonogenic potential, and
decreased global repressive epigenetic modifications.

2.2 Materials and Methods
2.2.1

Feeder layer and Embryonic Stem Cell Culture

DR4 strain MEF feeders were mitotically arrested with γ-irradiation (8,000 rad) and
maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) and 1X GlutaMAX. For co-cultures with cESCs, MEFs were
seeded at a density of 2 x 104 cells/cm2 and allowed to adhere overnight in MEF medium.
cESCs were derived at the Ontario Veterinary College (OVC, University of Guelph,
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Ontario) from explanted blastocysts (OVC.EX) and characterized in an earlier report
(Wilcox et al., 2009). cESCs were seeded onto growth-arrested MEFs and cultured in
basal media: KnockOut DMEM/Ham’s F12, 15% KnockOut Serum Replacement
(KOSR), 1X GlutaMAX, 1X nonessential amino acids, 10 ng/mL recombinant insulinlike growth factor (R3IGF1; Sigma-Aldrich), and 0.1 mM 2-mercaptoethanol. Basal
medium was supplemented with 10 ng/mL human recombinant LIF and 4 ng/mL
recombinant human FGF2 (L/F) for maintenance of control cESCs; or 10 ng/mL human
recombinant LIF, 0.5 µM MEK inhibitor PD0325901 (Selleck Chemicals), and 3 µM
GSK3β inhibitor CHIR99021 (BioVision) for establishment and culture of 2iL cESCs.
LIF-FGF2 cESC colonies were mechanically isolated, dissected into small clumps, and
transferred onto fresh MEFs every 4–6 days. 2iL cESC colonies were picked from
culture, dissociated enzymatically with TrypLE Express, and split onto new feeder layers.
For feeder-free cESC cultures, dishes were covered in dilute Geltrex (1:100) solution and
incubated at 37 °C for one or more hours. cESCs transferred to Geltrex-coated dishes
were cultured with 70% MEF-conditioned medium balanced with nonconditioned basal
media. Culture medium was exchanged daily and incubators were maintained at 37 °C,
5% CO2, and ambient oxygen tensions. Unless otherwise stated, all reagents for cell
culture were from Thermo Fisher Scientific.

2.2.2

Metaphase Spread Preparation and Karyotyping

Cells were seeded into Geltrex-coated T75 flasks and grown to 60% confluency before
metaphase spread preparation. Approximately 16 hours before spread preparations,
dividing cells were synchronized with 100 nM Methotrexate in fresh media. Cells were
released from replication block with 10 mM thymidine and incubated for 3 hours at 37
°C. Cells were treated with 1.25 mM Ethidium Bromide for 50 minutes to prevent
excessive chromosome compaction and 10 µg/mL Colcemid for 30 minutes to induce
metaphase arrest. Cells were then dissociated, suspended in hypotonic solution (75 mM
Potassium Chloride), and incubated at 37 °C for 15 minutes. A few drops of ice-cold
Carnoy’s fixative (3:1 methanol: acetic acid) were added and mixed by gentle agitation.
The cells were pelleted and resuspended in the fixative twice before dropping the cells
onto fixative-soaked microscope slides to prepare metaphase spreads. At least 30
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metaphase cells were examined for each treatment group. Karyotypes were assembled
according to ideograms using SmartType (Digital Scientific UK Ltd).

2.2.3

Reverse Transcription and Quantitative PCR

Cells were rinsed once with PBS and harvested directly into TRIzol Reagent. After
phenol-chloroform extraction, the RNA was purified using the PureLinkTotal RNA
Purification Kit. Quality and quantity of RNA samples were determined through
spectrometry using a NanoDrop ND-2000. Genomic DNA was removed using RQ1
RNase-free DNase (Promega). Approximately 300 ng of total RNA was reverse
transcribed using the SuperScript III First Strand cDNA synthesis kit (Thermo Fisher
Scientific) with a random hexamer and oligo (dT)15 primers (Promega). Primer pairs for
each target gene were designed using NCBI Primer BLAST software, spanning an exon–
exon junction where possible. Specificity of each primer set was determined if a single
amplicon of the correct size was detected on a 2% agarose gel following electrophoresis.
For primer sequences and amplicon sizes, see Table 2-1. Quantitative polymerase chain
reaction (qPCR) was performed using the CFX384 detection system (BIO-RAD
Technologies). To each reaction 5 µL Power SYBR Green, 1 µL custom oligonucleotide
primers (250 nM final), 1 µL water and 3 µL template cDNA were added. Thermocycling
conditions are as follows: 95 °C for 10 minutes, followed by 40 cycles of 95 °C for 20
seconds and 60 °C for 45 seconds. Relative transcript levels were normalized to internal
reference gene TATA binding protein (TBP) using the 2-ΔΔCt method and are expressed as
relative ratios to L/F cESC samples.
Table 2-1. Custom oligonucleotide primer sequences
Gene Identifier
STAT3
KLF4
REX1
GBX2
TBX3

Sequence (5’ to 3’)
F - CTGGGCATCAATCCTGTGGT
R - CTCAGTCCTCGCTTTGTGGT
F - CCATGGGCCAAACTACCCAC
R - TGGGGTCAACACCATTCCGT
F - CGCCGACACCGTCCTCATCG
R - GTTCCGCAGGGAGCGGCGGGC
F - GCCTCTCCCGAGCGCGTCTA
R - AGACGAAATGGCCGGGGCTG
F - AGACAGCCCTGCTACGGGGG
R - CCCCTGCCACGTTGCGTGAT

Amplicon Size (bp)
144
154
161
140
133
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PECAM1
LIN28
T/BRA
CER1
FGF5
OTX2
SOCS3
ACVR2B
LAMB1
GATA6
SNAI1
ELF5
HAND1
FLK1
TBP

2.2.4

F - GCACCCCCAGCCAACTTCACC
R - TCCCACTGTCCGTCGCAGAGG
F - GGCGGTGGAGTTCACCTTTA
R - CCTTTGATCTGCGCTTCTGC
F - TGCAGTACCGAGTGGACCACCT
R - GCCGTTCTTGGTCACGATCATC
F - ACCTGGGACCCATGCCCTCAC
R - GATCGTCTGGCCGAAGGGCAC
F - AGCCACCTGATCCTCAGCGCC
R - CGGGTCCGGGTTGCCCTTTG
F - CTGCGAAGCAGTAAACCAGC
R - GAACCCAGCCAGAAGGTCTC
F - CCCGCTTCGACTGCGTGCTC
R - GAAGGCGGCTGCTCCGACAC
F - TTCTGGATGTACCGCATCG
R - TCATGAGCTGTGCCTTCCAG
F - ATGGTTCACGGACACTGCAT
R - ATGTCGAAGTGGCACGAACT
F - AGTGCGTGAACTGCGGCTCC
R - ACGCGCTTCTGCGGCTTGAT
F - GTTTACCTTCCAGCAGCCCT
R - AGAGAGTCCCAGATGAGCGT
F - CTCCAGTCACCACACGTCG
R - CCTGGGTTAGCAAGGCCC
F - AGCTGCAACAACACACTTGG
R - AAGCATAGGGGCTTCGAAAT
F - GTTGGGAGAGGAGAGAGGGT
R - CAGTGCACCACAAAGACACG
F - GAGCTCTGGGATCGTGCCGC
R - TCAGTGCAGTGGTTCGGGGC

94
134
167
196
70
129
115
163
167
136
108
132
218
112
169

Indirect Immunofluorescence Microscopy

Cells in multiwell dishes or Lab-Tek Chamber Slides (Thermo Fisher Scientific) formats
were rinsed with PBS and fixed with 4% formaldehyde for 15 minutes. Cells were
permeabilized with 0.1% Triton X-100 for 20 minutes. Epitope blocking was performed
with 10% normal goat, donkey, or rabbit serum (Sigma-Aldrich) for 1 hour. The
following primary antibodies were diluted to the indicated concentrations and incubated
overnight at 4 °C: anti-OCT4, anti-OTX2, anti-GATA2, anti-GATA4, anti-TUJ1, antiNES, anti-H3H27Me3 and anti-pSMAD2. For information regarding primary antibodies,
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see Table 2-2. AlexaFluor 488 and/or AlexaFluor 547 secondary antibodies were diluted
1:250 in 5% serum and incubated at room temperature for 1 hour. Cells were
counterstained with NucBlue specialized DAPI formulation. Cells were imaged on a
Leica DMI 6000B with Orca Flash digital camera (Hamamatsu Photonics) using Leica
Application Suite Advanced Fluorescence software (Leica Microsystems). H3K27me3immunolabeled cells were observed with a Zeiss LSM 510 Duo Vario confocal
microscope (Zeiss Canada, Inc.). Serial optical sections were taken in a total depth of 50–
80 µM. More than 30 images were assessed per treatment in three independent
experiments. Nuclei were categorized based on the presence of well-delineated
H3K27Me3 foci throughout the input stack. For representative images, extended depth of
field composites was generated using ZProjector on ImageJ (National Institutes of
Health). The primary antibody was replaced with diluent and incubated with the
AlexaFluor secondary antibody to control for antibody specificity. Light or laser settings
were unchanged when detecting the same primary antibody across samples. Brightness or
contrast was set using secondary-only control and equivalent imaging parameters were
applied to all other images.
Table 2-2. Primary antibody information
Target Protein
OCT4
SOX2
NANOG
OTX2
GATA2
GATA4
TUJ1
NESTIN
STAT3
p-STAT3 (T705)
ERK1/2
p-ERK1/2
(T202/204)
SMAD2/3
p-SMAD2
(S465/467)

Isotype
Species
Mouse
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Mouse

Application (Dilution)

Supplier (Catalog)

WB (1:1000); IF (1:150)
WB (1:1000)
WB (1:500)
WB (1:1000); IF (1:200)
IF (1:200)
IF (1:200)
IF (1:300)

Rat
Rabbit
Rabbit
Rabbit
Rabbit

IF (1:150)
WB (1:1000)
WB (1:1500)
WB (1:2000)
WB (1:2000)

Santa Cruz (sc-5729)
Cell Signaling (3579)
Santa Cruz (sc-33759)
Millipore (AB9566)
Santa Cruz (sc-9008)
Abcam (AB84593)
BioLegend (MMS435P)
DSHB (Rat-401)
Santa Cruz (sc-482)
Santa Cruz (sc-7993-R)
Cell Signaling (4695)
Cell Signaling (4377)

Rabbit
Rabbit

WB (1:1000)
WB (1:1000); IF (1:150)

Cell Signaling (3102)
Cell Signaling (3101)
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SMAD4
Histone H3
Histone H3Ac
H3K27me3
β-actin

2.2.5

Rabbit
Rabbit
Rabbit
Rabbit
Mouse

WB (1:1000)
WB (1:1000)
WB (1:1000)
WB (1:1000); IF (1:250)
WB (1:30000)

Santa Cruz (sc-7154)
Cell Signaling (9715)
Millipore (06-599)
Millipore (07-449)
Sigma (A3854)

Protein Extraction, SDS-PAGE and Western Blotting

Cells were rinsed in ice-cold PBS, scraped from 60 mm culture dishes and lysed in 200
µL RIPA buffer (150 mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulfate, 50 mM Tris pH 8.0) with a protease and phosphatase inhibitor
cocktail (EMD Millipore). Total protein concentration was determined by DC Protein
Assay (BIO-RAD Technologies). Protein lysates were resolved on 4%–12% SDS-PAGE
gels and transferred onto Immobilon polyvinylidene difluoride membranes. Epitope
blocking was achieved by incubation with 5% skim milk powder/TBS/0.1% Tween-20
for 1 hour. The following primary antibodies at the indicated dilution were used: antiOCT4, anti-SOX2, anti-NANOG, anti-OTX2, anti-pSTAT3, anti-STAT3, anti-pERK1/2,
anti-ERK1/2, anti-pSmad2, anti-Smad2/3, anti-Smad4, anti-histone H3 lysine 27
trimethylated, anti-histone H3 acetylated, anti-histone H3, and β-actin horseradish
peroxidase (HRP) conjugate. After 16 hours of primary antibody incubation, membranes
were washed with TBS/0.1% Tween-20. Horseradish peroxidase (HRP)-coupled
secondary anti-rabbit or anti-mouse IgG antibodies (Jackson Laboratories) were diluted
in TBS/0.1% Tween-20 and applied to membranes for 1 hour at room temperature.
Immune reactive protein epitopes were visualized by chemiluminescence on Molecular
Imager VersaDoc System (BIO-RAD) and Quantity One software (BIO-RAD
Technologies). Densitometry was performed using ImageLab 3.0 software (BIO-RAD
Technologies).

2.2.6

Embryoid Body Formation and Directed Differentiation of
Outgrowths

Cells were mechanically isolated and briefly triturated in basal culture media lacking 2iL.
Disaggregated cESCs were transferred to suspension culture in non-adherent dishes to
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form embryoid bodies (EBs). Basal media were exchanged daily for 7 days by allowing
EBs to settle at the bottom of a conical tube and aspirating the supernatant. To promote
neuroectoderm differentiation, 2iL-derived embryoid aggregates were gently dissociated
and seeded onto laminin- and poly-L-ornithine-coated dishes in the presence of
Activin/NODAL signaling antagonist 1 µM SB431542 (SB431542) and 20 ng/mL
Noggin (Sigma-Aldrich). Mesodermal fate was induced using 10 ng/mL BMP4 and 10
ng/mL FGF2 on a gelatin substratum. Endoderm differentiation was induced by chemical
stimulation of WNT signaling using 1 µM CHIR99021 and co-supplemented with 20
ng/mL Activin A on Geltrex-coated dishes. After 7 days under differentiation conditions,
each experimental group were fixed with formaldehyde for immunocytochemistry.

2.2.7

Neural Progenitor Cell Formation Assay

Cells were mechanically isolated and disaggregated into small clumps by gentle
pipetting. Cells were resuspended in basal culture medium lacking self-renewal
supplements (e.g. LIF and FGF2, 2i and LIF) and transferred to suspension culture in
non-adherent dishes to form EBs. Basal media were exchanged every other day for 5
days. The resultant EBs from L/F or 2iL cESCs were gently dissociated by pipetting and
allowed to adhere to multiwell dishes coated with laminin and poly-L-ornithine. EB
outgrowths were allowed to differentiate in basal media (i.e. spontaneous differentiation)
or in basal media supplemented with 20 ng/mL Noggin (i.e. directed differentiation).
After four days under adherent differentiation conditions, cells were fixed with 4%
formaldehyde and prepared for indirect immunofluorescence microscopy. Primary and
secondary antibody staining was performed with anti-NES antibody and AlexaFluor 488
secondary antibody. The number of EB outgrowths exhibiting positive NES staining were
enumerated for each condition.

2.2.8

Manipulation of TGFβ Signaling

For the BMP4 differentiation assay, LIF-FGF2 and 2iL cESCs were exposed to 20 ng/mL
recombinant human BMP4 in addition to their standard culture media preparation for a
period of 96 hours. Cells were harvested from multiwell dishes using TRIzol reagent for
RNA isolation. RNA purification and first-strand cDNA synthesis were performed for
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RT-qPCR. Transcript abundances indicative of mesoderm and extraembryonic lineages
(e.g. CDX2, HAND1, GATA6, FLK1) were assessed. To examine LIF-FGF2 cESC
responsiveness to SMAD2/3 signaling, cultures were supplemented with either 10 µM
activin receptor-like kinase (ALK) inhibitor SB431542 or 20 ng/mL Activin A for 96
hours before protein lysate harvest for western blotting.

2.2.9

Single-cell Cloning Efficiency Assay

To examine clonogenic potential, individual L/F or 2iL cESC colonies were mechanically
isolated and incubated in 0.05% Trypsin to dissociate into single cells. Cells were
resuspended in culture media containing LIF only, FGF2 only, L/F, or 2iL and passed
through a 40-µM cell strainer. Media with no growth factor or chemical inhibitor
supplementation were applied for negative controls. Five hundred cells were seeded per
well of a 24-well plate (n = 6). After 7 days, cells were washed in PBS and stained with
AlexaFluor 488 anti-SSEA4 antibody (eBioscience) diluted 1:150 in cESC culture media.
Following a 60 minutes incubation in a humidified incubator, cells were washed with
PBS and direct immunofluorescence was visualized. Colony-forming efficiency was
calculated as a percentage of SSEA4+ colonies per number of cells seeded.

2.2.10

Cell Counting and Population Doubling Time Calculation

For linear phase population doubling, 50,000 cESCs were seeded onto MEF-coated
multiwell dishes in triplicate. Cells were detached at 96 and 144 hour timepoints using
0.05% trypsin to achieve a single-cell suspension. The total live cell number was
determined using a hemocytometer. Population doubling time was calculated using the
# 𝑐𝑒𝑙𝑙𝑠 𝑑𝑎𝑦 6

following formula: 𝑃𝐷 = 48 𝑋 [𝑙𝑜𝑔 2 ÷ 𝑙𝑜𝑔(# 𝑐𝑒𝑙𝑙𝑠 𝑑𝑎𝑦 4)].

2.2.11

5-methylcytosine Enzyme-linked Immunosorbent Assay
(ELISA)

L/F or 2iL cESCs were dissected from culture dishes, pelleted by centrifugation and
rinsed with PBS. Genomic DNA was purified using PureLink Genomic DNA kit. Global
5-methylcytosine (5-mC) levels were determined using the 5-mC DNA ELISA kit (Zymo
Research Corp.) according to the manufacturer’s instructions. A standard curve was
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generated using E. coli control samples provided with the kit and raw data were
calculated as percent 5-mC per 150 ng genomic DNA. Output values were corrected by
the CpG density specific to canine genomic assembly and expressed as a relative ratio to
L/F cESC samples.

2.2.12

Immunodeficient Mouse Xenograft Assay

1.2 x 106 LIF-FGF2 or 2iL cESCs (n = 3) were transplanted into Non-Obese Diabetic
Severe Combined Immunodeficient (NOD/SCID) interleukin-2 receptor -chain null
(IL2R-/-) mice (Jackson Laboratory). HES2 hESC lines were injected as positive controls
(n = 2). Cells were suspended in 50 mL Geltrex and kept on ice (<20 min) before
intramuscular injection in rear hind leg. Injection sites were monitored every other day by
palpation. Between 6 weeks and 10 weeks post-injection, mice were anesthetized with
isofluorane and sacrificed by cervical dislocation, and the area of muscle around the
injection site was excised. Samples were rinsed in PBS before overnight fixation in 4%
paraformaldehyde. Fixed tissues were processed for embedding and sectioning.
Hematoxylin and eosin staining were performed on sections. Animal experiments were
approved by the Animal Use Subcommittee, AUP #2018–033 (Appendix C).

2.2.13

Statistical Analysis

Experiments were performed a minimum of three times with sample sizes indicated in
figure legends. Data were analyzed using GraphPad Prism 6 by two-sample t-test or oneway analysis of variance (ANOVA) followed by Tukey's honestly squared difference
multiple comparison method as appropriate. P < 0.05 was considered statistically
significant. Data were visualized using GraphPad Prism 6 and presented as mean ±
standard error of the mean (SEM).

2.3 Results
2.3.1

PD0325901, CHIR99021 and LIF (2iL) induce compact
cESC colony morphology

OVC.EX cESCs were expanded on MEFs by mechanical dissociation and expansion in
LIF-FGF2 (L/F) medium. L/F cESCs were grown to high confluency (~80%) prior to
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switching to 2iL supplemented medium due to strong negative selection associated with
coercing pluripotent state transitions by kinase inhibitors (Fig. 2-1A). Consistent with
earlier work on the same cESC lines (Wilcox et al., 2009), L/F cESCs exhibited planar
morphology akin to hESCs/EpiSCs (Fig. 2-1B) and did not survive passaging regimens
involving enzymatic dissociation reagents or mechanical dispersion to single-cells. 2iL
culture was initially associated with observable cell death for a period of 72 hours.
Within 4 to 5 days, three-dimensional cell clusters emerged from a proportion of cESC
colonies. By 10 to 14 days, hemispherical colonies with compact borders were observed
(Fig. 2-1B). Confocal microscopy and z-stack reconstruction of DAPI-stained colonies
verified that 2iL treated cells formed multilayer stacks of cells, as opposed to L/F cESCs
that invariably grew as monolayer colonies (Fig. 2-1C). Mature 2iL cESC colonies were
maintained in the same medium applied for their induction and reproduced a canine 78
XY karyotype of the originating L/F cESC population (Fig. 2-2A).
When 2i is removed from the growth media, cESCs rapidly lose dome-like colony
morphology (Fig. 2-2B). Before enzymatic dissociation could be employed, 2iL cESCs
initially had to be enriched by sequential pick-passaging, to reduce the carry-over of
neural progenitor-like cells that arose during the induction of 2iL cESCs (Fig 2-2C-D).
As genetic background has been shown to influence the ability to derive naïve PSCs, the
procedure was repeated in three independent OVC.EX cESC lines (Ohtsuka and Niwa,
2015; Wilcox et al., 2009) (OVC.EX.IO3, OVC.EX.IO7, and OVC.EX.BE5) with
preliminary characterization of morphology and SSEA4 immunostaining (Fig. 2-3).
OVC.EX.BE5 cESC that readily differentiate into each of the three germ layers in vitro
(Wilcox et al., 2009) were selected for extended passaging and subsequent analysis in
L/F and 2iL conditions. These findings suggest that removal of FGF2 and replacement
with 2i permits the expansion of a scarce ESC-like population, which can be
subsequently enriched based on compact colony architecture.

2.3.2

2iL cESCs are pluripotent and up-regulate transcript markers
of an earlier developmental identity

To ensure 2iL-expanded canine cells retained pluripotent characteristics, we performed
immunoblotting and immunofluorescence of pluripotency-associated transcription
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Figure 2-1. PD0325901, CHIR99021 and LIF (2iL) induce compact cESC colony
morphology.
(A) Timeline schematic of induction, isolation and analysis of 2iL cESCs. (B)
Representative phase-contrast micrographs of BE5 cESCs in (I) LIF and FGF2 (L/F) or
(II) 2iL cESCs. Scale bar unit length is 200 µm. (C) Representative cross-section of
reconstructed Z-stack image for DAPI-stained (I) L/F (monolayer) and (II) 2iL (multilayer) cESC colonies. Dashed white line approximates the culture surface. Scale bar unit
length is 50 µm.
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Figure 2-2. 2iL cESCs are dependent on the 2i molecules for compact morphology.
(A) Representative diploid karyotype (2n = 78 XY) from the BE5 2iL cESC line. (B)
Representative phase-contrast micrograph of (I) steady-state 2iL cESC or (II)
differentiating 2iL cESC colony 48 hours after 2i removal. Scale bar unit length is 100
μm. (C) Representative phase-contrast micrograph of neural progenitor-like cells derived
from LIF-FGF2 (L/F) cESCs that proliferate in 2iL culture. Scale bar is 200 μm. (D)
Indirect immunofluorescence image for class III neuronal beta-tubulin (TUJ1) antibody
stain and DAPI nuclear counterstain. Scale bar unit length is is 150 μm.
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Figure 2-3. Establishment of 2iL cultures in the IO3 cESC line and preliminary
characterization by stage-specific embryonic antigen 4 (SSEA4) staining.
(A) Representative phase-contrast micrographs of IO3 cESCs in (I) LIF and FGF2 (L/F)
or (II) 2iL cESCs. Scale bar is 200 µm. (B) Direct immunofluorescence image for stagespecific embryonic antigen 4 (SSEA4) antibody stain. Scale bar unit length is 50 µm.
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factors. There was no difference in OCT4 or SOX2 protein abundance between L/F and
2iL cESCs (Fig. 2-4A-B, P = 0.76 & P = 0.36). Both L/F and 2iL cESCs exhibited
nuclear OCT4 staining (Fig. 2-4C). However, there was a significant induction of
NANOG in 2iL cESC lysates compared to L/F cESC samples (Fig. 2-5A, P = 9.0 x 10-4).
Further, OTX2 was significantly decreased in 2iL cESCs compared to L/F cESCs. (Fig.
2-5B, P = 3.5 x 10-3). OTX2 immunostaining was localized to the nucleus and perinuclear
region of L/F cESC colonies, whereas specific intracellular OTX2 staining was not
observed in 2iL cESCs (Fig. 2-5C). 2iL cESCs formed embryoid body (EB) aggregates in
suspension culture to assess cESC pluripotency in vitro (Fig. 2-6A). 2iL cESCs formed
EBs that could be directed to form putative early progenitors of endoderm, mesoderm,
and ectoderm as assessed by fluorescent immunocytochemistry for expression of
GATA4, GATA2, and neuronal beta-III tubulin (TUJ1), respectively (Fig. 2-6B-D).
We next investigated the gene expression signatures of several orthologous markers of
naïve and primed pluripotency in L/F or 2iL cESCs to determine whether these cells bear
transcriptional similarities to naïve mESC or primed mEpiSC/hESC. RT-qPCR analysis
revealed that naïve-like cESCs stabilized in 2iL exhibit significant reductions in the
relative transcript abundance of late epiblast markers, including FGF5, ACVR2B and
OTX2 (Fig. 2-7A, P < 0.039). Conversely, a significant induction of naïve pluripotency
markers REX1, TBX3, GBX2, PECAM1, and STAT3 (Fig. 2-7B, P < 0.035) was
observed in 2iL cESCs. The relative abundance of KLF4 and LIN28 transcripts did not
differ between L/F and 2iL cESCs (Fig. 2-7B). The down-regulation of naïve
pluripotency-associated transcripts following 2i removal is consistent with destabilization
of a naïve-like pluripotency program (Fig. 2-7B). These results suggest that 2iL promotes
a pluripotent phenotype with altered transcriptional profile resembling the ICM/early
epiblast, which is dependent on persistent repression of GSK3β and MEK1/2 signaling.

2.3.3

STAT3 phosphorylation but not SMAD2/3 signaling are
influenced by 2iL culture

To examine signaling pathways associated with maintenance of undifferentiated L/F and
2iL cESCs, we assessed the phosphorylation status of FGF-ERK, Activin-SMAD2/3, and
LIF-STAT3 signal transduction proteins. The fraction of phosphorylated ERK1/2
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Figure 2-4. 2iL cESCs express SOX2 and OCT4 with nuclear localization.
Representative western blot images from whole cell lysates and quantification by
densitometry for (A) OCT4 and (B) SOX2. Means are normalized to internal standard βactin and expressed as a relative ratio to LIF-FGF2 (L/F) cESC samples. Bars represent
standard error of the mean (SEM), n = 3. Means followed by the same letter are not
significantly different, P < 0.05. (C) Representative indirect immunofluorescence image
of OCT4 antibody stain and DAPI nuclear counterstain in (I) L/F cESCs and (II) 2iL
cESC colonies. Scale bar unit length is 150 μm.
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Figure 2-5. 2iL cESCs accumulate NANOG and down-regulate OTX2 compared to
L/F cESCs.
(A). Representative western blot images from whole cell lysates and quantification by
densitometry for (A) NANOG and (B) OTX2. Means are normalized to internal standard
β-actin and expressed as a relative ratio to L/F cESC samples. Bars represent standard
error of the mean (SEM), n =3. Means followed by the same letter are not significantly
different P < 0.05. (C) Representative indirect immunofluorescence image of OTX2
antibody stain and DAPI nuclear counterstain in (I) L/F cESCs and (II) 2iL cESC
colonies. Scale bar unit length is 150 μm.
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Figure 2-6. Canine ESCs expanded in 2iL retain tri-lineage differentiation capacity
in vitro.
(A) Isolated 2iL cESCs form embryoid bodies (EBs) in suspension culture. EB
outgrowths undergo directed differentiation to embryonic lineages in the presence of
specific chemical inhibitors and growth factors. Scale bar unit length is 300 μm. (B)
GATA4-positive cells form in the presence of Activin A and GSK3β inhibitor CHIR. (C)
Neuronal βIII tubulin (TUJ1)-positive cells form in the presence of BMP inhibitor
Noggin and ALK inhibitor SB431542. (D) GATA2-positive cells form in the presence of
FGF2 and BMP4. Scale bar unit length is 75 μm and applies to panels B, C and D.
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Figure 2-7. 2iL cESCs up-regulate several known naïve pluripotency-associated
transcripts but not primed pluripotency-related markers.
(A) Abundance of discriminatory transcripts of mammalian primed pluripotency within
L/F cESCs and cESCs cultured in 2iL. (B) Abundance of discriminatory transcripts of
mammalian naïve pluripotency in L/F cESCs, 2iL cESCs and the cell population formed
96 hours after 2i removal (LIF Only). Means are normalized to internal standard TATAbinding protein (TBP) and expressed as relative ratios to L/F cESC samples. Bars
represent standard error of the mean (SEM), n=3. Means followed by the same letter are
not significantly different, P < 0.05.
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(T202/204) was not significantly different between L/F and 2iL cESCs (Fig. 2-8A, P =
0.20). However, there was a significant increase in the ratio of phospho-STAT3 (Y705)
to total STAT3 in 2iL cESC lysates compared to L/F cESCs (Fig. 2-8B, P = 1.2 x 10-3).
Whereas the ratio of phospho-SMAD2 (S465/467) to total SMAD2/3 was unchanged
between cESCs populations (Fig. 2-8C, P = 0.74). Fluorescence immunocytochemistry
revealed no obvious difference in phospho-SMAD2 staining intensity, but unexpectedly
revealed a clear pattern of nuclear exclusion under both conditions (Fig. 2-9A-B).
We further assessed the integrity of the SMAD2/3 signaling pathway in L/F cESCs, as
well as the acute dependence on this pathway in steady-state culture. We quantified the
relative abundance of phospho-SMAD2 and SMAD4 in the presence of exogenous
Activin A or ALK inhibitor (SB431542). L/F cESCs were responsive to Activin A
supplementation, inferred from elevated SMAD2 phosphorylation after 96 hours of
treatment (Fig. 2-9C, P = 1.8 x 10-3). However, L/F cESCs also tolerated 10 µM
SB431542 with no overt differentiation over the same time course. Furthermore,
SB431542 treatment did not significantly alter the ratio of phospho-SMAD2 to total
SMAD2/3 protein levels compared to steady-state L/F cESCs (Fig. 2-9C, P = 0.17).
Collectively these results suggest that 2iL cESCs have more pronounced STAT3
signaling with no change in SMAD2 phosphorylation. Furthermore, L/F cESCs have
intact Activin-SMAD2/3 signal transduction machinery and need only low basal levels of
SMAD2/3 phosphorylation for proliferation in vitro.

2.3.4

L/F cESCs exhibit a greater lineage-specific bias for
neurectoderm and mesoderm differentiation

To investigate whether 2iL culture alters the inherent neural lineage bias of L/F cESCs,
the ability of either cESC population to form NESTIN (NES) positive neural
stem/progenitor cells under spontaneous and directed differentiation conditions were
compared. Intriguingly, 2iL cESCs exhibited a lower efficiency of neural differentiation
under spontaneous differentiation conditions (P = 2.7 x 10-3), but not under directed
differentiation culture (P = 0.402), compared with L/F cESCs (Fig. 2-10A-B). Given the
context-dependent role of BMP4 signaling in promoting mESC maintenance or inducing
non-ectodermal differentiation of mEpiSC (Bernardo et al., 2011; Ying et al., 2003),
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Figure 2-8. Enhanced STAT3 phosphorylation in 2iL-enriched cESCs.
Representative western blot membrane images and quantification by densitometry for
phosphorylated (p) and total (A) ERK1/2, (B) STAT3 and (C) SMAD2 Means are
normalized to internal standard β-actin and expressed as relative ratios to L/F cESC
samples. Bars represent standard error of the mean (SEM), n = 3. Means followed by the
same letter are not significantly different P < 0.05.
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Figure 2-9. Steady-state L/F cESCs exhibit cytosolic phospho-SMAD2 and tolerate
acute inhibition Activin-like kinase (ALK) activity.
Representative indirect immunofluorescence image for phosphorylated SMAD2
(pSMAD2) in (A) LIF-FGF2 cESCs and (B) 2iL cESCs. Nuclei were counterstained
DAPI and the scale bar unit length is 200 μm. (C) Representative immunoblot and
densitometric quantification of phosphorylated and total SMAD2 as well as SMAD4 in
L/F cESCs treated with 10 µm SB431542 (ALKi) or 20 ng/mL Activin A (AcvA) for 96
hours. Bars represent standard error of the mean (SEM), n = 3. Means followed by the
same letter are not significantly different, P < 0.05.
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Figure 2-10. L/F cESCs exhibit a greater sensitivity for spontaneous neural
differentiation and BMP4-induced mesendoderm differentiation.
(A) Representative indirect immunofluorescence image of neural intermediate filament
protein Nestin (NES) antibody stain and DAPI nuclear counterstain. Scale bar unit length
is 150 μm. (B) Enumeration of NES+ embryoid body outgrowths L/F cESCs or 2iL
cESCs in the presence of minimal media (spontaneous), or Noggin and SB431542
(directed). (C) Representative phase-contrast micrographs resultant L/F cESC or 2iL
cESC cultures following 20 ng/mL BMP4 treatment for 96 hours. Scale bar unit length is
150 μm. (D) Relative quantity of early differentiation transcripts associated with nonectodermal lineages in L/F and 2iL cESC cultures in the presence and absence of 20
ng/mL BMP4. Bars represent standard error of the mean (SEM), n=3. Means followed by
the same letter are not significantly different, P < 0.05.
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we assessed the sensitivity of 2iL and L/F cESCs to differentiation in the presence of
BMP4. L/F cESCs supplemented with 20 ng/mL BMP4 for 96 hours lost planar
epithelium-like morphology and formed a heterogeneous mixture of narrow fibroblastic
and broader vacuolated derivatives (Fig. 2-10C). In contrast, 2iL cESCs exhibited no
observable morphological differentiation in a parallel BMP4 treatment (Fig. 2-10C). The
expression of mesodermal markers Snail family transcriptional repressor (SNAI1), fetal
liver kinase 1 (FLK1) and heat and neural crest derivatives expressed 1 (HAND1) were
significantly upregulated following BMP4 addition to L/F cESCs (P < 0.032), but not for
2iL cESCs (Fig. 2-10D). Transcripts for pan-endodermal markers (SOX17, FOXA2) and
visceral endoderm marker hepatocyte nuclear factor 4A (HNF4A) were not detected in
BMP4-treated cESCs by RT-qPCR. In summary, 2iL cESCs exhibit a lesser intrinsic
neural differentiation bias and a lower sensitivity to BMP-induced mesodermal
differentiation. These results indicate that 2iL cESCs exhibit different regulative
characteristics than L/F cESCs.

2.3.5

DNA methylation and H3K27me3 modifications are depleted
in 2iL cESCs

To investigate whether 2iL enriched cESCs contain a lower abundance epigenetic
modifications associated with development, we probed genomic DNA and protein
samples from cESCs using antibodies that selectively recognize epitopes containing these
covalent modifications. Culture of cESCs in 2iL induced a significant decrease in relative
genome-wide DNA methylation compared with L/F cESCs (Fig. 2-11A, P = 0.048). In
addition, the ratio of H3K27me3 to total histone H3 was increased in L/F cESCs
compared to 2iL cESCs (Fig. 2-11B-C, P = 0.031). Pan histone H3 acetylation (H3Ac)
did not significantly differ between L/F and 2iL cESCs (Fig. 2-11D, P = 0.92). Subtle
differences in the pattern of nuclear H3K27me3 localization was also observed between
cESC populations. L/F cESCs displayed non-uniform condensations of H3K27me3,
whereas H3K27me3 immunofluorescence showed diffuse patterns in 2iL cESCs (Fig. 212A-C, P < 6.5 x 10-3). Collectively, our results suggest that epigenetic modifications
associated with developmental gene silencing are less prominent in 2iL cESCs.

97

Figure 2-11. DNA methylation and H3K27me3 modifications are depleted in 2iL
cESCs.
(A) Percent of 5-methylcytosine (5-mC) per 100 ng of purified genomic DNA, quantified
in L/F cESCs and 2iL cESCs by 5-mC DNA ELISA. (B) Representative western blot
images for total acetylated histone H3 (H3Ac), histone H3 lysine 27 trimethylation
(H3K27Me3) and total histone H3. Densitometric quantification of (C) H3Ac and (D)
H3K27Me3 normalized to total histone H3. Mean are expressed as relative ratios to
canine dermal fibroblasts (cDFs) samples. Bars represent standard error of the mean
(SEM), n=3. Means followed by the same letter are not significantly different, P < 0.05.
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Figure 2-12. Decreased nuclear condensations of H3K27me3 antibody stain are
observed in 2iL cESCs.
(A) Representative indirect immunofluorescence image of H3K27Me3 antibody staining
in (I) L/F cESCs and (II) 2iL cESC colonies. The scale bar unit length is 100 μm (B)
Barplot depicting the percentage of H3K27Me3+ nuclei that meet staining pattern criteria.
Bars represent standard error of the mean, n=4. Means followed by the same letter are not
significantly different, P < 0.05. (C) Digital zoom of merged image of L/F cESC in panel
A with a scale bar unit length of 25 μm. The asterisks symbol (*) denotes a nucleus with
a single focus, the dagger symbol (†) represents a nucleus with multiple H3K27Me3
clouds and the hash symbol (#) indicates a nucleus without observable condensations.
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2.3.6

Enhanced colony-forming efficiency but not tumorigenicity of
2iL cESCs

Population doubling time and colony-forming efficiency were quantified to compare
growth kinetics of cESCs populations, which is relevant for gene-targeting applications.
Culture with 2iL significantly prolonged the calculated linear-phase population doubling
time from approximately 33 hours in L/F cESCs to 52 hours in 2iL cESC cultures (Fig. 213A, P = 3.0 x 10-3). Moreover, the population doubling interval of both L/F and 2iL
cESCs were significantly greater than that of conventional mESC and hESC lines (Fig. 213A, P < 0.035). Upon single-cell dissociation, the ability of L/F cESCs to re-establish
pluripotent SSEA4+ colonies (~ 0.03% efficiency) was not significantly different from
control media lacking LIF and/or FGF2 (Fig. 2-13B-C). In contrast, singularized 2iL
cESCs re-seeded into 2i medium without LIF formed SSEA4+ colonies at a significantly
lower efficiency (0.25%) compared with 2iL cESCs (3.18%) (Fig. 2-13D, P < 0.0001).
The cloning efficiency achieved with 2i alone was significantly greater than medium
containing only LIF or control basal medium (Fig. 2-13D, P = 0.045). Individualized 2iL
cESCs have greater viability in single-cell suspensions compared to L/F cESCs following
enzymatic dissociation (Fig. 2-13E, P = 0.039). Our findings suggest that 2iL culture
compromises the rate of cESC proliferation but improves the ability of cESCs to form
clonal populations, in part by reducing cell death when colonies are disaggregated.
Intramuscular xenograft assays were performed in NOD/SCID/IL2R-/- immune deficient
mice to examine whether 2iL and L/F cESCs differ in their capacity for proliferation and
differentiation in vivo. Control mice injected with hESCs (n = 2/2) generated well-formed
teratomas by 6 weeks (Fig. 2-14A), composed of mature derivatives of mesoderm
(hyaline cartilage), endoderm (villus epithelium), and ectoderm (melanocytes). However,
no overt tumor growth was observed 10 weeks following transplantation of either L/F (n
= 0/3) or 2iL (n = 0/3) cESCs.
Prolonged culture of independent 2iL cESC derivations (>20 passages) revealed that
cESCs in 2iL media have a limited replication capacity in the undifferentiated state. It
remains possible that karyotypically abnormal cells accumulate within extended cESC

100

Figure 2-13. Altered growth kinetics and colony-forming efficiency between L/F and
2iL cESCs.
(A) Calculated population doubling time (hours) from cell counts in steady-state growth
conditions for L/F cESCs, 2iL cESCs, human ESC line HES2 and mouse ESC line R1.
(B) Representative images of SSEA4+ colonies from (I) L/F cESC or (II) 2iL cESC
cultures, five-days post dissociation and seeding at clonal density. Scale bar unit length is
150 µm. SSEA4+colonies from (C) L/F cESC or (D) 2iL cESC cultures were counted,
and single-cell cloning efficiency was calculated as a percentage of cells seeded. (E)
Percentage of viability cESCs following enzymatic dissociation to single-cells of
individual cESCs was identified by Trypan Blue exclusion. Bars represent standard error
of the mean, n=3-6. Means followed by the same letter are not significantly different, P <
0.05.
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Figure 2-14. In vivo tumorigenicity and differentiation potential of typical human
ESC line is not recapitulated by either L/F or 2iL cESCs.
(A) Representative hematoxylin and eosin stained sections of tumour derived from
human ESC xenografts. Cell types and lineages represented include (I) villus gut
epithelium (endoderm), (II) hyaline cartilage (mesoderm) and (III) pigmented epithelium
(ectoderm). (B) Representative metaphase spreads of normal diploid (I) and abnormal
polyploid (II) canine karyotypes.
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culture by genetic drift. Metaphase spreads and Giemsa staining revealed detectable
polyploid cell populations alongside karyotypically normal (2n = 78 XY) cESCs (Fig. 214B). Therefore, disruptions in cESC self-renewal long-term are associated with the
emergence of karyotypic abnormalities in prolonged cESC culture.

2.4 Discussion
cESC lines with differing morphological and cell surface glycoproteins have been
derived from canine preimplantation embryos (Vaags et al., 2009; Wilcox et al., 2009).
However, heterogeneous features ascribed to these cESC cultures may be explained by
the unique genetic backgrounds between individual embryo outgrowths. Previous cESC
studies have limited the scope of investigation to core pluripotency-associated factors,
rather than discriminatory markers of naïve versus primed pluripotency. Our data indicate
that culture in 2iL enriches for a morphologically and molecularly distinct cESC
population from originating L/F cESCs, which shares several features to other
mammalian naïve PSCs. This naïve pluripotency-like phenotype was associated with
elevated STAT3 phosphorylation, induction of several RNA transcripts characteristic of
the mammalian epiblast and fewer epigenomic modifications associated with gene
silencing. These findings provide the first evidence that partial repression of MEK1/2 and
GSK3β in the absence of exogenous FGF2 may support an earlier developmental state in
cESCs.
After initial comparisons of the dog and human genome assembly revealed a high degree
of genomic synteny (Ostrander and Wayne, 2005), the stem cell community was
optimistic that cESC would exhibit greater similarly to hESC than mESC (Tecirlioglu
and Trounson, 2007). In the absence of small molecule inhibitors, cESCs require
exogenous FGF2 co-supplementation for in vitro proliferation (Vaags et al., 2009;
Wilcox et al., 2009), which is reminiscent of primed mEpiSC/hESC. Conventional hESC
lines are insensitive to LIF and refractory to nuclear reprogramming towards naïve-like
pluripotency with 2i alone (Dahéron et al., 2004; Hanna et al., 2010). In contrast,
mEpiSCs may be reverted to naïve pluripotent state in LIF-containing media and this
process may accelerated through the application of 2i (Adachi et al., 2018; Han et al.,
2010; Onishi et al., 2012). In this respect, L/F cESCs more closely resemble the
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developmental plasticity exhibited by mEpiSCs, which may be conferred to a subset of
cESCs by pre-existing STAT3 signaling pathway activity. Accumulating evidence
suggest that stabilization of naïve-like pluripotent state in primates requires a more
comprehensive selection of inhibitors and growth factors (Gafni et al., 2013; Takashima
et al., 2014; Theunissen et al., 2014; Ware et al., 2014). Hyperactivity of JAK/STAT3
signaling can drive reprogramming towards a naïve-like pluripotent state despite the
presence of other antagonistic cues in both mice and humans (Chen et al., 2015; Van
Oosten et al., 2012), lending support to a conserved role of STAT3 transcriptional
activity in promoting a naïve pluripotency transcriptional network
Evolutionary variation to the wiring of pluripotency-associated transcription factors and
their relationships to developmental signaling pathways may result in species-specific
GRN memberships, hierarchical relationships, or characteristics of permissive niche
microenvironments (Barakat et al., 2018; Glinsky, 2015; Kojima et al., 2017). We show
that OCT4 and SOX2 are detected at similar levels in L/F and 2iL cESCs. Furthermore,
we observe reciprocal changes in the abundance of NANOG and OTX2, which are
expressed in the murine ICM/early epiblast or the late epiblast/anterior primitive streak,
respectively (Acampora et al., 2012; Aizawa et al., 2004; Chambers et al., 2007). These
findings indicate that changes to core pluripotency GRN topology in cESC during
transitions between pluripotent states may share greater similarity to mESC/mEpiSC than
human primed and naïve PSCs. With respect to the functional relevance of extrinsic
factors promoting canine pluripotency, Luo et al. stipulated that LIF and FGF2 have antiapoptotic and pro-proliferation roles in canine iPSC lines, respectively (Luo et al., 2011).
In a follow up study, the same LIF and FGF2-dependent canine iPSC lines rely on
paracrine Activin A signaling from MEF feeders (Luo and Cibelli, 2016). Conversely,
L/F cESCs described in the present study appear to have adopted a self-renewal program
largely unaided by Activin-SMAD2/3 signaling. We have not yet extended SB431542
treatments beyond a single passage of L/F cESCs to directly investigate the fundamental
importance of ALK-SMAD2/3 signaling to long-term maintenance of primed-like cESCs.
In our culture microenvironment, we provide exogenous ligands for the phosphoinositide
3 kinase-protein kinase B pathway (e.g. IGF, FGF2) that has been shown to modulate
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SMAD2/3 signaling in hESC and in other cell types promote the cytosolic sequestration
of SMAD2/3 (Conery et al., 2004; Remy et al., 2004; Singh et al., 2012).
Naïve and primed PSCs correspond to distinct spatiotemporal iterations of the developing
embryo, and hence may be differentially responsive to lineage specifying cues in ways
that reflect their in vivo approximate. BMP4 has a role in both naïve pluripotency
maintenance and lineage restriction in the gastrulating embryo, the latter of which shares
transcriptomic similarity to primed PSCs (Bernardo et al., 2011; Kojima et al., 2014;
Ying et al., 2003). Induction of definitive mesoderm markers following BMP4 exposure
in L/F cESCs but not in 2iL cESCs suggest the former is characteristic of precursors
undergoing epithelial-to-mesenchymal transition. This response is consistent with the role
of BMP4 in murine gastrulation in the formation primitive streak mesoderm (Winnier et
al., 1995). We note that cell fate trajectories of BMP4-treated primed PSCs are highly
contextual, and relative activities of the FGF or WNT signaling pathways may influence
the predominant cell fate by crosstalk mechanisms (Bernardo et al., 2011; Bhushan et al.,
2012). mEpiSCs share a transcriptome signature with the anterior primitive streak and
appear to be poised for neural specification primed PSC (Iwafuchi-Doi et al., 2012;
Kojima et al., 2014). Our L/F cESCs share a similar lineage bias towards neural lineages
(Wilcox et al., 2011). We found that 2iL cESCs exhibit a less pronounced neural lineage
bias under spontaneous differentiation conditions but not when differentiation is directed
with Noggin. These findings indicate that 2iL cESC are likely not a direct precursor to
the neural lineage and have a similar capacity for neural differentiation when
appropriately specified.
2iL cESC colonies are induced over a prolonged time course (1-2 weeks), which is
consistent with a selection or epigenetic reprogramming event rather than an adaptive
response to a unique microenvironment. The difference in global DNA methylation
between 2iL enriched cESCs compared to L/F cESCs is indicative of an epigenetic
barrier that prevents the resetting of the most parental cESCs. Similar magnitudes of
DNA demethylation are observed upon treatment of S/L mESC with 2i and has been
mechanistically linked altered DNMT and TET enzyme activity (Hackett et al., 2013;
Leitch et al., 2013). Consistent with the notion that 2iL cESCs adopt an earlier
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developmental identity, we observed a decline in global H3K27me3. The H3K27me3
modification is a hallmark of polycomb repressive complex activity that establishes
facultative heterochromatin during differentiation and the naïve to primed transition
(Gifford et al., 2013; Tosolini et al., 2018). Histone H3 acetylation was maintained in 2iL
culture compared to LIF-FGF2 cESCs, which may reflect generalized chromatin
plasticity of the pluripotent state (Melcer et al., 2012; Meshorer et al., 2006). Further
experimentation in genetically female cESC lines may shed light on the dynamics of Xchromosome inactivation in canine development. Interestingly, Whitworth et al. detected
two active X-chromosomes in female canine iPSC lines and multipotent stromal cells,
which may indicate species-specific regulation of X-chromosome activation status
(Whitworth et al., 2014). Otherwise a lack of X-chromosome dosage compensation in
canine iPSC-derived somatic cells could result from incomplete silencing of the six
reprogramming transgenes (Whitworth et al., 2014).
Low clonogenicity related to slow growth kinetics and sensitivity to enzyme-induced
apoptosis is generally understood as a property of primed PSCs (Hanna et al., 2010).
Improvements in cloning efficiency with 2iL cESCs (~ 3%) are consistent to what other
groups have reported in naïve porcine cell lines (~12%), but far below cloning
efficiencies achieved in hESC and mESC lines (~40%) (Gafni et al., 2013; Gu et al.,
2014). Furthermore, expansion of cESCs in 2iL did not grant teratoma-forming ability in
immunodeficient mouse xenografts. Canine PSCs have had low success and poor
reproducibility with these traditional in vivo assays of self-renewal and differentiation
into mature lineages. The lack of any tumor mass following transplantation suggests that
apoptosis or senescence within the in vivo niche may be a barrier to successful teratoma
assay outcomes. Whereas the finite proliferation of 2iL cESCs is similar to what has been
described for naïve ESC lines independent of ectopic transfactors (Hanna et al., 2010)
and may reflect the inability of the culture conditions to sustain the naïve transcriptional
circuitry long-term.
In summary, the described work represents the first evidence for population-level
metastability in canine PSCs and reveals an opportunity to alter pluripotent
characteristics of cESCs using small-molecule kinase inhibitors. This study lends
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additional support to a conserved role for 2iL in promoting a naïve-like pluripotent state
in mammals. However, the 2iL culture medium appears to be unable to fully support the
self-renewal of reset cESCs long term. Given the recent success of empirically
consolidated kinase inhibitor combinations in primate ESCs, we suspect that subtle
modifications to the 2iL culture system, alone or in combination with genetic
modification, may support a stable naïve pluripotency phenotype. Although the growth
kinetics and bioprocessing characteristics of cESC are suboptimal for applications in
transplantation medicine, our results demonstrate that the binary L/F and 2iL cESC
cultures can yield new insights into canine preimplantation development and conserved
features of mammalian pluripotency.
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Chapter 3

3

Pluripotent state influences metabolic activity and
mitochondrial structure in canine embryonic stem cells

A version of this chapter has been published:
Tobias, I.C., Isaac, R.R., Dierolf, J.G., Khazaee, R., Cumming, RC, and Betts, D.H.
(2018). Metabolic plasticity during transition to naïve-like pluripotency in canine
embryo-derived stem cells. Stem Cell Research 30, 22-33.
Reproduced here with permission from Elsevier publishers (Appendix B).
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3.1 Introduction
Naïve and primed PSCs are metastable and occasionally interconvertible cell lines, which
represent different temporal cellular compartments within the pre-implantation embryo
(Brons et al., 2007; Nichols and Smith, 2009; Tesar et al., 2007). The naïve pluripotent
state may be established directly from cells of the inner cell mass (ICM) or induced by
pharmacological manipulation of primed PSCs, with or without the assistance of
transgenes favouring naïve pluripotency (Bao et al., 2009; Guo et al., 2009; Nichols et al.,
2009). The molecular and functional characteristics that distinguish naïve pluripotency
are tolerance to partial repression of mitogen-activated protein kinase kinase (MEK)
signaling and abrogation of T-cell factor 3 (TCF3) signaling (Meek et al., 2013; Wray et
al., 2011; Zhou et al., 2015), global epigenomic de-repression (Ficz et al., 2013; Leitch et
al., 2013), reactivation of the silent X-chromosome in female cells (Gafni et al., 2013;
Ware et al., 2014), ease of clonogenic selection and contribution to embryonic lineages of
pre-gastrulation embryos (Buecker et al., 2010; Gafni et al., 2013).
Both naïve and primed PSCs exhibit high rates of glycolysis in hyperoxic environments,
resembling the aerobic glycolysis phenotype observed in certain transformed cells
(Racker, 1972; Vander Heiden et al., 2009; Zhang et al., 2012a). The diversion of
metabolic intermediates from complete mitochondrial oxidation supplies intermediates to
anabolic pathways, while mitigating the production of reactive oxygen species (ROS)
(Folmes et al., 2011; Panopoulos et al., 2012; Varum et al., 2009). This metabolic state
differs from specialized post-natal cell types, which prioritize efficient adenosine
triphosphate (ATP) synthesis by oxidative phosphorylation (OXPHOS) (Chung et al.,
2007). Interestingly, naïve PSCs have greater rates of respiration despite housing less
mature mitochondria compared to their primed counterparts (Sperber et al., 2015; Zhou et
al., 2012). Mitochondrial function is restrained in primed PSCs by uncoupling the
oxidation of glycolysis-derived pyruvate (Samudio et al., 2009; Zhou et al., 2012).
Mitochondrial homeostasis and energy production may be linked to pluripotency and
self-renewal via the metabolic sensor AMP-activated protein kinase (AMPK) (Liu Y et
al., 2019). However, it remains unclear whether the AMPK pathway is differentially
regulated in a pluripotent state-specific manner.

114

The existence of a de facto naïve pluripotent state in non-rodent species is controversial.
However, naïve-like PSC lines have been characterized in various mammalian species
including porcine (Nakano et al., 2013), rabbit (Osteil et al., 2013), equine (Whitworth et
al., 2014) and bovine (Verma et al., 2013). Canine ESCs (cESCs) can be derived and
expanded on mouse embryonic fibroblast (MEF) feeder layers in the presence of
leukemia inhibitory factor and fibroblast growth factor 2 (L/F) (Tobias et al., 2013).
These LIF-FGF2 dependent cESCs exhibit features of primed pluripotency such as
sensitivity to enzymatic passaging regimes, expression of primed pluripotency markers
(e.g. OTX2, FGF5) and a neural lineage bias in minimal media (Wilcox et al., 2011,
2009). In the previous chapter, I showed that dual inhibition of MEK and GSK3β along
with LIF (2iL) conditionally stabilizes cESCs in a pluripotent state that shares several
properties with canonical naïve PSCs (Chapter 2). Interestingly, our 2iL cESCs show
markedly slower in vitro growth compared to initiating LIF-FGF2 cESC populations
(Tobias et al., 2016). Nevertheless, the fundamentals of pluripotent state progression
appear to be conserved in placental mammals, making it a priority to define the divergent
attributes and culture requirements of non-rodent equivalents to naïve and primed PSCs.
PSC metabolism is inherently flexible, permitting the maintenance of proliferation and
differentiation capacity within a dynamic physicochemical environment (Harvey et al.,
2016), but the persistence of suboptimal conditions would be expected to negatively
impact PSC physiology. All canine ESC/iPSC lines established to date are maintained in
media formulations previously optimized for the growth of human or mouse PSCs (Betts
and Tobias, 2015). Furthermore, imprecise definition of the extrinsic requirements for
canine PSC self-renewal may hinder the ability of these lines to proliferate extensively in
vitro or demonstrate pluripotency in vivo through teratoma formation. The goal of this
work is to assess mitochondrial function and the contribution of bioenergetic pathways to
proliferation in the undifferentiated state for primed-like LIF-FGF2 cESCs and naïve-like
2iL cESC populations. We propose that different metabolic pathway activities support
ATP generation and biomass accumulation necessary for proliferation of cESCs.
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3.2 Materials and Methods
3.2.1

Feeder Layer and Embryonic Stem Cell Culture

MEF monolayer preparation and culture of cESCs were conducted as previously
described (Tobias et al., 2016). Briefly, E12.5 DR4 MEFs were mitotically arrested and
seeded at 1.5 x 104 cells/cm2 for ESC co-culture. Canine ESC lines (BE5, IO3) derived at
the Ontario Veterinary College from embryo explants (OVC.EX) (Wilcox et al., 2009)
were seeded onto growth-arrested MEFs and cultured in base media: KnockOut
DMEM/F12, 15% KnockOut Serum Replacement (KOSR), 1X GlutaMAX, 1X nonessential amino acids, 10 ng/mL recombinant insulin-like growth factor (R3IGF1; Sigma
Aldrich) and 0.1 mM 2-mercaptoethanol. Base medium was supplemented with 10
ng/mL human LIF and 4 ng/mL human FGF2 for maintenance of control L/F cESCs; or
10 ng/mL human LIF, 0.5 μM MEK inhibitor PD0325901 and 3 μM GSK3β inhibitor
CHIR99021 for establishment and culture of 2iL cESCs (Tobias et al., 2016). To deplete
MEF contamination prior to experiments, cESCs were transferred to Geltrex-coated
dishes and cultured with 70% MEF-conditioned medium balanced with non-conditioned
base media. Control human ESC line HES-2 (Reubinoff et al., 2000) and murine ESC
line R1 (Nagy et al., 1993) were adapted and maintained in base medium containing 15%
KOSR for at least three passages prior to analyses to standardize nutrient availability
(Zhang et al., 2016). Incubators were maintained at 37°C, 5% CO2 and ambient oxygen.
Unless otherwise stated, all cell culture reagents were obtained from Thermo Fisher
Scientific (MA, USA). Inhibitors of metabolic enzymes were from Sigma Aldrich (MO,
USA).

3.2.2

Oxygen Consumption Rate and Extracellular Acidification
Rate

Cells were seeded onto Geltrex-coated XFe24 Seahorse plates (Agilent Technologies) at 3
× 104 or 6 × 104 cells per well. Culture media were exchanged for unbuffered media
supplemented with either 1 mM sodium pyruvate and 10 mM glucose (Mitochondrial
assay); or 2 mM glutamine (Glycolysis assay) one hour before the assay. After basal
metabolic readings were recorded, substrates and selective inhibitors were injected to
achieve final concentrations of: glucose (2.5 mM), 4-(trifluoromethoxy) phenylhydrazone
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(FCCP, 1 μM), oligomycin (1 μM), 2-deoxyglucose, (2-DG, 50 mM) antimycin A (2.5
μM) and rotenone (2.5 μM). Changes in oxygen consumption rate (OCR) and
extracellular acidification rate (ECAR) in response to the addition of substrates/inhibitors
were described as the mean change after injection compared with the average OCR or
ECAR before the injection. The OCR and ECAR values were normalized to the total
quantity of protein isolated from each well.

3.2.3

Protein Extraction, SDS-PAGE and Western Blotting

Cells were lysed in 100 μL RIPA buffer (150 mM sodium chloride, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris, pH 8.0) with a protease
and phosphatase inhibitor cocktail (EMD Millipore) for 15 minutes on ice. Supernatant
protein concentration was determined by DC™ Protein Assay (BIO-RAD Technologies).
Protein lysates were resolved on 4-12% SDS-PAGE gels (Thermo Fisher Scientific),
transferred onto Immobilon polyvinylidene difluoride membranes followed by incubation
with 5% skim milk powder/TBS/0.1% Tween-20 for 1 hour. Antibodies used in the work
are summarized in Table 3-1. After 16 hours of primary antibody incubation, membranes
were incubated with HRP-coupled secondary antibodies for 1 hour at room temperature.
Immune-reactive proteins were visualized by chemiluminescence on Molecular Imager®
VersaDoc™ System and Quantity One software (BIO-RAD Technologies). Densitometry
was performed using ImageLab 3.0 software (BIO-RAD Technologies).
Table 3-1. Primary antibody information
Target Protein
ACC1
p-ACC (S79)
AMPKα
p-AMPKα (T172)
ATP5A
FASN
GLUT1
HXK2
LDHA
MIC60
PDH (E1α)
p-PDH (S232)

Isotype Species
Rabbit
Rabbit
Rabbit
Rabbit
Mouse
Mouse
Rabbit
Mouse
Rabbit
Rabbit
Mouse
Rabbit

Application
(Dilution)
WB (1:1000)
WB (1:1000)
WB (1:500)
WB (1:500)
WB (1:1000)
WB (1:1000)
WB (1:500)
WB (1:2000)
WB (1:1000)
WB (1:2000)
WB (1:2000)
WB (1:2000)

Supplier (Catalog)
Cell Signaling (3662)
Cell Signaling (3661)
Cell Signaling (2603)
Cell Signaling (2535)
Abcam (AB14748)
Santa Cruz (sc-48357)
Santa Cruz (sc-7903)
Novus (NBP2-02272)
Cell Signaling (2012)
Novus (NB100-1919)
Abcam (AB110334)
Millipore (AP1063)
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PKM1
PKM2
PDHK1

Rabbit
Rabbit
Rabbit

WB (1:1000)
WB (1:1000)
WB (1:1000)

SDHB
TOMM2
UQCRC2

Mouse
Rabbit
Mouse

WB (1:1000)
WB (1:1000)
WB (1:1000)

3.2.4

Proteintech (15821-1AP)
Proteintech (15822-1AP)
Enzo (ADI-KAPPK112)
Abcam (AB14745)
Proteintech (11802-1AP)
Abcam (AB14714)

Flow Cytometric Analysis of cESC-MEF Co-cultures

To discriminate cESCs from feeder cells, the plasma membrane of MEFs were stained
with lipophilic dialkylcarbocyanine dyes (Nakayama et al., 1992) in either the green (SPDiOC18) or far red (Di-D) fluorescent spectrum. Adherent MEFs were stained with 5
μg/mL of Di-D or SP-DiOC18 diluted in culture media for two hours at 37°C. MEFs were
washed twice with PBS prior to seeding L/F or 2iL cESCs. Events were recorded using
the Accuri C6 platform (BD Bioscience) using standard laser configuration, a flow rate of
35 μL/minute and the following optical filters: 533/30 (FL-1), 585/40 (FL-2), 670 LP
(FL-3) and 675/25 (FL-4). Single colour or fluorescence minus one control samples
containing an equivalent volume of diluent were included to set analyses gates and to
threshold background autofluorescence. Briefly, the single-cell population was gated by
pulse processing (pulse height vs. pulse area) to remove cell dublets and obvious debris.
Markers were applied to FL-1A and FL-4A cytograms to exclude SP-DiOC18 or Di-D
stained MEFs from further interrogation. Average fluorescence intensity values from are
presented as the geometric mean.

3.2.5

Chemifluorescence and Flow Cytometry

JC-1 green fluorescence reflects JC-1 monomers and the formation of J+-aggregates in
the mitochondrial matrix leads to orange fluorescence. The dual-colour properties of JC-1
allows a ratiometric comparison of relative mitochondrial polarization states (Cossarizza
et al., 1993; Smiley et al., 1991). Tetramethylrodamine methyl ester (TMRM) is a
yellow-red fluorescent stain, which is highly sensitive to changes in the mitochondrial
electrochemical gradient (Scaduto and Grotyohann, 1999). However, MitoTracker Green
FM has been reported to stain mitochondria regardless of chemical ablation of the ΔΨm
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(Buckman et al., 2001). For mitochondrial labelling, single live cells in suspension were
adjusted to a density of approximately 1 x 106 cells/mL in flow staining buffer and
incubated with 200 nM MitoTracker Green or 5 μg/mL JC-1 for 30 minutes protected
from light. Alternatively, single live cells were incubated with 150 nM TMRM for 15
minutes. 30,000 total events were recorded at a flow rate of 35 μL/minute. In JC-1
experiments, spectral compensation was performed by subtracting 12% of FL-1A from
FL-2A. In TMRM experiments, spectral compensation was performed by subtracting 9%
of FL-1A from FL-2A. Relative ΔΨm was calculated as geometric mean of FL-2A
fluorescence intensity (for TMRM) or the ratio of FL2-A: FL1-A geometric mean
fluorescence intensity (J+-aggregate: JC-1 monomer).

3.2.6

Chemifluorescence and Live Cell Imaging

Cells were stained for 1 hour with 1 μM Calcein Green AM and then 15 minutes with 25
nM TMRM diluted in Live Cell Imaging Solution (Thermo Fisher Scientific). Cells were
imaged within a 5% CO2 live cell imaging chamber mounted on the stage of a Leica DMI
6000B microscope. Digital images were captured with an Orca Flash camera
(Hamamatsu Photonics) and Application Suite X software (Leica Microsystems).
Exposure time, illumination intensity and experimental duration were minimized to
preserve mitochondrial integrity and avoid artefactual changes in fluorescence intensity
(Iannetti et al., 2016; Mitra and Lippincott-Schwartz, 2010). Brightness and contrast
were standardized to unstained control samples and the equivalent imaging parameters
were applied to all other images using ImageJ. Membrane potential was calculated as the
change in fluorescence intensity of TMRM in redistribution (non-quenching) mode after
FCCP-induced mitochondrial depolarization. Calcein fluorescence was recorded to
control for plasma membrane integrity. Fluorescent intensity was monitored for five
minutes to establish baseline values (set to 100%) and an additional fifteen minutes after
treatment with 250 nM FCCP or vehicle (DMSO). The mean fluorescent intensity of
cytoplasmic foci corresponding to mitochondria in cESCs was measured using ImageJ
(National Institutes of Health, MD).
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3.2.7

Mitochondrial and Genomic DNA Isolation and Quantitative
PCR

Mitochondrial DNA (mtDNA) and genomic DNA were purified from cESC pellets using
GenElute Mammalian Genomic DNA Miniprep Kit (Sigma Aldrich), according to
manufacturer's instructions. Quality and quantity of DNA was determined through
spectrometry using a NanoDrop ND-2000 (NanoDrop Technologies). Oligonucleotide
primers targeting cytochrome oxidase II (MTCOII) were designed from published canine
mtDNA sequences (Kim et al., 1998) using accession number U96639.2. Polycystin-1
(PKD1) was selected as a single copy genomic reference gene in the domestic dog
(Dackowski et al., 2002). Primer sequences and amplicon sizes are summarized in Table
3-2. Specificity of each primer set was determined by gel electrophoresis, band excision
and sequencing of the resultant amplicon using the Applied Biosystems 3730 DNA
Analyzer (London Regional Genomics Center). Quantitative PCR was performed using 6
ng of template DNA and SensiFAST ™ SYBR (Bioline Reagents, MA). Thermal cycling
conditions included 2 minutes at 95°C followed by 39 cycles of 95°C for 5 seconds, 62°C
for 10 seconds and 72°C for 20 seconds. Reaction data were corrected for individual
primer amplification efficiencies, calculated from a standard dilution series. Relative
transcript abundance was determined using CFX384 Real-time system on a C1000
Thermal Cycler (BIO-RAD Technologies) CFX software and calculated using 2-ΔΔCt
method.
Table 3-2. Custom oligonucleotide primer sequences.
Gene Identifier
MTCO2
PKD1

3.2.8

Sequence (5’ to 3’)
F – ATCGCTCTACCTTCCCTCCG
349
R – ACAGTCCTGGTCGTATGGCT
F – AGCTGCATAACTGGATCGACAAC 128
R – ATGTAACGCATGGGGAACCG

Size (bp)

Sample Preparation for Transmission Electron Microscopy

Briefly, cells were washed with PBS and fixed directly on the plate with a pre-warmed
1:1 mixture of media and Karnovsky’s fixative (2% Paraformaldehyde, 2.5%
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Glutaraldehyde, 0.1 M Sodium Cacodylate, pH 7.4) for 10 minutes. Cells were gently
scraped into a 1.5 mL microcentrifuge tube and gently pelleted at a very low speed (200
RCF with no centrifuge braking). Cells were resuspended in pure Karnovsky’s fixative
(10-20X the pellet volume) for 15 minutes, then gently pelleted and resuspended in fresh
Karnovsky’s fixative. Primary fixation continued for 2 hours, then cells were washed four
times in 0.1 M Sodium Cacodylate buffer, pH 7.4 for 5 minutes each. Samples were
encapsulated 2% agarose, cut into 1 mm cubes using a razor and soaked for one hour in
0.5% Osmium Tetroxide in foil-wrapped glass tubes on crushed ice. Samples were rinsed
three times in 0.1 M Cacodylate buffer for 10 minutes each, followed by another three
washes in water for 40 minutes each. Samples were soaked for eight hours in a halfsaturated Uranyl Acetate solution, and then rinsed six times in water for 30 minutes each.
Agarose pieces were transferred through a graded series of acetone at: 20%, 50%, 70%,
95%, and finally three times at 100% for 15 minutes each. Samples were placed on a
rotary mixer will be embedded with graded mixtures of Epon-Araldite resin and acetone
at 1:2 overnight, 1:1 for eight hours, 2:1 overnight and finally pure resin for five hours.
Molds of samples were prepared and baked at 60 °C for 96 hours. Ultra-thin sections (70
nm) were retrieved from cell-containing areas of the resin blocks and placed on 200 mesh
nickel grids. Post-staining of grids was carried out with 2% Uranyl Acetate for 15
minutes and Reynold’s Lead Citrate for 1 minute, rinsing with water between stains.
Grids were air-dried and imaged within 48 hours.

3.2.9

Mitochondrial Morphometric Image Analysis

At least 60 images containing 18 distinct cells were taken from coded L/F and 2iL cESC
samples using a Philips CM10 transmission electron microscope at 34,000X
magnification for observation of 380 total mitochondria. Mitochondrial counts,
dimensions and cristae orientation were assessed by blinded investigators using ImageJ.
The aspect ratio was calculated as the ratio between the unit length of major and minor
axes for mitochondrial ellipsoids. The cristae density was calculated from the cristae
number normalized to calculated mitochondrial surface area. To evaluate the degree of
cristae alignment within mitochondria, cristae angles were recorded to calculate the mean
incident angle between cristae.
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3.2.10

Metabolic Inhibitor Treatment and Cell Counting

20,000 cESCs were seeded into multiwell plates and total cell counts were performed
every 24 hours for 4 days using a hemocytometer. For inhibitor treatments, cells adhered
overnight in the absence of inhibitors and growth in the presence of inhibitors was scored
after 48 hours. Data are presented as the fold change in total cell number relative to the
initial cell number at the 0-hour time point. 2-deoxy-D-glucose (2-DG) and Rotenone
(RTN) were diluted into culture media to final concentrations of 1.25 mM and 250 nM,
respectively. Concentrations used in our assays were determined by single inhibitor dosetitrations to find the minimum concentration affecting cell proliferation.

3.2.11

Cellular ATP Detection Assay

L/F and 2iL cESCs were treated with 2-DG, RTN or vehicle and diluted to 100,000
cells/mL in cESC culture media. Cell suspensions were transferred to an opaque white
96-well microplate (10,000 cells/well) and ATP content was determined using the
Luminescent ATP Detection Assay Kit (Abcam). Luminescence was quantified with the
SpectroMax M5 (Molecular Devices, CA) instrument and ATP content (pM/cell) was
interpolated from an eight-point standard curve.

3.2.12

Cell Death and Apoptosis Assay

The incidence of cell death and apoptosis during steady-state growth and inhibitor assays
was assessed by measuring the percentage of 7-aminoactinomycin D (7-AAD)/AnnexinV positive cells. Briefly, single cells suspended in Annexin binding buffer (10 mM
HEPES, 140 mM Sodium Chloride, 2.5 mM Calcium Chloride, pH 7.4) were stained with
fluorescein isothiocyanate (FITC) Annexin-V conjugate (Thermo Fisher Scientific) for
20 minutes and 7-AAD Viability staining solution (eBioscience) for 5 minutes. 20,000
total events were recorded using an Accuri C6 flow cytometer (BD Biosciences). Spectral
compensation was performed by subtracting 2% of FL1 from FL3 to adjust for minor
FITC overlap into FL-3. Changes in cell viability was assessed as the mean proportion of
Annexin-V-FITC-/7-AAD- (viable), Annexin-V-FITC+/7-AAD- (apoptotic) or AnnexinV-FITC+/7-AAD+ (dead) cells.
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3.2.13

Statistical Analysis

Data were analyzed using R (version 3.2.3) by two-sample composite t-test or one-way
analysis of variance (ANOVA) followed by Tukey’s HSD multiple comparison method
as appropriate. P < 0.05 was considered statistically significant. Data were visualized
using GraphPad Prism 6 and presented as mean +/- standard error of the mean (SEM).

3.3 Results
3.3.1

Enhanced glucose oxidation and respiratory capacity in 2iL
cESC

Glycolytic and oxidative metabolism in ESCs were assessed by measuring the
extracellular acidification rate (ECAR) and oxygen consumption rate (OCR), respectively
(Zhang et al., 2012b). To explore if activation of mitochondrial respiration is a feature
conserved in naïve-like cESCs, we compared the metabolic rate measurements of BE5
cESCs maintained in L/F or 2iL, HES-2 human (h)ESCs and R1 murine (m)ESCs. OCR
was monitored after cells were successively exposed to oligomycin (OLIGO), 4(trifluoromethoxy)-phenylhydrazone (FCCP) and antimycin A/rotenone (Fig. 3-1A).
In the presence of glucose, both R1 mESCs (P=1.03 x 10-4) and 2iL cESCs (P=0.025)
have greater OCR: ECAR ratio compared to primed-like L/F cESCs and hESCs (Fig. 31B). The respiration attributable to ATP-synthase activity did not differ between hESCs,
LIF-FGF2 or 2iL cESCs (P=0.25) but was markedly greater in mESCs (P=6.8 x 10-6)
(Fig. 3-1C). The fold change in OCR following FCCP-stimulated maximal respiration (a
measure of mitochondrial spare capacity) is significantly elevated in 2iL cESCs (P=1.40
x 10-3) and R1 mESCs (P=7.2 x 10-6) in comparison to primed human ESCs and L/F
cESCs (Fig. 3-1D). However, rate measurements correlating to basal oxygen
consumption (P=0.024), ATP synthase-linked respiration and mitochondrial spare
capacity (P=0.013) in 2iL cESCs all remain below naïve mESCs.
To assess if enhanced 2iL cESC respiration is reproducible in a different genetic
background, we examined OCR responses to chemical manipulation of mitochondrial
function in IO3 cESCs (Fig. 3-2A). Like BE5 cESCs, we observed a statistically

123

Figure 3-1. Culture in 2iL enhances glucose oxidation and respiratory capacity of
BE5 cESCs.
(A) Oxygen consumption rate (OCR) tracing of BE5 LIF-FGF2 cESCs, BE5 2iL cESCs,
HES-2 hESCs and R1 mESCs. Addition of oligomycin reduces OCR and reflects
respiration independent of oxidative phosphorylation. Addition of FCCP stimulates
electron transport chain activity and maximal OCR. Addition of Antimycin A/Rotenone
(mitochondrial chain complex inhibitors) shows OCR independent of mitochondrial
metabolism. (B) Basal OCR with respect to ECAR in glucose-containing media (C)
Relative decreases in OCR after oligomycin injection. (D) Relative increases in OCR
after FCCP injection. Rate measurements were normalized to total protein quantified by
Lowry assay. Bars represent standard error of the mean (SEM), n = 5. Means followed by
the same letter are not significantly different, P < 0.05.
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Figure 3-2. 2iL-induced respiration is reproducible in IO3 cESC line.
(A) Oxygen consumption rate tracing of IO3 LIF-FGF2 cESCs, IO3 2iL cESCs, R1derived epiblast-like stem cells and R1 mESCs. (B) Basal OCR with respect to ECAR in
glucose-containing media (C) Relative decreases in OCR after oligomycin injection. (D)
Relative increases in OCR after FCCP injection. Rate measurements were normalized to
total protein quantified by Lowry assay. Bars represent standard error of the mean (SEM),
n = 5. Means followed by the same letter are not significantly different, P < 0.05.
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significant increase in basal OCR: ECAR ratio (P=1.94 x 10-5) and mitochondrial spare
capacity (P=0.042), but not ATP-coupled respiration (P=0.30) in IO3 2iL cESCs
compared to L/F cESCs (Fig. 3-2B-D).

3.3.2

Altered mitochondrial ultrastructure but not mitochondrial
biomass in 2iL cESC

We next sought to quantify mitochondrial content to determine if altered mitochondrial
biomass contributed to cESC metabolic function. Lipophilic dialkylcarbocyanine dyes
were applied to co-cultured MEFs to discriminate cESC-specific signals by flow
cytometry (Fig. 3-3A-B). The geometric mean of MitoTracker Green FM fluorescence
intensity was significantly lower in the 2iL cESC population (Fig. 3-3C-D, P=4.40 x 103

). Whereas, the geometric mean of forward scatter (FSC) intensity, an estimate of cell

size, was not different between L/F and 2iL cESCs (Fig. 3-3E-F, P=0.97). Therefore, it is
unlikely that altered cell volume contributed to the observed change in MitoTracker
Green FM accumulation in cESCs. We probed cESC lysates for TOMM20, an integral
component of the outer mitochondrial membrane (Rassow and Pfanner, 2000), as a
surrogate measure of mitochondrial content. TOMM20 abundance was not different in
2iL cESCs compared to originating L/F cESCs (Fig. 3-4A, P=0.21). Similarly, we
observed no change in the relative mitochondrial DNA (mtDNA) quantity between L/F
and 2iL cESCs (Fig. 3-4B, P=0.53). The level of Mitofilin (MIC60), an inner
mitochondrial membrane protein associated with tubular cristae formation (Hessenberger
et al., 2017), was significantly reduced in 2iL cESCs compared to L/F cESCs (Fig. 3-4C,
P=9.0 x 10-4).
Alterations to 2iL cESC mitochondrial ultrastructure may affect MitoTracker Green FM
accumulation despite indications that overall mitochondrial biomass are unchanged.
Using transmission electron microscopy, we observed that mitochondria of both L/F and
2iL cESCs were typically arranged in perinuclear clusters (Fig. 3-5A). Furthermore, the
internal structure of L/F and 2iL mitochondria exhibited several contrast features selected
for detailed morphometric analysis (Fig. 3-5B-C). Mitochondria visualized in L/F cESCs
tended to have lower overall abundance and larger surface area compared to
mitochondria within 2iL cESCs, but these metrics were not considered statistically
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Figure 3-3. 2iL cESCs show lower MitoTracker Green FM accumulation
independent of cell size.
Representative inclusion gating of (A) Di-D labelled MEFs and (B) unstained cESCs in
co-culture on SSC-A vs. FL4-A cytograms to exclude contaminating MEFs from flow
cytometric analysis. (C) Overlay FL1-A histogram and (D) quantification of geometric
mean MitoTracker Green FM intensity as an estimate of mitochondrial mass in
singularized L/F and 2iL cESCs. (E) Overlay histogram of forward light scatter area
(FSC-A) and (F) quantification of change in FSC-A as an estimate of relative L/F or 2iL
cESC size. Bars represent standard error of the mean (SEM), n = 3. Means followed by
the same letter are not significantly different, P < 0.05.
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significant (Fig. 3-5D, P=0.1403 and P=0.1866). 2iL cESCs contained shorter and more
rounded mitochondria with respect to mean aspect ratio compared to mitochondria within
L/F cESCs (Fig. 3-6A, P=0.003). Mitochondria from L/F and 2iL cESCs exhibit a similar
density of cristae membranes (Fig. 3-6B, P=0.861). Interestingly, the mitochondria in 2iL
cESCs exhibited poorer pairwise alignment of crista membranes (i.e. 0° represents
parallel membrane orientation), with a mean incident cristae angle of 58.02° compared to
38.07° in L/F cESCs (Fig. 3-6C, P=0.019).

3.3.3

Increased mitochondrial membrane potential and ATP level
in 2iL cESC

Cellular ATP production is regulated by mitochondrial membrane potential (ΔΨm),
which is established by electron transport and the coincident transport of protons to the
intermembrane space (Ehrenberg et al., 1988; Kamo et al., 1979). We assessed
mitochondrial polarization state using the ΔΨm-sensitive dyes tetramethylrhodamine,
methyl ester (TMRM) and JC-1 to explore the relationship between mitochondrial
respiration and proton-motive force in cESCs.
Contrary to the anticipated result, quantification of cells stained with JC-1 (Fig. 3-7A,
P=4.60 x 10-3) or TMRM (Fig. 3-7B, P=1.30 x 10-3) by flow cytometry showed
significant reductions in the relative ΔΨm of 2iL cESCs compared to those expanded in
L/F. However, quantification of fluorescent intensity per cell may not be a reliable
comparison if ultrastructural changes in mitochondria affect probe uptake and retention
kinetics between L/F and 2iL cESCs. Rather than performing a static comparison
between whole cell mitochondrial polarization states, we sought to quantify the dynamic
re-distribution of TMRM upon selective depolarization of ΔΨm by live cell fluorescent
microscopy (Fig. 3-7C). 2iL cESCs exhibited a significantly greater decrease in TMRM
fluorescence intensity following FCCP-mediated depolarization compared to L/F cESCs
(Fig. 3-7D, P=0.0106). Calcein Green AM fluorescence intensity was maintained after
FCCP treatment (Fig. 3-8), suggesting that viability or plasma membrane integrity do not
confound TMRM re-distribution.
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Figure 3-7. Dynamic redistribution but not static accumulation of mitochondrial
polarization-sensitive dyes correlates with respiratory activity in cESCs.
(A) Geometric mean J-aggregate intensity to JC-1 monomer intensity ratio (FL2-A : FL1A) in singularized L/F and 2iL cESCs. (B) Geometric mean tetramethylrhodamine,
methyl ester (TMRM) fluorescence intensity (FL2-A) in singularized L/F and 2iL cESCs.
(C) Time course of TMRM mean fluorescence intensity before (baseline) and after
selective depolarization FCCP. Calcein Green AM mean fluorescence intensity was also
recorded as an indicator of plasma membrane integrity. (D) Magnitude of FCCPmediated reduction in TMRM staining in redistribution conditions. Bars represent
standard error of the mean, n = 4-6. Means followed by the same letter are not
significantly different, P < 0.05.
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Figure 3-8. Selective decrease in mitochondrial but not cytosolic staining with FCCP
treatment.
L/F and 2iL cESCs were monitored for TMRM (red) or Calcein Green AM (blue)
fluorescence for a duration of 20 minutes. Initial readings establish baseline fluorescence
intensity (0-5 minutes) and afterwards the change in fluorescence intensity after FCCP
(250 nM) or vehicle treatment (6-20 minutes) was monitored. Representative
micrographs are shown, and scale bar unit length is 50 µm.
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We next investigated the abundance of mitochondrial chain complex subunits by
immunoblot analysis. 2iL cESCs exhibited a significant increase (P=1.5 x 10-3) in
succinate dehydrogenase iron sulfur subunit B (SDHB; complex II) and lower (P=0.026)
F1-ATP synthase subunit 5 alpha (ATP5A; complex V) (Fig. 3-9A-C) abundance
compared to L/F cESCs. Ubiquitinol-cytochrome c reductase core protein 2 (UQCRC2;
complex III) did not significantly differ between L/F and 2iL cESCs (Fig. 3-9D, P=0.53).
Furthermore, steady-state ATP levels were greater in 2iL cESCs compared to L/F cESCs
(Fig. 3-10A, P=1.0 x 10-5). This result is corroborated by enhanced phosphorylation of
AMP-activated protein kinase (AMPK) at Thr172 (Fig. 3-10B-C, P=0.044) as well as
increased Ser79 phosphorylation of acetyl-CoA carboxylase (ACC1), a canonical AMPK
target enzyme, in L/F cESCs compared to 2iL cESCs (Fig. 3-10D, P=0.020). Reliable
signals could not be obtained for antibodies directed against human cytochrome C
oxidase 2 (MTCOX2; complex IV) and NADH: ubiquinone oxidoreductase subunit B8
(NDUFB8; complex I) due to poor amino acid conservation in the canine homologs
(<85% similarity by blastp algorithm).

3.3.4

Differentiation regulation of pyruvate metabolizing enzymes
is associated with altered lipid accumulation

Multiple enzymes responsible for pyruvate flux into the TCA cycle are differentially
regulated in naïve versus primed PSC populations (Zhang et al., 2011; Zhou et al., 2012).
Therefore, we assessed the levels of proteins involved in pyruvate handling by
immunoblot analysis. L/F cESCs exhibited increased levels of lactate dehydrogenase
isoform A (LDHA), a key enzyme in maintaining high glycolytic flux, compared to 2iL
cESCs (Fig. 3-11A-B, P=0.01). Whereas levels of M2 isoform of pyruvate kinase
(PKM2), an isoenzyme associated with elevated aerobic glycolysis in transformed cells,
exhibited similar levels in L/F and 2iL cESCs (Fig. 3-11C, P=0.65). However, the M1
isoform of pyruvate kinase (PKM1), which is suggested to promote mitochondrial
pyruvate oxidation (Taniguchi et al., 2016), was significantly enriched in 2iL cESCs (Fig.
3-11D, P=0.013). Surprisingly, levels of pyruvate dehydrogenase (PDH) kinase 1 (Fig. 311E-F, P=0.045) and the ratio phosphorylated PDH to total PDH (Fig. 3-11G, P=7.0 x 103

) were both elevated in 2iL cESCs.
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Figure 3-9. Altered respiratory chain complex subunit abundances between L/F
and 2iL cESCs.
Representative western blot membrane images of L/F and 2iL cESC whole lysates
probed for F1 ATP synthase alpha subunit (ATP5A), succinate dehydrogenase beta
(SDHB), ubiquinol-cytochrome c reductase core protein 2 (UQCRC2) and reference
protein beta-actin. Densitometric quantification of protein levels for (B) SDHB, (C)
ATP5A, and (D) UQCRC2. Means are normalized to internal standard beta-actin and
expressed as relative ratios to L/F cESC samples. Bars represent standard error of the
mean, n = 4. Means followed by the same letter are not significantly different, P <
0.05.
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Figure 3-10. 2iL cESCs display elevated ATP content and AMPK signaling.
(A). Calculation of cellular ATP by interpolating standard curve values in a
luminescent microplate assay and normalized to cell number. (B) Representative
western blot membrane image for phosphorylated and total AMP-activated protein
kinase (AMPK) or acetyl-CoA carboxylase (ACC). Protein quantification by
densitometry for (C) AMPK phosphorylation (D) ACC phosphorylation. Means are
normalized to internal standard beta-actin and expressed as relative ratios to L/F
cESC samples. Bars represent standard error of the mean (SEM), n= 4-7. Means
followed by the same letter are not significantly different, P < 0.05.
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Incomplete oxidation of glucose may favour the redirection of intermediate metabolites
towards anabolic processes, such as lipogenesis (Tohyama et al., 2016). We therefore
investigated the level of neutral lipids within L/F and 2iL cESCs using Nile Red. Flow
cytometric analysis revealed greater mean fluorescence intensity associated with neutral
lipids in L/F cESCs compared to 2iL cESCs (Fig. 3-12A-B, P=3.0 x 10-4). Nile Red
fluorescence attributable to polar lipids, such as phospholipids, did not significantly differ
between L/F and 2iL cESCs (Fig. 3-12C, P=0.78). Indeed, fatty acid synthase (FASN), a
key enzyme in de novo lipogenesis, was significantly more abundant in L/F cESC than
2iL cESC protein lysates (Fig. 3-12D, P=0.015).

3.3.5

HXK2 level and glycolytic capacity are correlated among
mammalian ESC lines

To examine glycolytic activity in PSC lines, ECAR was monitored after the sequential
addition of glucose, oligomycin and 2-deoxy-D-glucose (2-DG) (Fig. 3-13A). ECAR
measurements in the absence of glucose, or after 2-DG exposure, did not differ between
all lines tested, implying that non-glycolytic acidification mechanisms did not
substantially contribute to ECAR observations. Glucose-induced ECAR (i.e. glycolytic
acidification) in L/F cESCs were equivalent to those recorded from naïve-like R1 mESCs
or 2iL cESCs (P=0.88) and lower than HES2 hESCs (P=0.046) (Fig. 3-13B).
Oligomycin-stimulated ECAR (i.e. maximum glycolytic capacity) was equivalent
between L/F and 2iL cESCs (P=0.98), but significantly lower than R1 mESC (P=6.3 x
10-3) and HES2 hESC lines (P=9.25 x 10-3) (Fig. 3-13C). However, the quotient of
oligomycin and glucose stimulated ECAR (i.e. glycolytic reserve capacity) was
augmented in 2iL cESCs (P=0.017), HES2 hESCs (P=4.59 x 10-3) and R1 mESCs (P=1.0
x 10-7) compared to LIF-FGF2 cESCs (Fig. 3-13D). Interestingly, L/F cESCs, 2iL cESCs,
HES2 hESC and R1 mESC did not show any difference in constitutive glucose uniporter
GLUT1 quantity (Fig. 3-14A, F=0.20456, P=0.89). However, rate-limiting glycolytic
enzyme Hexokinase-2 (HXK2) (Bissonnette et al., 1996) differed among ESC
populations (Fig. 3-14B, F=11.38, P = 3.0 x 10-4). HXK2 level was significantly greater
in HES2 (P=3.02 x 10-2) and R1 (P=2.0 x 10-4) compared to L/F cESCs, which exhibited
similar HXK2 levels to 2iL cESCs (P=0.68).
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Figure 3-13. Both L/F and 2iL cESC exhibit lower glycolytic capacities than human
or mouse ESC.
(A) Extracellular acidification rate tracing of LIF-FGF2 cESCs, 2iL cESCs, HES-2
hESCs and R1 mESCs measured by Seahorse extracellular flux analyzer. Addition of
glucose to cells equilibrated in glucose-free media establishes the basal glycolytic rate.
Addition of oligomycin stimulates glycolytic flux in response to a deficiency in
mitochondrial ATP production resulting in maximum ECAR. The difference between
baseline ECAR and rate measurements after injection of 2-DG is non-glycolytic
acidification. (B) Relative changes in ECAR after glucose injection. (C) Relative changes
in ECAR after oligomycin injection. (D) Difference between oligomycin and glucose
stimulated ECAR. Rate measurements were normalized to total protein quantified by
Lowry assay. Bars represent standard error of the mean (SEM), n = 5. Means followed by
the same letter are no significantly different, P < 0.05.
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Figure 3-14. Both L/F and 2iL cESCs exhibit lower HXK2 abundance compared to
human or murine ESC.
(A) Representative western blot membrane image of hexokinase 2 (HXK2), constitutive
glucose uniporter (GLUT1) and reference protein beta-actin in L/F cESC, 2iL cESC,
HES2 hESC and R1 mESC. Protein quantification by densitometry for (B) GLUT1 and
(C) HXK2. Bars represent standard error of the mean (SEM), n = 3. Means followed by
the same letter are not significantly different, P < 0.05.
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3.3.6

Bioenergetic pathway inhibition differentially affects L/F and
2iL cESCs

We used inhibitors of the electron transport chain (ETC) and glycolysis to dissect the
contributions of these metabolic pathways to acute L/F and 2iL cESC proliferation.
Given that 2iL cESCs have greater respiratory and glycolytic reserve capacities than L/F
cESCs, we posited that 2iL cESC expansion would be less sensitive to bioenergetic
pathway antagonism. Expansion of L/F cESCs was impaired by 2-DG, a competitive
inhibitor of HXK (Fig. 3-15A, P=2.24 x 10-3), without altering the proportion of live cells
(Fig. 3-16B, P=0.58). In contrast, the mitochondrial complex I inhibitor RTN did not
alter L/F cESC proliferation (Fig. 3-15A, P=0.67) or viability (Fig. 3-15B, P=0.89). 2iL
cESC expansion was unaffected by the presence 2-DG (Fig. 3-15C, P=0.92), however,
RTN exposure decreased acute proliferation 2iL cESC expansion (Fig. 3-15C, P=6.30 x
10-3) without a change in cell viability (Fig. 3-15D, P=0.67).
Exposure of L/F cESCs to 2-DG and RTN during steady-state growth did not
significantly affect the ATP content (Fig. 3-16A, F=3.185, P=0.065). Whereas, ATP
levels within 2iL cESCs were sensitive to the presence of partial blockade of bioenergetic
pathways (Fig. 3-16B, F=61.439, P=9.08 x 10-9). Interestingly, treatment of 2iL cESCs
with RTN (P=1.0 x 10-7), but not with 2-DG (P=0.93), significantly decreased ATP
concentrations. No significant changes in the proportion of apoptotic or dead cells were
detected in either cESC population for the duration of 2-DG exposure (Fig. 3-17A-C,
P=0.84 & P=0.20) or RTN treatment (Fig. 3-17D-F, P=0.80 and P=0.74).

3.4 Discussion
Our data indicate that 2iL-enriched cESCs display enhanced mitochondrial respiration,
increased mitochondrial intermembrane potential, remodeling of mitochondrial
ultrastructure, and changes in the abundance of enzymes involved in pyruvate handling,
electron transport and lipid synthesis. Pluripotent state-associated changes in cESC
metabolic pathway activity and enzyme abundance have a functionally relevant impact
on cESC ATP synthesis and proliferation. Our study provides the first evidence for
suboptimal glycolytic flux in cESCs lines as well as extensive remodeling of the cristae
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Figure 3-16. Selective metabolic pathway inhibition affects ATP level of 2iL cESCs
but not L/F cESCs.
Quantification of cellular ATP level in (A) L/F cESCs or (B) 2iL cESCs following acute
exposure to 2-deoxy-D-glucose (2-DG) or rotenone (RTN). Bars represent standard error
of the mean (SEM) n = 5. Means followed by the same letter are not significantly
different, P < 0.05.
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Figure 3-17. Titrated metabolic pathway inhibitors do not increase apoptotic or
dead cESCs.
(A) Representative dotplots of Annexin V-FITC and 7-aminoactinomycin D (7-AAD)
stained cESCs treated with 2-deoxyglucose (2-DG) or vehicle. Quantification of (B)
apoptotic and (C) dead cells following treatment with 2-DG or vehicle. (D)
Representative dotplots of Annexin V-FITC and 7-AAD stained cESCs treated with
rotenone (RTN) or vehicle. Quantification of (E) apoptotic and (F) dead cells following
treatment with RTN or vehicle. Bars represent standard error of the mean (SEM) n = 3.
Means followed by the same letter are not significantly different, P < 0.05.
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membranes associated with a metabolic switch towards mitochondrial metabolism with
naïve-like pluripotency induction.
We found that 2iL subculture enriches for a cESC population with greater respiratory
spare capacity and a preference for mitochondrial glucose oxidation under steady-state
conditions compared to L/F cESCs. Augmented cellular respiration has also been
reported upon induction of naïve-like hESCs (Takashima et al., 2014) and may represent
a conserved attribute of naïve pluripotency in placental mammals. We found that elevated
respiratory capacity 2iL cESCs is not associated with any difference in overall
mitochondrial biomass with respect to L/F cESCs. However, 2iL cESCs predominantly
contain smaller, rounded mitochondria that morphologically similar to those within
mouse ESC and chemically induced naïve-like human ESC (Sperber et al., 2015; Zhou et
al., 2012). We investigated glycolytic enzymes upstream of mitochondrial substrate
provision and identified increased levels PKM isoform 1 and a lower LDH isoform A
level in 2iL cESCs. These observations are suggestive of increased mitochondrial
pyruvate and NADH availability at the expense of LDH-mediated NAD+ regeneration
(Fantin et al., 2006). Elevated phosphorylation of PDH would be expected to limit
pyruvate conversion to acetyl-CoA in 2iL cESCs, implicating reductive carboxylation of
pyruvate as an alternative mechanism of TCA cycle replenishment. As a plausible
consequence of greater pyruvate oxidation, fewer metabolic intermediates may be
available for anabolic pathways such as de novo lipogenesis (Tohyama et al., 2016). We
found that L/F cESCs exhibited greater FASN abundance and accumulated more
intracellular neutral lipids than 2iL cESCs.
In contrast to previous reports that mitochondria within naïve-like ESCs are qualitatively
cristae-poor (Ware et al., 2014; Zhou et al., 2012), we observed that mitochondrial cristae
density is preserved in 2iL cESCs. Furthermore, we quantified previously unrecognized
changes to the degree of cristae organization between different states of pluripotency in
vitro. 2iL cESCs contained mitochondria with disorganized cristae that project along the
periphery of the organelle rather than assuming a lamellar, axis-spanning orientation. The
arch-like inner mitochondrial membranes within 2iL cESCs are similar to those described
in early preimplantation embryos (Baharvand and Matthaei, 2003; Sathananthan and
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Trounson, 2000), suggesting that immature mitochondrial morphology is not an artifact
of in vitro culture. Altered cristae architecture is associated with changes to the
abundance of Mitofilin/MIC60, a component of the mitochondrial contact site and cristae
organizing system (Hessenberger et al., 2017). We also observed, but did not directly
quantify, the widening of cristae, particularly at the tips and the cristae junctions.
Conceivably, lower abundance of catalytic ATP synthase subunits in 2iL cESCs could
limit the pool of oligomerized ATP synthase complexes, which induce membrane
curvature and restrict the circumference of cristae rims and tips (Davies et al., 2012).
Structural changes to the cristae inflate the intracristal space, increasing the diffusion
distance needed to traverse the outer mitochondrial membrane and plausibly function as a
proton or ROS reservoir (Plecitá-Hlavatá and Ježek, 2016).
The transition from OXPHOS to aerobic glycolysis in human and mouse ESCs is
accompanied by coordinated changes in mitochondrial chain complex subunit expression
(Zhou et al., 2012), electron transport chain (ETC) activity and ATP synthesis by
OXPHOS. However, reconfiguration of membrane composition or chain complex
stoichiometry can have a less obvious influence on mitochondrial function through the
formation of supercomplexes that channel substrates and electron carriers (Dudek et al.,
2013; Lapuente-Brun et al., 2013). We identified an enrichment of SDHB subunit (i.e.
complex II) and a reduction of ATP5A subunit (i.e. complex V). The observed changes in
respiratory chain subunits implicate both altered OXPHOS kinetics or efficiency and
expedited conversion of succinate to fumarate in the TCA cycle. Our data also suggest
that increased cellular ATP level may promote global changes in 2iL cESCs through
retrograde signaling via the energy-sensing AMPK pathway (Herzig and Shaw, 2018), or
speculatively ATP-dependent chromatin remodeling enzymes (Zhang et al., 2018).
We find that L/F cESCs do not exhibit the mitochondrial reserve capacity to oxidize
pyruvate thereby rendering L/F cESCs dependent on glycolysis for in vitro growth.
Indeed, inhibition of electron transport had no effect on the acute expansion of L/F cESC,
whereas blockade of glycolysis was observed to reduce L/F cESC proliferation
independent of ATP. This is consistent with respirometry experiments with hESCs
(Sperber et al., 2015) and reports that ETC activity is dispensable for maintenance of
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primed pluripotency (Varum et al., 2009). In contrast, 2iL cESCs showed both elevated
respiratory and glycolytic reserve capacity and were tolerant to partial inhibition of
glycolysis by 2-DG, implicating that divergent metabolic programs support proliferation
in L/F and 2iL cESCs with regards to glucose utilization. Comparative experiments
including hESC/mEpiLC, mESC, L/F and 2iL cESC lines indicate that glycolytic
capacity is not influenced by pluripotent state. However, there appears to be a caninespecific reduction in glycolytic capacity that coincides with prolonged population
doubling intervals observed cESC lines. Glucose uptake and metabolism are typically coregulated by transcriptional programs controlling cell growth and proliferation (e.g.
MYC), however we observe a selective decrease in HXK2 in cESCs compared to mESC
or hESC (Dang et al., 2008). Indeed, several tumor-suppressor pathways involving
micro-RNA species or autophagic clearance have been implicated in selective HXK2
repression (Jiao et al., 2018; Liu et al., 2017; Peschiaroli et al., 2013).
Enhanced glycolytic reserve capacity observed in oxidative 2iL cESCs suggests a degree
metabolic pathway flexibility that resembles the ‘bivalent’ metabolic responses observed
with naïve R1 mESCs than primed HES-2 hESCs. However, 2iL cESC proliferation and
ATP generation was sensitive to RTN exposure, which is dissimilar to experiments
performed in naïve mESC (Vlaski-Lafarge et al., 2019). Lower ATP content of RTNtreated 2iL cESCs could signify that glycolysis alone cannot meet the bioenergetic
demand for steady state growth of 2iL cESCs. Conversely, RTN treatment may be
associated with ROS production (Li et al., 2003) and indirectly affecting cellular ATP
through retrograde ROS signaling mechanisms. We have not yet followed up on the
potential contributions of redox-sensitive retrograde signaling pathways such as nuclear
respiratory factor (NRF), p53 and p21 that are understood to influence the cell cycle and
mitochondrial metabolism (Chandel et al., 2000; Khacho et al., 2016; Passos et al., 2010).
The described work represents the first evidence of suboptimal glycolytic flux in cESCs
lines as well as extensive remodeling of the cristae membranes associated with a
metabolic switch towards mitochondrial metabolism with naïve-like pluripotency
induction in the dog. Our data demonstrate that L/F cESCs exhibit a preferentially
glycolytic and anabolic phenotype. Whereas 2iL cESCs acquire both glycolytic and
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respiratory reserve capacities but remain less bioenergetic and metabolically flexible than
naïve mESC. This study lends additional support to the notion that cellular metabolism is
a conserved discriminatory readout of pluripotent states in placental mammals. However,
species-specific attributes appear to constrain glycolytic flux in cESCs and metabolic
bivalency achievable through a 2iL-supported naïve pluripotent state.
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Chapter 4

4

Bioactive metabolite supplementation promotes
mesenchymal-to-epithelial transition in early canine
reprogramming

4.1 Introduction
Domestic dogs are susceptible to a spectrum of inherited and acquired diseases with
analogy to humans (Ostrander et al., 2000; Sutter and Ostrander, 2004). Exposure to
environmental mutagens during human-canine coexistence (Backer et al., 2008) as well
as similarities in immune system anatomy and development (Storb and Thomas, 1985)
have likely contributed to these shared pathologies. Approximately 94% of the canine
genome is syntenic to the human assembly and considered conserved ancestral sequence
(Lindblad-Toh et al., 2005; Ostrander and Wayne, 2005). Modeling the effect of diseaseassociated loci in a variety of cell types has been made feasible by the ectopic expression
of a defined set of factors to generate induced pluripotent stem cells (iPSCs) (Takahashi
and Yamanaka, 2006). However, the routine use of canine iPSCs has been limited by
protocol inconsistency (Betts and Tobias, 2015), low number of clonal iPSC lines
established (Chow et al., 2017; Luo et al., 2011) and a lack of quantitative evidence of
long-term self-renewal. Despite a high degree of synteny through evolution, studies of
several putative canine iPSC lines have revealed unique features compared to human
iPSC including the requirement of LIF/STAT3 signaling for prolonged self-renewal
(Chow et al., 2017; Koh et al., 2013; Luo et al., 2011).
Global analyses of epigenetic modifications in reprogramming intermediates suggest that
progress towards a pluripotent state is constrained by repressive modifications on
chromatin (Apostolou and Hochedlinger, 2013; De Carvalho et al., 2010). Focal DNA
demethylation during iPSC generation and maintenance of hypomethylated chromatin in
pluripotent cells are mediated by the ten-eleven translocation (TET) family of
methylcytosine dioxygenase (Bagci and Fisher, 2013; Wu and Zhang, 2017). TET
enzymes mediate active-active and active-passive mechanisms of DNA demethylation,
through the oxidation of 5-methylcytosine (5-mC) into a variety of cytosine substituents
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that may be recognized by base-excision repair machinery (He et al., 2011; Ito et al.,
2011). Functional genomics and computational modelling of iPSC derivation indicate
that engagement of reprogramming transfactors with previously silent regulatory
sequences facilitates local epigenetic remodeling and elevated transcriptional output at
critical pluripotency regulators (Koche et al., 2011; Soufi et al., 2012). Recently, it was
demonstrated that TET recruitment and active demethylation at pluripotency-associated
enhancers and promoters, occurs prior to chromatin opening and stable transcriptional
activation (Sardina et al., 2018).
The density of CpG islands (CGIs) is the highest in the domestic canine genome
assembly among completely sequenced placental mammals, despite no genome-wide
difference in the parameters used to define CGIs (Han et al., 2008). Mammalian genomes
contain subgroups of high CpG (HCP), intermediate CpG (ICP) and low CpG promoters
(LCP), each with a distinct relationship between DNA methylation and transcriptional
activity (Meissner et al., 2008). HCPs contain at least one de facto CGI (Fouse et al.,
2008) and are generally not transcriptionally active when methylated (Antequera et al.,
1990; Deaton and Bird, 2011; Weber et al., 2007). TET binding is elevated at CpG-rich
sequences such as CGIs, owing to its CXXC domain (Williams et al., 2011; Xu et al.,
2011). TET enzymes lacking the CXXC domain exhibit similar genomic localization,
albeit with lower enrichment, suggesting that protein-protein interactions also contribute
to TET recruitment (Zhang et al., 2016). 5-hydroxymethylcytosine (5-hmC), a stable
product of TET-catalysis (Bachman et al., 2014), is critical to the maintenance of active
cis-regulatory modules (CRMs). The demethylated state of pluripotency-associated
enhancers and promoters are dependent on TET because these regions gain the greatest
de novo methylation in TET1-3 triple knockout mESCs (Lu et al., 2014). At least one
competent TET paralog is required for successful acquisition of pluripotency by somatic
cell reprogramming (Hu et al., 2014).
Reprogramming canine fibroblasts with integrating vectors is reported to be highly
protracted process (30-40 days) (Koh and Piedrahita, 2015), and the molecular events
during canine reprogramming have not been characterized or time-resolved. An
understanding of the bottlenecks in canine somatic cell reprogramming is vital to increase
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the probability of successful reprogramming and map the molecular events in canine
pluripotency acquisition. The temporary use of small molecules to enhance the
endogenous DNA demethylation machinery is a promising strategy to improve the
efficiency and kinetics of reprogramming in challenging cell populations. Kinetics are
critical for non-integrating gene delivery systems, such as Sendai virus (SeV) vectors,
with a limited timeframe for cells to achieve transgene-independence.
Several physiological metabolites have been demonstrated to regulate TET abundance,
catalytic activity or recruitment including alpha-ketoglutarate, L-ascorbic acid (Vitamin
C) and retinoic acid (a derivative of Vitamin A) (Blaschke et al., 2013; Carey et al., 2014;
Hore et al., 2016; Yin et al., 2013). TET enzymes have affinity for CpG-rich sequences
that are frequent in a canine genome, as well as other regulatory elements when recruited
by pluripotency transcription factors in a reprogramming context. It is conceivable that
TET proteins might have an important role in active DNA demethylation, or otherwise
enable more permissive histone modifications by indirect cross-talk mechanisms, at
endogenous DNA- and chromatin-binding pluripotency regulators in the uniquely CpG
island-rich canine genome. However, the soluble factors controlling TET abundance and
activity in a somatic nuclear environment, and how they could be leveraged in
reprogramming canine cells has yet to be explored.
Taking advantage of the efficient, non-integrating CytoTune SeV gene-delivery system,
which is designed as self-limiting and non-transmissible (Ban et al., 2011; Fusaki et al.,
2009), we investigated whether modifiers of DNA methylation could promote early
canine de-differentiation. We highlight that initiation of canine fetal fibroblast
reprogramming features a mesenchymal-to-epithelial transition within the first week,
which is bolstered by physiological metabolites that enhance TET-mediated 5-hmC
generation.

4.2 Materials and Methods
4.2.1

Genomic Sequence Retrieval and Processing

Genomic sequence and gene features were retrieved from the Ensembl genome browser
(Release 92) using the biomaRt/Bioconductor package. The 5’-flanking sequences of 1-1-
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1 orthologous genes from the canine (CanFam3.1), human (GRCh38.p12) and mouse
(GRCm38.p6) genomic assemblies were accessed using biomaRt (Drost and Paszkowski,
2017). For hierarchical cluster analysis, the common orthologs of three additional
Eutherian species were included: rabbit (OryCun2.0), porcine (Sscrofa11.1) and bovine
(UMD3.1). See Table 4-1 for specific details regarding the retrieval of differentially
expressed gene sets accessed in this work. Our analysis included regions 2 kilobases
upstream and 500 bases downstream of each transcription start site, as defined by track
RefSeq genes (O’Leary et al., 2016). Retrieved sequences with large gaps (ambiguous
bases [N] > 250) were excluded from further analyses, whereas smaller gaps were
accounted for in DNA string length calculations.
Table 4-1. Summary of conserved reprogramming-associated gene products.
Study Information
Mouse Fibroblast
Reprogramming
(Nefzger et al., 2017)

Human Fibroblast
Reprogramming
(Tanaka et al., 2015)

4.2.2

Data Accessed
Accessed list of highly correlated
genes (fibroblast versus
neutrophil/keratinocyte) with
correlation coefficient cut-off of 0.9
and a minimum of 4-fold change
Accessed list of Type III/ESC
genes (Table S3). Identified by
factor loadings in principle
components.

Resultant Gene List
POU5F1, PRDM14,
DNMT3B, TET1, SALL4,
EZH2, NANOG, DPPA4,
SOX2, JARID2, LIN28A,
OTX2, NR5A2, NR0B1,
ZFP42, TRIM71, TET2,
FOXH1, WDR5, MYBL2,
KDM2B.

Identification of CpG Islands and Calculation of CpG
Sequence Metrics

Promoter sequence bioinformatics were performed using applications from the European
Molecular Biology Open Software Suite (EMBOSS 6.6.0) (Rice et al., 2000). Putative
CGIs were revealed with the “newcpgreport” EMBOSS tool, using the default application
parameters. Promoters were further characterized as High CpG Promoters (HCP),
Intermediate CpG Promoters (lCP) or Low CpG Promoters (LCP) according to
established criteria (Fouse et al., 2008; Weber et al., 2007): Briefly, HCP must contain at
minimum a 500-bp window where fractional GC-content is greater than 0.55 and
CpGobs/CpGexp ratio is greater than 0.6; whereas ICP include any regions falling
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between LCP and HCP; finally LCP must lack a CpG rich 500 bp window but exhibit a
CpGobs/CpGexp ratio is >0.4.
We identified and scored focal CpG-rich regions using the “newcpgseek” EMBOSS tool,
which computes a running sum of clustered CpG dinucleotides from all positions in the
sequence. Additionally, for each retrieved promoter the whole sequence CpGobs/CpGexp
ratio was calculated:
𝐶𝑝𝐺 𝑅𝑎𝑡𝑖𝑜 =

4.2.3

(𝐶𝑜𝑢𝑛𝑡𝐶𝑝𝐺 × 𝐿𝑒𝑛𝑔𝑡ℎ𝑏𝑝 )
(𝐶𝑜𝑢𝑛𝑡𝐶 × 𝐶𝑜𝑢𝑛𝑡𝐺 )

Sequence Alignment and Motif Discovery

In the obtained promoters, pairwise alignment and identification of conserved non-coding
sequence was performed using mVISTA (http://genome.lbl.gov/vista/index.shtml).
Position weight matrices were accessed from the JASPAR 2018 database. Transcription
factor binding motif discovery was performed with “jaspscan” EMBOSS tool using the
default parameters. Consensus motifs were visualized as a sequence logo graphic
(http://weblogo.threeplusone.com/).

4.2.4

Primary Cell Culture

Primary canine adult dermal fibroblast was purchased from National Institute of General
Medical Science Repository (Coriell Institute, Camden, NJ). Additionally, canine fetal
fibroblasts amendable to somatic cell nuclear transfer-mediated reprogramming (Jeong et
al., 2012) were a gift from Dr. Jeong Yeon-Woo of Sooam Biotech Research Foundation
(Seoul, South Korea). Somatic cells maintained in DMEM high glucose supplemented
with 10% FBS, 2 mM GlutaMax, 1X non-essential amino acids and 0.5 mM 2mercaptoethanol.

4.2.5

Somatic Cell Reprogramming

Two days prior to transduction, canine fibroblasts were seeded at 5 x 104 cells/well of a
six-well plate. Using the CytoTune 2.0 Reprogramming Kit, Sendai viral vectors (SeV)
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encoding human KOS (KLF4/OCT4/SOX2), c-MYC and KLF4 were added to individual
wells containing 2 x 105 cells according to manufacturer’s protocol with some
modifications. The KOS and c-MYC SeV vectors were applied at a multiplicity of
infection (MOI) of 6, based on transduction efficiencies achieved using CytoTune
emGFP reporter (Thermo Fisher Scientific). The KLF4-SeV vector MOI was increased
from 3 to 5 to improve the transcriptional output of the reprogramming vectors (personal
communication with Thermo Fisher Scientific).
Two days post-infection (DPI), fibroblast medium was supplemented with either 0.1 nM
Retinoic Acid/100 µM Ascorbic Acid (RA/AA) or an equivalent volume of diluent
(vehicle). Treatments were applied with daily medium exchanges for four days. At 6 DPI,
the transduced cells were bulk passaged and transferred (3 x 104 cells) to 10 cm culture
dishes containing 2 x 104/cm2 γ-irradiated CF1 strain MEFs (Applied Stem Cell). For
analysis of 6 DPI intermediates, 0.8 x 106 cells were pelleted, submerged in 300 µL
RNAlater (Sigma Aldrich) and stored at -80°C until nucleic acid extraction. Presumptive
canine iPSCs were maintained in basal medium containing Knockout DMEM/F12, 20%
KSR (Tobias et al., 2016; Yoshida et al., 2009) or DMEM with 10% FBS. Co-cultures of
transduced canine fibroblasts and arrested MEFs were monitored for epithelialization and
the emergence of primary colonies. For clonal isolation (10-20 DPI), primary colonies
were mechanically isolated with a pipet tip and transferred into a Geltrex- and MEFcoated 48-well plate.

4.2.6

Reverse Transcription and Quantitative PCR

Total RNA from cultured cells was isolated using PureLink RNA kit (Thermo Fisher)
and quantified using a NanoDrop spectrophotometer. 500 ng of total RNA was treated
with RQ1 DNase (Promega) and used to synthesize cDNA using the Superscript III
Reverse Transcription kit (Thermo Fisher) with 1.25 µM each of oligo dT and random
hexamers. Aliquots of cDNA were diluted 1:20 in nuclease-free water for use as template
in qPCR reaction mixtures containing: 5 µL SensiFast SYBR (BioLine Reagents), 1 µL
primer mixture (500 nm final), 2 µL nuclease-free water and 2 µL template. PCR assays
were run on using the CFX384 Real-Time System (BIO-RAD). Thermal cycling
conditions included 2 minutes at 95°C followed by 39 cycles of 95°C for 15 seconds and
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60°C for 30 seconds. Annealing temperatures were optimized for the amplification of a
single product of expected size, excised and sequenced at the London Regional Genomics
Center (Robarts Research Institute, ON) to confirm specificity. All custom primer
sequences and amplicon sizes can be found in Table 4-2. Reaction data were corrected
for individual primer amplification efficiencies, calculated from a standard dilution
series. The expression ratio for genes of interest were normalized to two reference genes
(TBP and RPS5) and calculated using the 2-ΔΔCt method.
Table 4-2. Custom oligonucleotide primer sequences.
Gene Identifier
TET1
TET2
TET3
CDH1
CDH2
DSP
KRT19
SMAD2
SNAI2
VIM
TBP
RPS5

4.2.7

Sequence (5’ to 3’)
F – CCAGTTAACCCGACCTGTCC
R – CGGCCGAGAGCCATTAGAAA
F – AGCACATTGGTATGCACCCT
R – TGTCGGCATGTCTTGACTGG
F – GCCCCCTACTCAGGAAATGA
R – GGTAGAAAAAGGGCTCTCGGG
F – AGGCTAACGTCGAAATCGCT
R – GAGGATGACCTCAAACGGGG
F – ACGGACCCAAACAGCAATGA
R – ACAGACACAGTTGCCGTTGA
F – AATCCTCTGGCCGTAGACCT
R – CCTGACGCATCGTTTTCAGC
F – AGCTCACCATGCAGAACCTC
R – GACGGGCATTGTCAATCTGC
F – AAGTGGTGTGAGAAAGCGGT
R – GGCCTGTTGTATCCCACTGA
F – GAACTGGACACGCACACAGT
R – CACACGGTAATGGGGCTGTA
F – TTCAGAGAGAGGAAGCCGAGA
R – AGGTCAGGCTTGGAAACATCC
F – GAGCTCTGGGATCGTGCCGC
R – TCAGTGCAGTGGTTCGGGGC
F – TCACTGGTGAGAACCCCCT
R – CCTGATTCACACGGCGTAG

Amplicon Size
124
224
223
236
155
175
237
187
116
214
167
141

Targeted Bisulfite PCR

Genomic DNA (gDNA) from cultured cells was isolated using GenElute Mammalian
Genomic DNA Miniprep kit (Sigma Aldrich). Genomic DNA was eluted in 30 µL of
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sterile TE buffer pH 8.0 and determine concentration using NanoDrop 2000 spectroscopy
(Thermo Fisher Scientific). Bisulfite modification and purification was performed using
the EZ DNA Methylation Gold kit (Zymo Research) with 400 ng of gDNA. Eluted
bisulfite-converted DNA was used immediately for PCR using Platinum Taq Polymerase
and primer pairs designed to target the 5’-flanking sequences close to the transcriptional
start site of canine OCT4 and NANOG (Luo et al., 2011). See Table 4-3 for primer
sequences and amplicon sizes. To account for stochastic amplification, three parallel 25
µL reactions for each template and primer combination were performed, pooled and realiquoted for future steps. Nested re-PCR was performed with 3 µL of the resultant
bisulfite-PCR reaction mixture. PCR amplifications used variations of the following
thermal cycling protocol: 3 minutes at 94°C; 35 cycles of 94°C for 20 seconds, 59-64°C
gradient for 15 seconds, 72°C for 15 seconds; 72°C for 5 minutes final extension. In
nested re-PCR reactions a touchdown annealing range of 70-64°C was added before
amplification cycles.
Table 4-3. NANOG and OCT4 primer sequences for bisulfite PCR.
Primer Set
Sequence (5’ to 3’)
NANOG_OUT F – GTATTTTTGATTTTAAAGGATGGA
R – AAAACCTCCACATATAAAAAATAAA
NANOG_IN
F – TAGAAATATTTAATTGTGGGGTT
R – CATATAAAAAATAAAAAAAAAACAAAAT
OCT4_OUT
F – AGGTTAGTGGGTGGGATTGG
R – CCTTAAAACAACAACCCCACTC
OCT4_IN
F – AGGTGTTGAGTAGTTTTTAGGAGA
R – ACTCCCACCTAAAATCCACAATA

4.2.8

Amplicon Size
359
312
362
314

Clone Sequencing and Methylation Analysis

Fresh PCR amplicons were ligated into pCR2.1 vectors and transformed into TOP10
competent E. coli using TA cloning kit (Thermo Fisher). Bacteria were plated onto LB
agar with ampicillin and streaked with X-gal. No more than 10 white bacterial colonies
were picked for each biological replicate and transferred into 3-mL of LB medium with
antibiotic. Clones were grown for 16 hours in a 37°C bacterial incubator. The plasmid
DNA were purified with Presto Mini Plasmid kit (Frogga Bio) and sequenced with 3730
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DNA Analyzer System (Applied Biosciences) using M13 forward and reverse primers
(London Regional Genomics Centre, Robarts Research Institute). Base calls, quality
trimming, vector clipping and contig assembly was performed using the pre-Gap and
Gap4 tools (Staden Package) (Staden, 1996). To determine accurate methylation patterns
on target regions, at least 18 total processed clone sequences were aligned to the
reference genomic sequence using methVisual R/Bioconductor package (Bioconductor
release 3.6) (Zackay and Steinhoff, 2010). Alignment and quality control functions were
used to compute bisulfite conversion rate and percentage sequence identity. The
methylation state for each CpG site was exported from the quality-checked aligned
sample sequences. For each acceptable clone, we adjusted cytosine methylation level to
the bisulfite conversion rate (Biscon):
𝐶𝑚𝑒𝑡ℎ
⁄𝐵𝑖𝑠 )
𝑐𝑜𝑛
𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑 𝐶𝑦𝑡𝑜𝑠𝑖𝑛𝑒 𝑀𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝐿𝑒𝑣𝑒𝑙 =
𝐶𝑡𝑜𝑡𝑎𝑙
(

4.2.9

DNA Enzyme-linked Immunosorbant Assay (ELISA)

Genomic DNA was isolated as described above (see Section 2.4), aliquoted and diluted to
10 ng/µL. Global 5-methylcytosine or 5-hydroxymethylcytosine level were assessed from
100 ng of total gDNA using 5-mC DNA ELISA Kit or Quest 5-hmC DNA ELISA Kit
(Zymo Research), according to the manufacturers’ recommendations. Briefly, percent 5mC or 5-hmC was interpolated from a five-point standard curve and adjusted based on
the CpG dinucleotide density of the reference genome assembly for the species under
investigation.

4.2.10

RT2 Profiler PCR Array Analysis

Total RNA from cultured cells was isolated using PureLink RNA kit (Thermo Fisher)
and quantified using a NanoDrop spectrophotometer. Genomic DNA digestion was
performed using the RNase-free DNase Set (Qiagen). For the RT2 Profiler PCR array,
400 ng of RNA was reverse transcribed to cDNA using the RT2 First Strand Kit (Qiagen).
Quantitative PCR was performed using the Canine Epithelial-Mesenchymal Transcription
RT2 Profiler PCR Array (Qiagen) according to manufacturer’s guidelines. Data generated
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from the PCR Array was analyzed as expression ratios using five reference genes
(ACTB, B2M, GAPDH, HPRT1, RPLP1) and calculated using the 2-ΔΔCt method.
Differentially expressed transcripts targets were validated using custom oligonucleotide
primers and qPCR analysis (see section 4.2.6).

4.2.11

Statistical Analysis

Experiments were not randomized, and the investigators were not blinded to allocation
during experiments and outcome assessment. No statistical method was used to
predetermine sample size. Sample sizes specific to each figure are denoted in figure
legends. A p-value < 0.05 was considered significant. When two groups were compared,
an unpaired t-test or, if assumptions of normality and equal variance were violated, a
Wilcoxon rank sum test was performed. For multiple group comparisons, either one-way
analyses of variance (ANOVA) or the non-parametric Welch’s ANOVA was applied. A
two-way ANOVA was performed in instances of two grouping variables. Where
significance existed for a grouping factor, Tukey or Games-Howell post-hoc methods
were carried out to determine differences between groups. Permutation tests were applied
to determine if promoter class assignments and CpG richness scores are independent. For
correlation analyses, the linear association was assessed using Spearman’s rho statistic.
All statistical analyses and plotting were carried out using R 3.5.0 statistical computing
environment.

4.3 Results
4.3.1

A subset of reprogramming-associated orthologues is CpGrich in the canine genome assembly.

We first sought to assess the conservation of CpG-rich sequences and CGIs, which are
targets of cytosine modification enzymes, in the promoter sequences of shared
orthologous genes between canine, human and mouse. To this end, we compiled a gene
set from the intersection of differentially expressed genes between day 0 of
reprogramming and the iPSC state in humans and mice (Nefzger et al., 2017; Tanaka et
al., 2015). The gene set filtered based on Gene Ontology terms “DNA binding” or
“Chromatin binding” and limited to those with a RefSeq annotated canine ortholog.
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STRING protein association network construction showed the resultant gene set form
two interconnected clusters of conventional pluripotency transcription factors (e.g.
NANOG, ZFP42) and epigenetic modifying enzymes (e.g. JARID2, DNMT3B) (Fig. 41A). Peripheral components of the set consist of general regulators of proliferation with
complex contributions to reprogramming (e.g. MYBL2, TRIM71) (Chang et al., 2012;
Ward et al., 2018).
The promoter class assignments in 22 qualifying regions associated with reprogramming
are distinct from the class allocations in 40 randomly selected background loci filtered
based on gene Ontology Terms “DNA binding” (GO:0003677) or “Chromatin binding”
(GO:0003682) (P = 0.039, Permutation Test). We observe marginally greater numbers of
HCPs in the canine promoter set, however this distribution of promoter classes was not
significantly different from human or mouse (Fig. 4-1B, P = 0.587 & P = 0.575,
Permutation Test). It remained plausible that canine promoter sequences are more CpGrich but fall below the threshold of CGIs. We performed pairwise comparisons between
CpG richness scores from each species, using permutational percentile tests which
account for subsets of promoter sequences contributing to data asymmetry within groups
(Mangiafico, 2015). The median was not significantly different among canine-human (P
= 0.156), canine-mouse (P = 0.08) or mouse-human (P =1) pairs. However, the 75th
percentile was significantly different between canine and mouse (P = 0.038), but not
canine-human (P = 0.107) or human-mouse (P = 0.526) pairs (Fig. 4-1C).
To determine if the CpG sequence features among canine promoters diverge from other
placental mammals (human, mouse, rabbit, porcine, bovine), we assessed paired
association of whole promoter CpG ratio. Hierarchical cluster analysis of species grouped
canine with murine promoter sets away from a porcine, human, bovine and rabbit cluster
(Fig. 4-2). This analysis also highlighted that, among the mammalian promoters
collected, canine sequences exhibit the greatest dissimilarity aside from rabbit. Whereas,
clustering of promoters revealed four groups: 1) high CpG ratio in all species (SOX2,

167

Figure 4-1. Class assignments and CpG-rich sequence score among promoters of
genes associated with somatic cell reprogramming.
(A) STRING network visualization of putative protein-protein interactions between
common differentially expressed genes in human and mouse reprogramming time course
transcriptome experiments. K-means clustering (k=2) of networks demarcates DNAbinding and chromatin modifying enzymes. (B) Proportion of sequences assigned to high
CpG promoter (HCP), intermediate CpG promoter (ICP) and low CpG promoter (LCP)
classifications. (C) CpG richness score of promoter sequences from canine, human and
mouse genome assemblies. Permutational percentile tests (PPT) were used to determine if
the distribution of samples were significantly different between species at different
quartiles (median = PPT50, Q3/upper quartile = PPT75). The indicated quartiles of
sample distributions that are followed by the same letter are not significantly different.
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Figure 4-2. A subset of promoters associated with reprogramming is exclusively
CpG-rich in the canine genome.
Comparison of CpG ratio by hierarchical cluster analysis between collected promoters
from different mammalian superorders: Euarchontoglires (Human, Mouse, Rabbit) and
Laurasiatheria (Canine, Porcine, Bovine). A CpG ratio approaching 0 indicates few
cytosine and guanine bases are arranged in CpG dinucleotides, whereas a CpG ratio
approaching 1 indicates that more cytosine and guanine bases are found in a CpG context
than expected by randomization. Dendrograms represent Euclidean distance.
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PRDM14), 2) high CpG ratio in rabbit (OTX2, ZFP42), 3) low CpG ratio in all species
(NANOG, POU5F1) and 4) high CpG ratio in dog (TET2, NR5A2, JARID2). Pairwise
association analysis revealed that canine promoter sets are significantly correlated with
other species, except rabbit (rho= 0.314, P=0.241) and human (rho= 0.499, P=0.054).
Collectively, these results suggest that the promoters of genes involved in mammalian
iPSC generation are not enriched for CGIs in dogs, however a subset of canine promoters
are composed of more CpG-rich compared to the murine promoter set.

4.3.2

OCT4 and NANOG promoters are methylated in canine
fibroblasts and partially reprogrammed cells

Manipulation of genomic DNA methylation is an effective means of increasing the
probability of complete reprogramming, but only when applied at the appropriate point in
the workflow (Mikkelsen et al., 2008). Indeed, we observe that global DNA
demethylation is significantly reduced in canine adult fibroblast (cAF) after four (P =
0.015) or seven (Fig. 4-3A, P = 0.024) days of exposure to 5-µM 5azaC. We established
three partially reprogrammed cell lines, cPR-L6, cPR-D7 and cPR-F9, in our attempt to
reprogram adult dermal fibroblast with CytoTune 2.0 Sendai reprogramming vectors and
transient DNMT inhibition. They produce heterogeneous cultures consisting of colonies
with compact centres consisting of cells positive for SSEA4, a marker of cESCs,
surrounded by cells with bipolar morphology (Fig. 4-3B). RT-qPCR analyses show
incomplete expression of the triad of core pluripotency markers in cPR clones (Fig. 43C).
To investigate the extent of pluripotency gene silencing in cPR cells and parental
fibroblasts compared to pluripotent cESCs we assessed the methylation status of regions
within the canine NANOG or POU5F1/OCT4 promoter. Differing methylation profiles
are evident in the OCT4 promoter region (Fig. 4-4A) and the NANOG promoter region
(Fig. 4-4B) between cDF, cPR and cESCs. Methylation of the POU5F1 promoter region
is lower in cESC compared to cDF (P = 0.032), but not cPR (Fig 4-4C, P = 0.082).
Methylation of the NANOG promoter region is lower in cESC compared to both cDF
(P=1.25 x 10-3) and cPR (P= 6.36 x 10-4) (Fig. 4-4D). In summary, DNMT inhibition
elicits global DNA demethylation in cDF but is limited as a reprogramming supplement
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Figure 4-3. Canine dermal fibroblasts exposed transiently to 5-azacytidine (5-AzaC)
generate partially reprogrammed cell lines.
(A) 5-mC level in canine dermal fibroblasts exposed to 5-µM 5-azacytidine (5-AzaC), a
DNMT inhibitor, for four or seven days. (B) Representative phase-contrast and direct
immunofluorescence image for stage-specific embryonic antigen 4 (SSEA4) antibody
stain of a partially reprogrammed clonal cell population (cPR-L6). (C) Transcript
abundance of core pluripotency factors (OCT4, SOX2, NANOG) and tri-lineage markers
(BRACHYURY, GATA6, NESTIN) in partially reprogrammed cell lines and parental
fibroblast (cDF). Transcript levels are normalized to internal reference gene TATAbinding protein (TBP) and expressed as relative ratios to cDF samples. Bars represent
standard error of the mean, n =3. Means followed by the same letter are not significantly
different, P < 0.05.
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in canines because only partially reprogrammed clones with methylated NANOG
promoters could be attained.

4.3.3

5-hmC level varies among species and cell type

TET activity is thought to have a conserved role in a variety nuclear reprogramming
systems by facilitating conversion of methylcytosine (5-mC) to 5-hydroxymethylcytosine
(5-hmC) (Gao et al., 2013; Hill et al., 2014). To determine if the degree of global
cytosine methylation (catalyzed by DNMTs) or cytosine hydroxymethylation (catalyzed
by TET) differs among mammalian somatic genomes, we performed a comparative
analysis of 5-mC and 5-hmC level in primary fibroblasts from canine, human and mouse.
Total genome methylation was significantly lower in canine fibroblasts, compared to
human neonatal BJ1 fibroblasts (Fig. 4-5A, P = 3.67 x 10-2) or embryonic fibroblast from
CF1 mice (Fig. 4-5A, P = 2.60 x 10-3). The degree of cytosine hydroxymethylation was
significantly greater in murine fibroblasts compared to human fibroblasts and canine
fibroblasts (Fig. 4-5B, P = 3.7 x 10-6 & P = 1.0 x 10-7). Furthermore, 5-hmC level was
also greater in human fibroblasts compared to canine fibroblasts. (Fig. 4-5B, P = 6.83 x
10-3). We compared canine adult (cAF) and fetal fibroblasts (cFF) to discern the impact
of donor tissue maturity on global cytosine modification level. Basal 5-mC and 5-hmC
were not significantly different between cFF and cAF (Fig. 4-5C-D, P = 0.22). Both
fibroblast cell populations exhibit lower 5-hmC compared to pluripotent cESCs (P < 1 x
10-7) and transitional cPR cells (Fig. 4-5C-D, P < 1 x 10-7). These results suggest that
steady-state cytosine modification levels, particularly 5-hmC, are detectably influenced
by covariates such as the species and age of the donor tissue and may impact the ability
of a given cell population to generate iPSCs.

4.3.4

Identification of L-ascorbic acid and retinoic acid
concentrations that increase TET activity

Before proceeding to a modified reprogramming study, we sought to profile pan-TET
activity and TET paralog expression in canine somatic cells upon exposure to
combinations of RA and AA at levels used for iPSC generation. In murine and human
ESCs or reprogramming cells, TET2 expression is responsive to a conserved retinoic
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Figure 4-5. 5-hydroxymethylcytosine level varies with species and cell type.
(A) Percent 5-methylcytosine (5-mC) in cultures of primary fibroblast derived from
canine, human and mouse. (B) Percent 5-hydroxymethylcytosine (5-hmC) in cultures of
primary fibroblast derived from canine, human and mouse. (C) Relative 5-mC level
levels in canine adult fibroblast (cAF), canine fetal fibroblast (cFF), canine partially
reprogrammed (cPR) and canine embryonic stem (cES) cells. (D) Relative 5-hmC level
in cAF, cFF, cPR and cES cells. The percentage of each modified base is corrected for
the CpG dinucleotide density for each specific genome assembly. Bars represent standard
error of the mean (SEM), n = 4-5. Means followed by the same letter are not significantly
different, P < 0.05.
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acid (RA) signaling element, distinct from the enzyme cofactor function of L-ascorbic
acid (AA) (Hore et al., 2016). Using the ratio of genome-wide 5-hmC to 5-mC as an
index of the overall catalytic output of TET enzymes (Ficz et al., 2011), we observed
both AA (Fig. 4-6A, F = 4.08, P = 2.83 x 10-2) and RA (Fig. 4-6A, F = 6.73, P = 4.26 x
10-3) have a significant independent influence on 5-hmC:5-mC ratio. Only the
combinations of 100 µM AA (Fig. 4-6A, P= 0.033) and 0.1 nM or 1 nM RA (Fig. 4-6A,
P= 0.035) significantly elevated 5-hmC:5-mC ratio compared to vehicle controls.
Analysis of endogenous TET expression levels revealed basal levels of TET transcript in
canine fibroblast ranging from 0.57% of reference gene expression for TET1, 8.30% for
TET2 and 1.58% for TET3 transcripts. Interestingly, exposure of canine fibroblast to
various RA concentrations did not alter TET paralog expression (Fig. 4-6B - 4-6D).
Significant changes in cTET1 (Fig. 4-6B, P= 0.0171) and cTET3 (Fig. 4-6D, P= 6.29 x
10-3) abundance were only detected in 250 µM AA compared to vehicle control. The
observation that cTET paralog expression is not sensitive to RA in canine fibroblast may
indicate that the reprogramming OKSM factors are required co-factors. Indeed, we have
identified a putative OCT4:SOX2 composite motif upstream of cTET1 and a partial
OCT4 motif upstream of cTET2 in conserved non-coding sequence (Fig. 4-6E).

4.3.5

Physiological oxygen changes the influence of metabolites
on TET activity

Physiological oxygen tensions (i.e. < 5% O2) have been shown to improve iPSC
derivation efficiency (Yoshida et al., 2009) and increased TET paralog expression in
cultured cells and embryos (Mariani et al., 2014; Skiles et al., 2018). We next sought
determine whether cTET transcript abundance and catalytic output are similarly
responsive to AA, a pleiotropic molecule with donor antioxidant activity (Du et al.,
2012), when cultured in a 5% oxygen environment. We observe relative 5-hmC levels
approximately 1.4-fold higher than at atmospheric oxygen cultures. Surprisingly, in a
physiological oxygen condition, neither AA (Fig. 4-7A, F = 0.30, P = 0.74) nor RA (Fig.
4-7A, F= 0.74, P= 0.57) significantly alter the 5-hmC:5-mC ratio compared to vehicle
controls. We find that all cTET paralogs are generally more abundant (between 1.3 and
2.5-fold) in 5% oxygen
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Figure 4-7. L-ascorbic acid suppresses hypoxia-mediated induction of cTET1 and
cTET3.
(A) 5-hmC:5-mC ratio in canine dermal fibroblasts cultured in a 5% physiological
oxygen environment and exposed to various concentrations ascorbic acid (AA) and/or
retinoic acid (RA). Each data point is calculated from paired aliquots from the same
purified gDNA sample and analyzed by separate ELISA assay kits. (B) Relative
transcript abundances for cTET1, cTET2 and cTET3 in canine dermal fibroblasts
cultured in physiological 5% oxygen and exposed to various concentrations of AA. (C)
Pairwise alignment of canine, human and mouse TET3 promoter with partially conserved
HIF-1 motif. (D) Weighted sequence motif logo for HIF-1. Bars represent standard error
of the mean (SEM), n = 4. Means followed by the same letter are not significantly
different, P < 0.05.
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without culture media supplements. (Fig. 4-7B). This hypoxia-mediated induction of
cTET1 and cTET3 transcripts is abrogated in the presence of AA at 250 µM (Fig. 4-7B, P
= 2.16 x 10-3 & P = 0.018). The notion that TETs may be a target of the hypoxic response
is supported by the presence of a partially conserved HIF1 motif in the cTET3 locus (Fig.
4-7C-D). In summary a negative regulatory effect of AA on the cTET1 and cTET3
hypoxic response may obscure the role of AA and RA in regulating 5-hmC and 5-mC
content in canine fibroblasts.

4.3.6

L-ascorbic acid and retinoic acid promote focal
epithelialization during early canine reprogramming

The KOS, KLF4 and c-MYC SeV vectors were applied at a multiplicity of infection
(MOI) of 5 or 6, based on transduction efficiencies achieved using control emGFP
control SeV reporter (Fig. 4-8A-B). Increased levels of reprogramming factor expression
have been shown to improve reprogramming in refractory mouse lacking NANOG
(Carter et al., 2014; Schwarz et al., 2014). Further, inadequate KLF4 expression has been
shown to pause the reprogramming process in independent of the remaining Yamanaka
transfactors (Nishimura et al., 2014). Low passage canine fetal fibroblast (cFF at p1) cells
were selected as the donor cell population. Throughout the first 48 hours after viral
transduction, we observed slightly greater levels of cytotoxicity in SeV-transduced cFFs
versus non-transduced control cells (~8% vs. ~20%, visual record) (Fig. 4-9A). After 24
hours of treatment with AA/RA or vehicle, transduced cFFs enter a hyperproliferative
state and reach confluency. Transduced cFFs treated with AA/RA exhibited small
clusters with epithelial character by 4 DPI which increased in size and frequency by 5
DPI (Fig. 4-9B). Interestingly, we observe that AA/RA-treated cells form more primary
colonies upon re-seeding onto MEF feeders (Fig. 4-9C, P = 0.029).
We next examined the abundance of transcripts associated with mesenchymal-toepithelial transition (MET) in 6 DPI reprogramming intermediates by qPCR array.
Pairwise correlation analysis and clustering revealed that targeted expression profiles of
biological replicates were highly similar (ρ > 0.94), suggesting that merging data across
arrays was robust to batch effects (Fig. 4-10A). This analysis also highlighted that
AA/RA treated intermediates were more dissimilar to non-transduced cFF cells by the
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Figure 4-8. Optimization of multiplicity of infection (MOI) in canine fibroblast using
Sendai emGFP control vector.
(A) Representative phase-contrast and fluorescent micrographs of canine dermal
fibroblast transduced with emGFP control Sendai vector at various multiplicity of
infection (MOI). Scale bar unit length is 125 µm. (B) Summarization of the mean percent
emGFP-positive cells at each MOI. Bars represent standard error of the mean (SEM), n =
2.
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Figure 4-10. L-ascorbic acid and retinoic acid enhance a transcriptional response
resembling mesenchymal-to-epithelial transition.
(A) Density matrix of Pearson correlation coefficients of transcript panel abundances in
each sample. (B) Relative abundances of transcripts associated with DNA binding
proteins. (C) Relative abundances of transcripts associated with secreted ligands or
extracellular matrix components. (D) Relative abundances of transcripts associated with
the cytoskeleton or cell adhesion that are down-regulated at 6 DPI. (E) Relative
abundances of transcripts associated with the cytoskeleton or cell adhesion that are upregulated at 6 DPI. Bars represent standard error of the mean (SEM), n = 3. Means
followed by the same letter are not significantly different, P < 0.05.
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Euclidean distance than vehicle-treated intermediates at 6 DPI. The transcripts of several
DNA-binding proteins involved in the repression of epithelial gene expression were
downregulated in 6 DPI samples (e.g. SNAI2, ZEB1) (Fig. 4-10B, P < 8.63 x 10-3).
Furthermore, SMAD2 transcript was significantly decreased in AA/RA intermediates
compared to vehicle control (Fig. 4-10B, P = 1.08 x 10-2). Similarly, 6 DPI intermediates
exhibited a lower abundance of several mesenchyme-associated transcripts with known
signaling or structural role in the extracellular space (e.g. FN1, BMP2, SERPINE1)
compared to parental cFF cells (Fig. 4-10C, P < 1.99 x 10-2). Among different TGFβ
isoforms, only TGFβ1 was significantly decreased in AA/RA intermediates relative to
vehicle control (Fig. 4-10C, P = 4.28 x 10-2). Strikingly, several transcripts related to
cytoskeletal (e.g. MSN, MAP1B, KRT7) and plasma membrane (e.g. F11R, TMEFF2)
components were differentially abundant in reprogramming intermediates compared to
donor cFF cells. (Fig. 4-10D-E, P < 1.30 x 10-2). Notably, characteristic mesodermal
markers CDH2 (P = 4.51 x 10-2) and VIM (P = 3.55 x 10-2) are significantly lower in
AA/RA-treated intermediates (Fig. 4-10D). Whereas, epithelial hallmark transcripts
CDH1 (P = 2.31 x 10-3), DSP (P = 6.54 x 10-3), KRT14 (P = 2.43 x 10-3) and KRT19 (P =
1.72 x 10-2) were significantly elevated in reprogramming intermediates exposed to
AA/RA (Fig. 4-10D). Custom oligonucleotides were designed to validate several
differentially abundant transcripts relevant to MET (Fig 4-11A-B).
Defining the culture conditions that support self-renewal of pluripotent cells from dogs
remains a challenge. We and others have expanded cESC (Tobias et al., 2016) and ciPSC
(Luo et al., 2011; Nishimura et al., 2013) in Knockout Serum Replacement (KOSR)containing medium optimized for hESC. In the previous chapter, I demonstrated that
cESCs cultured in this medium exhibit deficiencies in the glycolysis pathway compared
to human or mouse ESCs (Chapter 3). To propagate presumptive ciPSCs, we attempted
single- and bulk-colony passaging techniques in different medium and growth factor
combinations (Fig. 4-12A). We found that cESC-like culture conditions containing
KOSR could not mature canine iPSC-like cells (Fig. 4-12B). Conversely, standard
DMEM with 10% FBS media was more effective at stabilizing early reprogramming
intermediates, which was accentuated with exogenous LIF supplementation (Fig. 4-12C).
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Figure 4-11. Validation of differentially abundant mesenchymal and epithelial
transcripts using custom oligonucleotide primers.
(A) Relative abundances of transcripts associated epithelial cell types quantified by
reverse-transcription qPCR. (B) Relative abundances of transcripts associated with
mesenchymal cell types quantified by reverse-transcription qPCR. Bars represent
standard error of the mean (SEM), n = 3. Means followed by the same letter are not
significantly different, P < 0.05.
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However, within three-to-four passages, presumptive ciPSCs progressively lost compact
border morphology and gradually formed monolayer structures with radial asymmetry
(Fig. 4-12D). These results suggest that LIF supplementation supports the emergence of
early reprogramming intermediates, but insufficient to propagate maturing canine iPSCs
long-term.

4.4 Discussion
It is currently unknown if canine reprogramming mirrors the trajectory of human or
mouse cells towards the iPSC state. Previous studies have focused on the molecular
characteristics and differentiation potential of a limited number of putative iPSC clones
derived from a single reprogramming experiment (Luo and Cibelli, 2016). To develop a
reproducible system to derive and maintain canine iPSCs, it is essential to identify the
most obstructive mechanisms to the reprogramming of canine cells by forced expression
of transcription factors. We found that global 5-hmC level varies among primary
fibroblast cultures from different species commonly used for reprogramming
experiments. Gene expression and epigenetic assays indicate that partially reprogrammed
cells exhibit limited pluripotency factor expression, methylation of the NANOG promoter
and lower 5-hmC levels compared to canine ESC lines. Our study also indicates that a
transcriptional response resembling MET occurs within the first week of canine
reprogramming. Morphological and transcriptional indicators of MET can be facilitated
using bioactive metabolites, which modulate 5-hmC accumulation in canine fibroblasts
independent of changes in TET paralog expression.
During iPSC generation thousands of loci gain or lose methylation (Polo et al., 2012) as
reprogramming factors direct active demethylation (Sardina et al., 2018) and outcompete
the somatic gene regulatory network allowing de novo methylation of lineage-associated
genes (Schwarz et al., 2018). Ultimately, genome-wide methylation in the established
pluripotent cells is estimated to be similar to somatic cells unless small molecular
inhibitors or activators are added to drive further epigenome erasure (Ficz et al., 2013;
Leitch et al., 2013). We have previously demonstrated that small molecule inhibitors of
MEK1/2 and GSK3 enrich for a population of cESCs with lower global 5-mC levels
(Tobias et al., 2016) and noted a previously recognized over-representation of CGIs in
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the canine genome assembly (Han et al., 2008). In addition to prompting targeted
chromatin remodeling, TET enzymes help to maintain the hypomethylated state of high
CpG density regions (Williams et al., 2011; Wu et al., 2011). Previous enrichment
analyses of canine-human homologous genes focused on subsets of loci with a CGI
present only in the human assembly (Han and Zhao, 2009). Due to a lack of a formal
gene ontology term affiliated with somatic cell reprogramming, we derived a gene list
from time-course transcriptome experiments in human and murine cells. Our sequence
analyses showed that there were no differences in the number of canine promoters with a
unique CGI among conserved reprogramming genes, but a subset of promoters (~20%)
consisted of uniquely CpG-rich sequence in the canine genome. A valuable extension of
this investigation would include collecting CpG-related sequence features from regions
associated with cis-regulatory modules, particularly distal regulatory elements predicted
from clustered pluripotency transcription factor motifs.
Higher reprogramming efficiencies between somatic cell types positively correlate with
the number hypermethylated tissue-specific genes shared with pluripotent ESCs (Barrero
et al., 2012). Furthermore, embryonic and fetal cell populations are often more efficiently
reprogrammed, occasionally with fewer ectopic transfactors, compared to differentiated
adult cells (Hansel et al., 2014; Kleger et al., 2012). We found no differences in the
fraction of 5-mC among total genome CpG dinucleotides between adult or fetal canine
fibroblasts, partially reprogrammed cells or ES cells. However, 5-hmC level was
associated with cES and cPR cells considered to be more plastic populations than somatic
fibroblasts. Interestingly, canine fibroblasts appear to be deficient in 5-hmC compared to
human and mouse fibroblasts. This may be due, in part to lower global levels of 5-mC
substrate available for oxidation, a species-dependent or time-dependent consequence of
adaptation to culture (Nestor et al., 2015).
Comparisons of time-resolved data from the reprogramming of different cell types and/or
species have identified context specific trajectories and barriers to acquired pluripotency
(Fu et al., 2018; Nefzger et al., 2017). We observed incomplete demethylation of the
NANOG promoter region, and as a plausible consequence endogenous NANOG
transcripts are not upregulated in partially reprogrammed clones. Limited epigenetic
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remodeling and endogenous pluripotency gene re-activation is also evident in porcine
reprogramming (Choi et al., 2016), another Laurasiatherian species. We found that
endogenous POU5F1 expression in cPR lines does not correlate well with the
methylation status of the -394 to -88 region targeted in this study. One possibility is that
cytosine residues with gene regulatory activity are present elsewhere in the canine
POU5F1 promoter. POU5F1 expression in cPR lines suggest that POU5F1 re-expression
dynamics resemble the human reprogramming time course, wherein POU5F1 is
reversibly re-expressed during MET, as opposed to during the later maturation phase in
murine reprogramming (Brambrink et al., 2008; Teshigawara et al., 2016).
To date, canine reprogramming studies have only applied small molecule inhibitors to
facilitate reprogramming (Betts and Tobias, 2015). In our hands, transient exposure to
DNMT inhibitor 5-azaC did not noticeably impact the initiation canine reprogramming
but enabled the stabilization of partially reprogrammed cell populations. Prolonged
disruption of DNMT is not desirable due to the potential to activate retrotransposons and
induce genome instability (Eden et al., 2003; Walsh et al., 1998). Analysis of cells
apparently trapped in partially reprogrammed states have provided useful information on
reprogramming obstacles, notably in the maturing iPSCs (Mikkelsen et al., 2008).
However, the continued emergence of partially reprogrammed cells has diminishing
value and may confound molecular analyses by misidentification with cells undergoing
productive reprogramming.
Experimental manipulations that increase TET abundance or catalytic activity promotes
5-methycytosine removal and iPSC generation in both human and murine cells (Costa et
al., 2013; Doege et al., 2012; Gao et al., 2013). L-ascorbic acid directly interacts with the
TET catalytic domain as a cofactor (Blaschke et al., 2013; Yin et al., 2013) and enhances
Fe (II) recycling (Hore et al., 2016) to elevate methylcytosine dioxygenase activity.
Whereas, retinoic acid may synergistically increase TET action via nuclear receptor
complex-dependent functions such as: up-regulation of TET2/TET3 expression (Hore et
al., 2016) and focal recruitment of TET1/2 and base-excision repair machinery (Hassan et
al., 2017). Interestingly, retinoid ligands appear to have TET-independent mechanisms to
regulate early human and mouse reprogramming via retinoic acid receptor-gamma
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(RARG) and binding partner NR5A2 (also known as LRH1) (Wang et al., 2011). As the
reactions catalyzed by TET enzymes are dependent on molecular oxygen, it is not
surprising that physiological levels of extracellular oxygen promote TET activity (Burr et
al., 2018). In the present study, we observed an antagonistic effect of L-ascorbic acid on
the expression of TET1 and TET3 in a 5% oxygen environment. Our result resembles the
ability of L-ascorbic acid to suppress the HIF-1 transcriptional response in cancer cells by
stimulating the activity of HIF-degrading prolyl hydroxylase enzymes (Kuiper and
Vissers, 2014).
The first phase of cell reprogramming is initiation, which encompasses several of
transgene-dependent events including hyper-proliferation and loss of somatic identity
(Stadtfeld et al., 2008). The specific cellular and molecular events that define the
initiation phase is dependent on cell type (Nefzger et al., 2017) and in fibroblast is
highlighted by MET (Li et al., 2010; Samavarchi-Tehrani et al., 2010). In our singleinfection reprogramming system, we observed altered expression of a variety of growth
factors, adhesion molecules, cytoskeletal components and transcriptional regulators on
day six, which is consistent with the process of MET. Interestingly, exposure to AA/RA
enhanced several previously established aspects of MET including a switch from
neuronal-type to epithelial-type cadherin expression (Araki et al., 2011) and the induction
of keratin gene expression (Kagawa et al., 2019). Clusters epithelial-like cells are
observed as early as four days post infection, but only in AA/RA treated reprogramming
intermediates. Surprisingly, the apparent timing of the initiation phase in canine cells in
our reprogramming system bears stronger resemblance to mouse reprogramming than
human reprogramming (Høffding and Hyttel, 2015; Teshigawara et al., 2016). We note
that other reprogramming vector systems may yield results that differ from our
observations because the trajectory of cell states towards pluripotency and overall
kinetics of iPSC generation are influenced by the reprogramming system utilized
(Chantzoura et al., 2015). Our strategy to stabilize maturing canine iPSC intermediates in
culture media used for routine culture of canine ESC and putative iPSC was unsuccessful
beyond days 26-30 of reprogramming. Fundamental questions remain outstanding
regarding the trophic requirements and regulatory processes that achieve a transgeneindependent pluripotent state in the dog.
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Our study represents the first investigation to identify phase-specific hurdles to canine
induced pluripotency. We identified several promoter regions controlling canine genes
involved in pluripotency regulation with distinctively CpG-rich sequence. Our
examination of early canine reprogramming suggests that MET initiates four-to-six days
after canine fibroblast infection, which is consistent with the kinetics of murine
reprogramming systems. The notion that the over-representation of clustered CpG
dinucleotides in the dog may influence the redistribution of DNA methylation during
canine reprogramming warrants further investigation by untargeted, genome-wide
approaches. This study also lends support to an evolutionarily conserved TET regulatory
mechanism controlling the MET program, which has broader implications in the areas of
developmental and cancer biology.
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Chapter 5

5

General Discussion and Conclusions

5.1 Discussion and Significance of Research
It has long been understood that manipulation of developmental signaling pathways can
influence lineage specification from the pluripotent state. A recent extension of this
paradigm suggest manipulations to the culture environment can affect the range of
characteristics and differentiation potential of plastic mammalian cell populations. In this
plateau model, developmental trajectories can be halted by specific extrinsic signals in a
lineage-primed pluripotent state. Under distinct environmental constraints, this
progression can even be reversed to stabilize an earlier developmental state on a nearby
plateau representing a closely-related cell population. In mammals, two discrete
pluripotency plateaus appear to be obtainable, known as naïve and primed, through direct
embryonic derivation or reprogramming technologies with developmentally appropriate
stimuli from culture environments. Direct reprogramming of somatic cells to either
pluripotent state requires ectopic TF overexpression and/or modulation of epigenome
modifying enzymes to override the somatic nucleus. In pluripotent stem cells derived
from large mammals, such as domestic dogs, there is little consensus regarding the
exogenous requirements for the acquisition or maintenance of stable pluripotency.
Variation among permissive culture environments may be confounded by the coexistence of multiple canine pluripotent states with exclusive input requirements and
discrete cellular and molecular characteristics.
The overall hypothesis of my thesis is that the culture environment can promote nuclear
and metabolic reprogramming of canine cell lines towards a more primitive state of
pluripotency. The main findings of this thesis that support my hypothesis and advance
this knowledge are:
1. Manipulation of FGF-ERK and WNT-β-catenin signaling pathways enriched for a
unique cESC population with ultrastructural, transcriptional and epigenetic
similarity to the naïve pluripotent state.
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2. Maintenance of cESCs in discrete culture environments are dependent on
different metabolic pathways for in vitro proliferation.
3. Combinatorial exposure to metabolites that influence cell signaling and
epigenetics facilitate the early de-differentiation of canine somatic cells.
With my thesis work, I have advanced our understanding of the extrinsic requirements
and potential intrinsic mediators for the induction and maintenance of phenotypically
distinct cESC. Furthermore, we illustrated the utility of metabolite supplementation
targeting epigenetic remodeling processes during de-differentiation to facilitate phasespecific progression towards a reprogrammed pluripotent state. Taken together, these
investigations establish a developmental context for cESCs that is dependent on complex
interactions between gene regulatory mechanisms, metabolic activities and the
microenvironment (Figure 5-1).
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5.1.1

Pluripotent state-specific signaling and metabolic pathways
support cESC maintenance

Extracellular signals cooperate with transcriptional regulatory machinery to organize
epigenetic features critical to multi-lineage plasticity and to minimize the loss of
pluripotent attributes through rapid symmetrical cell divisions. Despite greater than a
dozen derivation and characterization studies of canine embryo-derived or
reprogramming factor-induced PSCs (Menon et al., 2019), the similarity of canine
ESC/iPSC to pluripotent state phenotypes described in rodents and primates remain
unexplored.
I propose a model in which blastocyst-derived canine pluripotent stem cells maintained in
LIF and FGF2 (L/F) represent a metastable lineage-primed state of pluripotency from
which a developmentally immature subpopulation may be enriched with selective
disruption of developmental signaling pathways. Application of small molecule inhibitors
of GSK3 and MEK signaling with LIF supplementation (2iL) support a pluripotent cell
population with transcriptional, epigenetic and differentiation tendencies suggestive of an
earlier developmental identity (Chapter 2). The discrete pluripotent cell populations
supported by L/F or 2iL exhibit morphologically and functionally distinct mitochondria,
that alter metabolic pathway prioritization for anabolism and ATP generation (Chapter 3)
(Figure 5-2).
LIF and FGF2-dependent canine ESCs/iPSCs spontaneously differentiate in vitro in the
absence of exogenous LIF (Koh et al., 2013; Vaags et al., 2009; Wilcox et al., 2009). We
show that pre-existing LIF-STAT3 signaling activity in L/F cESCs is enhanced with the
induction and culture of naïve-like cESCs in 2iL (Chapter 2). The induction of STAT3
signaling is consistent with an evolutionarily conserved role in the establishment and
maintenance of naïve pluripotency among rodents, primates and ungulates (Chen et al.,
2015; Meng et al., 2015; Van Oosten et al., 2012; Wu et al., 2019). We also observe that
2iL cESCs have elevated respiratory capacities compared to L/F cESCs (Chapter 3).
During primed-to-naïve pluripotency resetting in mice, STAT3 has been shown to
directly promote respiration by activation of mtDNA transcription (Carbognin et al.,
2016). Reprogramming of mEpiSC to mESC by LIF-STAT3 signaling is halted by
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Figure 5-2. Different metabolic pathway activities support proliferation of canine
ESCs approximating primed and naïve pluripotency.
Conversion of LIF-FGF2 (L/F) cESCs to a naïve-like pluripotent state in 2iL medium is
associated with enhanced mitochondrial respiration and membrane potential (ΔΨm).
Incomplete oxidation of glucose in L/F cESCs is accompanied by lower ATP production
and elevated neutral lipid accumulation. Remodeling of mitochondrial ultrastructure in
2iL cESCs includes shorter mitochondria and disorganized cristae. Elevated
mitochondrial activity in 2iL cESCs may have a widespread influence on cellular
processes by altering retrograde AMPK signaling. Abbreviations: Glucose (GLU),
Phosphoenolpyruvate (PEP), pyruvate (PYR), lactate (LAC), fatty acid synthase (FASN).
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respiratory complex I inhibitor rotenone, implying that electron transport chain activity is
important for rewiring the pluripotency GRN (Carbognin et al., 2016). There is some
evidence that 2i has a complementary function to LIF by suppressing PGC-1α expression
to maintain the structural immaturity of mitochondria (Mahato et al., 2014). We
qualitatively observed the broadening of cristae outlets and tips and detected significant
decreases in MIC60 and assembled F1 ATP synthase subunits (Chapter 3). A similar
mitochondrial morphology is apparent in 2i mESC compared to S/L controls, suggesting
that 2i may directly affect cristae remodeling in naïve PSC (Mahato et al., 2014).
Activin/Nodal-SMAD2 signaling is believed to have an evolutionarily conserved role in
mEpiSC/hESC coordinating the primed pluripotency GRN and reducing paracrine BMP
signaling that drives lineage specification (Bertero et al., 2015; Sakaki-Yumoto et al.,
2013; Senft et al., 2018). We found no difference in SMAD2 phosphorylation between
L/F and 2iL cESCs indicating that this pathway is not likely to oppose the stabilization of
naïve or primed pluripotency in canines (Chapter 2). We noted that Activin receptor type
2B (ACVR2B) transcript abundance is down-regulated in 2iL cESCs, which implies that
2iL cESCs may be less sensitized to TGFβ ligands (Chapter 2). Additionally, phosphoSMAD2 level was not significantly different between ALK inhibitor SB431542 treatment
and steady-state L/F cESC culture suggesting low basal SMAD2 signaling may be
supported by alternative signaling cascades (Chapter 2). A comparison of independently
derived metastable porcine iPSC lines with distinct culture requirements (+LIF; +FGF2;
+LIF+FGF2) demonstrated that OCT4 and NANOG expression and self-renewal is
improved with Activin A exposure (Yang et al., 2017). Furthermore, exogenous Activin
A was recently shown to replace FGF2 signaling and induce NANOG expression in LIF
and FGF2-dependent canine iPSCs (Luo and Cibelli, 2016). Taken together, these studies
indicate that a more stable primed pluripotent state may be obtained through an
evolutionarily conserved Activin-SMAD2/3-NANOG axis.

5.1.2

Intracellular signaling pathways may link bioenergetics to
self-renewal and tumorigenicity of cESCs

Quantification of cESC proliferative rates during steady-state growth indicated that
culture conditions may be suboptimal, and that cell metabolism is influenced by the
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pluripotent state (Chapter 2). These observations were confirmed with quantifiably lower
glycolytic capacities and HXK2 abundances in cESCs compared to hESC and mESC
cultures, despite culture in controlled nutritional environments (Chapter 3). Furthermore,
2iL cESCs exhibit greater spare respiratory and glycolytic reserve capacities than L/F
cESCs (Chapter 3). These observations raise fundamental questions regarding the
regulation of glycolysis and proliferation in ESCs derived from dogs. It should be noted
that indirect measurements of glycolytic and mitochondrial activities were used in this
wrk. A direct analysis of metabolic flux and dissection of metabolic pathway dynamics
could be achieved through stable isotope-assisted metabolomics.
Glycolytic flux in PSC and embryos are regulated at the level of glucose uptake by
GLUT transporters as well as glycolytic enzyme abundances or activities. Constitutive
transporter GLUT1 is expressed in both hESC and mESC, correlates with glucose uptake
and mediates hypoxic adaptation of PSC to anaerobic glycolysis following HIF
stabilization (Forristal et al., 2013; Wu et al., 2017). While we found no difference in the
abundance of GLUT1 (Chapter 3), we cannot formally rule out differential rates of
glucose consumption underlying significantly different glycolytic capacities between
cESCs and hESCs or mESCs. We did not investigate the contribution of GLUT3, which
is developmentally regulated and shows high correspondence with OCT4 expression
(Carayannopoulos et al., 2014; Christensen et al., 2015). Recently, blunted glycolytic
rates in iPSC lines derived from aged donors was associated with elevated ROS and
depleted of TCA cycle phenotype that was rescued by GLUT3 overexpression (Zhang et
al., 2017). Manipulation of glycolytic flux in cESCs may be required to mitigate the
incidence of spontaneous differentiation, improve scalable culture as well as promote in
vivo survival and proliferation following xenotransplantation assays.
Gene regulatory networks controlled by OCT4 and C-MYC/N-MYC promote high
glycolytic flux in both mESC and hESC by regulating glycolytic enzyme expressions
including HXK2, LDHA and PKM2 (Cliff et al., 2017; Gu et al., 2016; Kim et al., 2015).
C-MYC/N-MYC double knockout studies indicate that growth-arrested mESCs remain
functionally pluripotent (Scognamiglio et al., 2016). Therefore, regulators of cell growth,
metabolism and pluripotency are strongly interconnected in PSC but disruption of

204

intracellular signaling networks can functionally uncouple pluripotency and self-renewal.
In the present work, we did not observe any difference in the abundances of core
pluripotency factor OCT4 or the level of HXK2 or PKM2 between L/F and 2iL cESCs
(Chapters 2 and 3). However, we found decreased HXK2 in both L/F and 2iL cESCs
compared to hESC or mESC (Chapter 3). The low proliferation rate in cESC cultures
bears a striking resemblance to a novel “paused” pluripotent state induced in mESC by
inhibition of mechanistic target of rapamycin (mTOR) (Bulut-Karslioglu et al., 2016).
Notably, progression through the cell cycle is slower in paused pluripotency without
appreciable apoptosis or differentiation (Bulut-Karslioglu et al., 2016). Inhibition of
mTOR promotes autophagy and suppresses global transcriptional and translational
output, all of which characterize paused pluripotent cells (Bulut-Karslioglu et al., 2016;
Sotthibundhu et al., 2016). Interestingly, selective HXK2 degradation by chaperonemediated autophagy is an anti-cancer mechanism employed by non-transformed cells
(Jiao et al., 2018; Xia et al., 2015).
Several lines of evidence suggest that cESCs in L/F or 2iL conditions may represent a
similarly idle pluripotent phenotype where glycolytic capacity is blunted by hyperactive
autophagy. In addition to mTOR, autophagy may be initiated in mammalian cells by liver
kinase B1 (LKB1)-AMPK signaling (Kim et al., 2011). We found that increased
mitochondrial respiration and ATP level in 2iL cESCs was associated with a decrease
AMPK activity compared to L/F cESC (Chapter 3). These observations provoke
questions regarding the roles of nutrient and energy sensing pathways in regulating
autophagy and related catabolic pathways (e.g. mitophagy) in pluripotency maintenance
and self-renewal. Future investigations should also attempt to disentangle the
contributions of regulated degradation versus fission-fusion homeostasis to mitochondrial
networks in pluripotent state transitions and lineage restriction.
PSC normally maintain low expression of p21 and exclude p53 from the nucleus to
rapidly progress through G1/S or G2/M cell cycle checkpoints (Calder et al., 2013;
Suvorova et al., 2016; Zhang et al., 2014). Unsurprising, mammalian PSC traditionally do
not exhibit contact inhibition in vitro and possess high tumorigenic potential in
immunocompromised hosts (Ben-David and Benvenisty, 2011). Observations that LIF
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and FGF2-dependent cESC lines derived in an independent laboratory generate teratomas
have not been replicated (Vaags et al., 2009). We showed that cESC transplantation from
either L/F or 2iL conditions do not readily yield tumors compared to hESCs that generate
mature teratomas (Chapter 2). Cell intrinsic factors that contribute to low tumorigenicity
of cESCs may resemble some combination of sensitivity to apoptosis, low competitive
fitness and/or poor transcriptional activation of proto-oncogenic GRNs. Transcriptional
networks centered around C-MYC/N-MYC typically show considerable overlap between
steady-state PSCs and cancer cells, which is largely related to a shared role in
transcriptional amplification (Kim et al., 2010; Lin et al., 2012). There are also speciesspecific drivers of tumorigenicity in PSCs such as embryonic ras-like gene (Eras). Eras
constitutively activates the PI3K-mTOR signaling pathway to augment the proliferation
and tumorigenicity of mESC but does not contribute to tumorigenic potential of primate
ESC (Takahashi et al., 2003; Tanaka et al., 2009; Yu and Cui, 2016).

5.2 Future Studies: Purification and analysis of canine
reprogramming intermediate cells
Somatic cell reprogramming is a multi-step process that requires phase-specific
epigenomic remodeling and transcriptional activity for productive transitions towards
pluripotency. Initiation of reprogramming in fibroblast populations is characterized by
silencing the somatic GRN that de-represses epithelial gene expression (Li et al., 2010;
Samavarchi-Tehrani et al., 2010). Productively reprogramming cells undergo
mesenchymal-to-epithelial transition (MET) characterized by the induction of gene
products that form epithelial tight junctions (Høffding and Hyttel, 2015; Shook and
Keller, 2003). Dose-optimization of the combination of L-ascorbic acid and retinoic acid
can reproducibly induce the accumulation of oxidized products of methylated DNA
catalyzed by the TET dioxygenase family enzymes (Chapter 4). Combined and transient
(2-6 DPI) metabolite treatment correlates positively with a MET transcriptional response
and increased frequency of reprogramming progression to the maturation phase (Chapter
4). However, exogenous growth factor/cytokine supplementation alone was not suitable
to stabilize canine reprogramming intermediates (Chapter 4).
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Pluripotency maturation is the greatest obstacle to successful reprogramming because it
depends on the rare and probabilistic activation of previously silent genomic regions.
Reactivation of pluripotency-associated loci during iPSC maturation is reversible and
sustained transcriptional output is dependent on the recruitment of chromatin modifying
enzymes to important CRMs (Teshigawara et al., 2016). The ability of a given region to
recruit histone or DNA modifying enzymes that support or oppose reprogramming is
partly dependent on the composition of the local genomic sequence (Behera et al., 2018;
Carcamo-Orive et al., 2017). We have assessed the conservation of CpG-sequence
richness among 1:1:1 orthologues that are differentially expressed during primate and
rodent reprogramming. A subset of promoters with substantial gains in CpG-sequence
richness were identified as potentially unique to the canine genome assembly (Chapter 4).
These sequence features are distinct from other Laurasiatherian mammals (e.g. pig, cow)
and therefore are more likely to be a consequence of canid evolution (Chapter 4). It is
tempting to speculate that localized gains in CpG-richness would increase the affinity and
grant regulatory control to specific enzyme classes containing CpG DNA binding
domains (e.g. CXXC, MDB) domains such as DNMTs, TETs and components of
polycomb group repressive complexes (Du Q et al., 2015; Risner et al., 2013). However,
we are limited in the scope of this investigation to shared orthologues selected from
genome-wide sequencing experiments from a different clade of placental mammals.
Future studies should prioritize unbiased identification of genes predictive of the
establishment and maintenance of different canine pluripotent states. In this regard, a
comparative transcriptomic approach between dissected canine preimplantation embryos
(e.g. embryonic ICM or epiblast) as well as cESC cultures approximating different
pluripotent states would identify both divergent and conserved molecular determinants of
canine pluripotency (Bernardo et al., 2018).
Complicating the study of iPSC maturation is high biological variation caused by nonhierarchical gene activation and clonal dominance effects (Kuno et al., 2018; Tanabe et
al., 2013). To address this challenge, strategies are required to enrich for cells exhibiting
early pluripotency characteristics. The inclusion of additional transfactors such as LIN28
and NANOG alongside O-K-S-M has been shown to increase reprogramming efficiency
or overcome age-related cellular senescence in donor cells (Lapasset et al., 2011; Liao et
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al., 2008). It is believed that LIN28 and NANOG function independent of cell division
kinetics by co-targeting pluripotency-associated CRMs and facilitating both
combinatorial and cooperative TF binding to stably reactivate endogenous pluripotency
loci (Hanna et al., 2009). Although, this approach increases the probability of
reprogramming intermediates reaching the maturation phase, it does not guarantee
deterministic reprogramming. Hence, biological heterogeneity would be expected to
persist and confound the identification of endogenous gene sets and processes important
for the completion of iPSC maturation.
MET-associated transcriptional response in early canine reprogramming implicates
several gene products localized to the cell surface. Sorting and enrichment of cell
populations based on epithelial or mesenchymal surface markers using FACS will
deconvolute the heterogeneity among the mixture of productively reprogramming canine
cell populations and alternative cell fates. Intermediate subpopulations undergoing a
productive reprogramming trajectory have been successfully isolated by monitoring the
loss of somatic surface markers and concomitant gain of epithelial surface markers
(Nefzger et al., 2015; Polo et al., 2012). This approach will allow us to dissect the
pathways and processes active in productively reprogramming versus refractory cell
populations (Fig. 5-3).
To this end, I have validated canine-reactive antibodies against glycoprotein epitopes
characteristic of mesenchymal cell types. Canine fibroblast populations are immunoreactive to mesenchymal surface markers such as the CD90/THY1 and CD44/ECMR-III
(Fig. 5-4A). These antigens are uniformly present (>98%) on fibroblast cultures, but only
CD90/THY1 is absent from control epithelial cell line MDCK-II and hence apparently
specific to the mesenchymal state (Fig. 5-4B). In contrast, the epithelial adhesion protein
CD324/CDH1 level is elevated in MDCK-II compared to fibroblasts (Fig. 5-4B).
CD324/CDH1 was significantly induced by AA/RA treatment at 6 DPI by reverse
transcription qPCR using commercial and custom oligonucleotide primers (Chapter 4). I
predict that CD90/THY1 and CD324/CDH1 will serve as selectable markers to
discriminate between epithelial and mesenchymal cells, among the heterogeneous
intermediates in early canine reprogramming for detailed molecular analyses.
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Figure 5-3. Strategy to investigate conserved and divergent reprogramming
mechanisms in the dog.
(A) Initiation and maturation phases of reprogramming are reversible and dependent on
reprogramming factor expression. Stabilization of induced pluripotency relies on
currently unknown extrinsic signals that are distinct from those involved in pluripotency
maintenance.

(B)

Putative

canine-reactive

antibodies

for

mesenchymal

(e.g.

CD44/ECMR-III, CD90/THY1) or epithelial (e.g. CD324/CDH1) glycoprotein antigens
may be applied to enrich for productively reprogramming intermediate cells that have
undergone mesenchymal-to-epithelial transition. Comparison of productive and
refractory reprogramming intermediates will identify gene products and processes
important to canine reprogramming. Interspecies differences may be elucidated by
comparing these datasets to publicly available human and mouse reprogramming studies
at matched reprogramming timepoints.
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Figure 5-4. Validation of canine-reactive surface markers to discriminate
mesenchymal or epithelial canine cells.
Representative direct immunofluorescence images in canine fetal fibroblast for
extracellular matrix

receptor III (CD44/ECMR-III) and thymus

cell antigen

(CD90/THY1). Scale bar unit length is 50 µm. (B) Representative overlay histograms of
canine fetal fibroblast (cFF) and Madin Darby Canine Kidney (MDCK-II) epithelial cell
line stained with CD44, CD90 or epithelial cadherin (CDH1/CD324).
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5.3 Summary
Pluripotency and self-renewal are widely presumed to be conserved features of the inner
cell mass and epiblast of mammalian embryos. Environmental stimuli change
dynamically during early development and so these distinct pluripotent cell populations
rely on variations of core gene regulatory mechanisms and metabolic activities. This
ensures that pluripotent cells are to undergo robust symmetric self-renewal, while
remaining poised for embryonic lineage specification. Evolutionary divergence in
reproductive physiology and early developmental progression lead to species-specific
pluripotent cell attributes, which will also likely alter the molecular roadmaps to an
induced pluripotent state. My discovery that cESC may adopt molecularly distinct
phenotypes with metabolic requirements mirroring primed and naïve pluripotent states
advances the knowledge of conserved pluripotent state regulators. In summary, this thesis
expands on the influence of the culture environment on phenotypic plasticity exhibited by
cESCs and canine reprogramming intermediates.

5.4
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Appendix A: Materials and Methods for cell surface marker
validation
Immunolabeling for Fluorescence Microscopy
For fluorescence microscopy, cells were stained for 1 hour with CD44-PE (1:100) or
CD90-PE (1:50) diluted in a 3% BSA staining solution. Table A-1 contains primary
antibody information. Cells were imaged on the stage of a Leica DMI 6000B microscope.
Digital images were captured with an Orca Flash camera (Hamamatsu Photonics) and
Application Suite X software (Leica Microsystems). Brightness and contrast were
standardized to isotype stained samples and the equivalent imaging parameters were
applied to all other images using ImageJ (National Institutes of Health, MD).

Table 0-1. Primary antibody information for flow cytometry.
Antibody
Anti-CD44 (IM7)
Anti-CD90 (YKIX337.217)
Anti-CD324 (DECMA-1)
Rat IgG Isotype Control
Rat IgG Isotype Control

Fluorochrome
PE
PE
FITC
PE
FITC

Supplier (Catalog)
Thermo Fisher (12-0441-82)
Thermo Fisher (12-5900-42)
Thermo Fisher (14-3249-82)
Thermo Fisher (12-4031-82)
Thermo Fisher (11-4321-80)

Immunolabeling for Flow Cytometry
For flow cytometry, cells were collected by a cell scraper after treating with enzyme-free
cell dissociation buffer containing EDTA for 5 min at 37 °C, and was treated TrypLE
enzyme for 6 minutes at 37 °C. Single live cells in suspension were filtered through a 70μm strainer adjusted to a density of approximately 1 x106 cells/mL in staining buffer (1%
bovine serum albumin, 0.075% Sodium Azide) and incubated with CD90-PE (1:50) or
CD44-PE (1:100) and CD324 (1:25) for 1 hour protected from light. Cells were washed
twice with staining buffer, transferred to a polystyrene tube and stained with 7-AAD
reagent to exclude dead cells. Events were recorded using the Accuri C6 platform (BD
Bioscience) using standard laser configuration, a flow rate of 35 μL/minute and the
following optical filters: 533/30 (FL-1), 585/40 (FL-2), 670 LP (FL-3) and 675/25 (FL-
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4). Single colour or fluorescence minus one control samples containing an equivalent
volume of diluent were included to set analyses gates and to threshold background
autofluorescence. Briefly, the single-cell population was isolated by pulse processing
(pulse height vs. pulse area) for further interrogation. Samples stained with the
appropriate isotype control were used to determine non-specific antibody binding.
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